<SEC-DOCUMENT>0001295345-15-000202.txt : 20150807
<SEC-HEADER>0001295345-15-000202.hdr.sgml : 20150807
<ACCEPTANCE-DATETIME>20150807115339
ACCESSION NUMBER:		0001295345-15-000202
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20150630
FILED AS OF DATE:		20150807
DATE AS OF CHANGE:		20150807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZAXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		151035947

	BUSINESS ADDRESS:	
		STREET 1:		7 IMBER STREET
		CITY:			PETACH TIVKA
		STATE:			L3
		ZIP:			4951141
		BUSINESS PHONE:		97237444505

	MAIL ADDRESS:	
		STREET 1:		7 IMBER STREET
		CITY:			PETACH TIVKA
		STATE:			L3
		ZIP:			4951141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFERGENE CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zxsi06302015.htm
<DESCRIPTION>FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2015
<TEXT>
<html>
<body>
<div style="text-align: left">

<hr SIZE="4" NOSHADE COLOR="#000000">

<hr SIZE="2" NOSHADE COLOR="#000000">

	<div style="text-align: center">

<b><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="4">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
</font><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="3">Washington, D.C. 20549<br>
</font></b><font SIZE="4" FACE="Times New Roman, Times, Serif">___________________<br>
<br>
<strong>FORM 10-Q<br>
</strong>___________________</font></div>
	</p>

<p style="MARGIN: 0in 0in 0pt 0.5in; COLOR: windowtext; TEXT-INDENT: -0.5in"
align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 12pt" face="Wingdings"
size="3">&#253</font><font style="FONT-WEIGHT: bold; FONT-SIZE: 3pt" size="1">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font><font style="FONT-WEIGHT: bold; FONT-SIZE: 12pt" size="3">QUARTERLY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></b></p>

<p style="MARGIN: 0in 0in 0pt; COLOR: windowtext" align="center"><font size="1">&nbsp; </font></p>

<p style="MARGIN: 0in 0in 0pt; COLOR: windowtext; TEXT-ALIGN: center" align="center"><font
style="FONT-SIZE: 10pt" face="Times New Roman" size="2">For the quarterly period ended
June 30, 2015</font></p>

<p style="MARGIN: 0in 0in 0pt; COLOR: windowtext" align="center"><font size="1">&nbsp;&nbsp;
</font></p>

<p style="FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; COLOR: windowtext; TEXT-ALIGN: center"
align="center"><font style="FONT-SIZE: 10pt" face="Times New Roman" size="2">Commission
file number: 0-15476</font></p>

<p style="FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; COLOR: windowtext; TEXT-ALIGN: center"
align="center"><font size="1">&nbsp; </font></p>

<p style="FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; COLOR: windowtext; TEXT-ALIGN: center"
align="center">&nbsp;</p>

	<div style="text-align: center">

<font face="TIMES NEW ROMAN, TIMES, SERIF" size="5"><b><u>ZAXIS
INTERNATIONAL INC.</u><br>
</b></font><font face="TIMES NEW ROMAN, TIMES, SERIF" size="1">(Exact Name Of Registrant
As Specified In Its Charter)</font>&nbsp;</div>
	</p>

<table border="0" cellpadding="0" cellspacing="0" width="100%">
  <tr>
    <td width="50%" align="center"><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>Delaware</u></font></td>
    <td width="50%" align="center"><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>68-0080601</u></font></td>
  </tr>
  <tr>
    <td width="50%" align="center" bgcolor="#ffffff"><font size="1">(State of Incorporation)</font></td>
    <td width="50%" align="center" bgcolor="#ffffff"><font size="1">(I.R.S. Employer
    Identification No.)</font></td>
  </tr>
  <tr>
    <td width="50%" align="center"><font size="1">&nbsp; </font></td>
    <td width="50%" align="center"><font size="1">&nbsp; </font></td>
  </tr>
  <tr>
    <td width="50%" align="center">
	<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>7 Imber Street,
	Petach Tivka, Israel</u></font></td>
    <td width="50%" align="center">
	<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><u>4951141</u></font></td>
  </tr>
  <tr>
    <td width="50%" align="center" bgcolor="#ffffff"><font size="1">(Address of Principal
    Executive Offices)</font></td>
    <td width="50%" align="center" bgcolor="#ffffff"><font size="1">(ZIP Code)</font></td>
  </tr>
</table>

	&nbsp;<p style="text-align: center"><font SIZE="2">Registrant's
Telephone Number, Including Area Code: (972) 3-744-4505</font></p>

	<div style="text-align: left">

<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2">Indicate by check
mark whether the registrant (1) has filed all reports required to be filed by Section 13
or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days.&nbsp;Yes&nbsp;</font><font
size="2" FACE="WINGDINGS">&#120</font><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2">&nbsp;No&nbsp;</font><font
size="2" FACE="WINGDINGS">&#168</font><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><br>
</font><font size="2">Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). </font><font
FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2">Yes&nbsp;</font><font size="2"
FACE="WINGDINGS">&#120</font><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2">&nbsp;No&nbsp;</font><font
size="2" FACE="WINGDINGS">&#168</font></div>
	</p>

<font
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check
mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer </font><font style="FONT-SIZE: 10pt" face="Times New Roman" size="2">(as
defined in Rule&nbsp;12b-2 of the Exchange Act)</font><font
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> or a smaller
reporting company.<br></font>

<table border="0" cellpadding="0" cellspacing="0" width="100%">
  <tr>
    <td width="25%" align="center"><font
    style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Large accelerated
    filer <font style="FONT-FAMILY: Wingdings">&#168</font></font></td>
    <td width="25%" align="center"><font
    style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Accelerated filer <font
    style="FONT-FAMILY: Wingdings">&#168</font></font></td>
    <td width="25%" align="center"><font
    style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Non-Accelerated
    filer <font style="FONT-FAMILY: Wingdings">&#168</font></font></td>
    <td width="25%" align="center"><font
    style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Smaller reporting
    company </font><font face="WINGDINGS" size="2">&#120</font></td>
  </tr>
</table>

<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="2"><br>On August 7, 2015,
the Registrant had 13,589,905 shares of common stock outstanding.</font></p>

<hr SIZE="2" NOSHADE COLOR="#000000">

<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always'>

<hr NOSHADE SIZE="5">
<font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="3">

<hr SIZE="1" NOSHADE COLOR="#000000">
</font>

&nbsp;</p>

	<div style="text-align: center">

		<strong><font size="2"><a name="TABLE_OF_CONTENTS">TABLE OF CONTENTS</a></font></strong></div>
	</p>

<table ALIGN="CENTER" CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="100%" height="68">
  <tr VALIGN="BOTTOM">
    <th nowrap ALIGN="LEFT" height="55"><font size="2">Item</font><hr SIZE="1" NOSHADE
    COLOR="#000000" ALIGN="left">
    </th>
    <th height="55"></th>
    <th nowrap ALIGN="LEFT" height="55"><font size="2">Description</font><hr SIZE="1" NOSHADE
    COLOR="#000000" ALIGN="left">
    </th>
    <th COLSPAN="3" nowrap height="55"><font size="2">Page</font><hr SIZE="1" NOSHADE
    COLOR="#000000" WIDTH="60%">
    </th>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="75%" bgcolor="#ffffff" style="text-align: center; height: 1px;"><font size="2"><strong>PART
    I - FINANCIAL INFORMATION</strong></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 1.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_1.&nbsp;FINANCIAL_STATEMENTS">FINANCIAL STATEMENTS</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">3</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 2.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_2._MANAGEMENTS_DISCUSSION_AND_ANALYSIS_AND_PLAN_OF_OPERATION">MANAGEMENT'S
    DISCUSSION AND ANALYSIS AND PLAN OF OPERATION</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">13</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 3.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_3._QUANTITATIVE_AND_QUALITATIVE_DISCLOSURES_ABOUT_MARKET_RISK">QUANTITATIVE
    AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">17</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 4.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_4._CONTROLS_AND_PROCEDURES">CONTROLS AND PROCEDURES</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="75%" bgcolor="#ffffff" style="text-align: center; height: 1px;"><font size="2"><strong>PART
    II - OTHER INFORMATION</strong></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 1.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_1._LEGAL_PROCEEDINGS">LEGAL PROCEEDINGS</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 1A.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_1A._RISK_FACTORS">RISK FACTORS</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 2.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_2._UNREGISTERED_SALES_OF_EQUITY_SECURITIES_AND_USE_OF_PROCEEDS">UNREGISTERED
    SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 3.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_3.&nbsp;DEFAULTS_UPON_SENIOR_SECURITIES">DEFAULT UPON SENIOR SECURITIES</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 4.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_4.&nbsp;MINE_SAFETY_DISCLOSURE_">MINE SAFETY DISCLOSURE</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 5.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_5.&nbsp;OTHER_INFORMATION">OTHER INFORMATION</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
  <tr>
    <td ALIGN="left" WIDTH="12%" bgcolor="#ffffff" style="height: 1px"><font size="2">ITEM 6.</font></td>
    <td WIDTH="3%" bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="left" WIDTH="75%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
	<a href="#ITEM_6.&nbsp;EXHIBITS">EXHIBITS</a></font></td>
    <td WIDTH="5%" ALIGN="RIGHT" nowrap bgcolor="#ffffff" style="height: 1px"></td>
    <td ALIGN="RIGHT" bgcolor="#ffffff" style="height: 1px"><font size="2">16</font></td>
    <td WIDTH="5%" ALIGN="LEFT" bgcolor="#ffffff" style="white-space: nowrap; height: 1px;"></td>
  </tr>
</table>

<p>&nbsp;</p>
<b><font FACE="TIMES NEW ROMAN, TIMES, SERIF" SIZE="3">

<hr SIZE="1" NOSHADE COLOR="#000000">
</font></b>

<hr NOSHADE SIZE="5">
<p Style='page-break-before:always; text-align: center;'>

<font size="2"><b>PART I - FINANCIAL INFORMATION</b></font></p>

<font size="2"><a name="ITEM_1.&nbsp;FINANCIAL_STATEMENTS">ITEM
1.&nbsp;FINANCIAL STATEMENTS</a> </font><font size="1">
	<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a><br><p>

<table border="0" cellpadding="0" cellspacing="0" width="100%">
  <tr>
    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><td
    width="98%"><font size="2">&nbsp;&nbsp;&nbsp; <a href="#Balance_Sheets_">Balance Sheets -
      June 30, 2015 (Unaudited) and December 31, 2014</a></font></td>
    <td width="2%" align="center"><font size="2">3</font></td>
  </tr>
  <tr>
      <td
    width="98%"><font size="2">&nbsp;&nbsp;&nbsp;
	  <a href="#Statements_of_Operations_">Statements
    of Operations - Three and Six Months Ended June 30, 2015 and 2014 (Unaudited)</a></font></td>
    <td width="2%" align="center"><font size="2">4</font></td>
  </tr>
  <tr>
      <td
    width="98%"><font size="2">&nbsp;&nbsp;&nbsp;
	  <a href="#Statements_of_Cash_Flows_">Statements
    of Cash Flows - Six Months Ended June 30, 2015 and 2014 (Unaudited)</a></font></td>
    <td width="2%" align="center"><font size="2">5</font></td>
  </tr>
  <tr>
      <td
    width="98%"><font size="2">&nbsp;&nbsp;&nbsp;
	  <a href="#Notes_to_Unaudited_Interim_Financial_Statements_">Notes to Unaudited Interim
    Financial Statements</a></font></td>
    <td width="2%" align="center"><font size="2">6</font></td>
  </tr>

	</font>
</table>

	</font>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

&nbsp;</p>

<table style="BORDER-BOTTOM: rgb(0,0,0) 1px" height="0%" cellSpacing="0" cellPadding="0"
width="100%" border="0">
  <tr>
    <td vAlign="middle" width="100%" colspan="5" align="center" bgcolor="#FFFFFF" style="height: 1px"><font
    size="2"><b>Zaxis International Inc.</b></font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="100%" colspan="5" align="center" style="height: 1px"><font size="2">
	<a name="Balance_Sheets_">Balance Sheets </a> </font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="100%" colspan="5" align="center" style="height: 1px"><font size="1">
	<a href="#ITEM_1.&nbsp;FINANCIAL_STATEMENTS">Back to Table of Contents</a></font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="1">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="1"><strong>
	June 30,
    2015</strong></font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="1">(Unaudited)</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="1"><strong>December 31, 2014</strong></font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="text-align: center; height: 1px;"><font size="2">ASSETS</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">Current assets:</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">&nbsp;&nbsp;
    Cash</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 1px; height: 1px;" vAlign="middle" align="right" width="2%" bgcolor="#FFFFFF"><font size="2">$</font></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%" bgcolor="#FFFFFF"><font size="2">
	467,380</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 1px; height: 1px;" vAlign="middle" align="right" width="2%" bgcolor="#FFFFFF"><font size="2">$</font></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%" bgcolor="#FFFFFF"><font size="2">1,000</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">&nbsp;&nbsp;
    &nbsp;&nbsp; Total current assets</font></td>
    <td style="border-bottom: 1px none rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="2%" bgcolor="#FFFFFF"></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%" bgcolor="#FFFFFF">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	467,380</font></td>
    <td style="border-bottom: 0px solid rgb(0,0,0); height: 0px;" vAlign="middle" align="right" width="2%" bgcolor="#FFFFFF"></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%" bgcolor="#FFFFFF">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	1,000</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%"
    style="border-bottom: 0px solid rgb(0,0,0); height: 1px;"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">&nbsp; </font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" bgcolor="#fffff" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Total Assets</font></td>
    <td vAlign="middle" align="right" width="2%" bgcolor="#fffff" style="height: 1px"><font size="2">$</font></td>
    <td vAlign="middle" align="right" width="13%" bgcolor="#fffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	467,380</font></td>
    <td vAlign="middle" align="right" width="2%" bgcolor="#fffff"
    style="border-bottom: 2px none rgb(0,0,0); height: 1px;"><font size="2">$</font></td>
    <td vAlign="middle" align="right" width="13%" bgcolor="#fffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	1,000</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px; text-align: center;"><font size="2">LIABILITIES
    AND STOCKHOLDERS' EQUITY</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">Current liabilities:</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2"></font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Accounts payable
	and accrued liabilities</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2">$</font></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">-</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2">$</font></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">7,500</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Advances
	payable</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">
	120,979</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Accrued
	interest payable</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">35,305</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">&nbsp;&nbsp;
    &nbsp;&nbsp; Total current liabilities</font></td>
    <td vAlign="middle" align="right" width="2%" bgcolor="#FFFFFF" style="height: 1px"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%" bgcolor="#FFFFFF"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td vAlign="middle" align="right" width="2%" bgcolor="#FFFFFF"
    style="border-bottom: 1px none rgb(0,0,0); height: 1px;"><font size="2"></font></td>
    <td vAlign="middle" align="right" width="13%" bgcolor="#FFFFFF"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">163,784</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">Long-term liabilities:</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Notes
	payable</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">22,375</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Total
    long-term liabilities</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	22,375</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" bgcolor="#fffff" style="height: 1px"><font size="2">&nbsp;&nbsp;
    &nbsp;&nbsp; Total liabilities</font></td>
    <td vAlign="middle" align="right" width="2%" bgcolor="#fffff" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" bgcolor="#fffff"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td vAlign="middle" align="right" width="2%" bgcolor="#fffff"
    style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td vAlign="middle" align="right" width="13%" bgcolor="#fffff"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">186,159</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">Stockholders'
	equity (deficit):</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Preferred stock,
    $0.0001 par value; 10,000,000 shares authorized; none issued</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Common stock,
    $0.0001 par value; 100,000,000 shares authorized; </font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">-</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">-</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;6,550,602 shares issued and outstanding at
	June 30, 2015 and December 31, 2014</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px">
	<font size="2">655</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">455</font></td>
  </tr>
    <tr>
    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Stock
	payable</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">
	385,000</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">-</font></td>
  	  </font>
	</tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Additional paid in
    capital</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">
	1,283,342</font></td>
    <td vAlign="middle" align="right" width="2%" style="height: 1px"></td>
    <td vAlign="middle" align="right" width="13%" style="height: 1px"><font size="2">
	388,450</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Accumulated deficit</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 1px; height: 1px;" vAlign="middle" align="right" width="2%"></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%"><font size="2">(1,201,617)</font></td>
    <td style="border-bottom: 0px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="2%"></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%"><font size="2">(574,064)</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Total
    stockholders' equity (deficit)</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 1px; height: 1px;" vAlign="middle" align="right" width="2%"></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%"><font size="2">
	467,380</font></td>
    <td style="border-bottom: 0px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="2%"></td>
    <td style="border-bottom: 1px solid rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%"><font size="2">(185,159)</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="70%" bgcolor="#fffff" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Total liabilities and stockholders' equity</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 2px; height: 1px;" vAlign="middle" align="right" width="2%" bgcolor="#fffff"><font size="2">$</font></td>
    <td style="border-bottom: 2px double rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%" bgcolor="#fffff"><font size="2">
	467,380</font></td>
    <td style="border-bottom: 2px none rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="2%" bgcolor="#fffff"><font size="2">$</font></td>
    <td style="border-bottom: 2px double rgb(0,0,0); height: 1px;" vAlign="middle" align="right" width="13%" bgcolor="#fffff"><font size="2">1,000</font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="100%" bgcolor="#FFFFFF" colspan="5" style="height: 1px"><font size="2">&nbsp;
    </font></td>
  </tr>
  <tr>
    <td vAlign="middle" width="100%" height="0" bgcolor="#FFFFFF" colspan="5"><font size="2">See
    notes to unaudited interim financial statements</font></td>
  </tr>
</table>
<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always; text-align: center;'>
<table height="1" cellSpacing="0" cellPadding="0" width="100%" border="0">
  <tr>
    <td width="100%" colspan="9" align="center" bgcolor="#ffffff" style="height: 1px"><font size="2"><b>Zaxis
    International Inc.</b></font></td>
  </tr>
  <tr>
    <td width="100%" colspan="9" align="center" style="height: 1px"><font size="2">
	<a name="Statements_of_Operations_">Statements of Operations </a> </font></td>
  </tr>
  <tr>
    <td width="100%" colspan="9" align="center" style="height: 1px">
    <font size="1">
	<a href="#ITEM_1.&nbsp;FINANCIAL_STATEMENTS">Back to Table of Contents</a></font></td>
  </tr>
  <tr>
    <td width="100%" colspan="9" style="height: 1px"><font size="2">&nbsp; </font></td>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Three Months</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Three Months</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Six Months</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Six Months</strong></font></td>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Ended</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Ended</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Ended</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Ended</strong></font></td>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>June 30, 2015</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>June 30, 2014</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>June 30, 2015</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>June 30, 2014</strong></font></td>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="1">(Unaudited)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="1">(Unaudited)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="1">(Unaudited)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="1">(Unaudited)</font></td>
  </tr>
  <tr>
    <td width="40%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
    <td width="2%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
    <td width="13%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
    <td width="2%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
    <td width="13%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
    <td width="2%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
    <td width="13%" bgcolor="#FFFFFF" align="right" style="height: 1px"></td>
  </tr>
  <tr>
    <td width="40%" bgcolor="#ffffff" style="height: 1px"><font size="2">Revenue</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="border-bottom: 2px none rgb(0,0,0); height: 1px;"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right" style="height: 1px">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right" style="height: 1px">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right" style="height: 1px">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right" style="height: 1px">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">Costs and expenses:</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">&nbsp;&nbsp; General and administrative</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">88,390</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">6,500</font></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">132,326</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">14,250</font></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">&nbsp;&nbsp; Other
	expenses - advances to related party</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">300,000</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">490,000</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">2,678</font></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">Total operating expenses</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">388,390</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">6,500</font></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">622,326</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">16,928</font></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
    <tr>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="40%" style="height: 1px"><font size="2">&nbsp;&nbsp; (Loss) from
	operations</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(388,390)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(6,500)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(622,326)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(14,250)</font></td>
    	</font>
	</tr>
	<tr>
    <td width="40%" style="height: 1px">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">&nbsp; </font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
		</td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
		</td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
		</td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
		</td>
    </tr>
	<tr>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="40%" style="height: 1px"><font size="2">&nbsp;&nbsp; Interest
	expense</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(1,688)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(307)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(4,699)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font
    size="2">(2,678)</font></td>
    	</font>
	</tr>
	<tr>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="40%" style="height: 1px"><font size="2">&nbsp;&nbsp; Gain on
	debt settlement</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">(528)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">(528)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    	</font>
	</tr>
	<tr>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="40%" style="height: 1px"><font size="2">Financial income
	(expense)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">(2,216)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">(307)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">(5,277)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	(2,678)</font></td>
    	</font>
	</tr>
  <tr>
    <td width="40%" style="height: 1px">&nbsp;&nbsp;</td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
  </tr>
    <tr>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="40%" style="height: 1px"><font size="2">Provision for income
	taxes</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    	</font>
	</tr>
  <tr>
    <td width="40%" style="height: 1px">&nbsp;&nbsp;</td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
  </tr>
  <tr>
    <td width="40%" bgcolor="#ffffff" style="height: 1px"><font size="2"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </strong>Net (loss)</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="border-bottom: 2px none rgb(0,0,0); height: 1px;"><font size="2">$</font></td>
    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">(390,606)</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"><font size="2">$</font></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">(6,807)</font></td>
      </font>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">(627,553)</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"><font size="2">$</font></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">(16,928)</font></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">Basic and diluted per share amounts:</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">Basic and diluted net loss</font></td>
    <td width="2%" align="right" style="border-bottom: 1px none rgb(0,0,0); height: 1px;"><font
    size="2">$</font></td>
    <td width="13%" align="right" style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font
    size="2">(0.08)</font></td>
    <td width="2%" align="right" style="height: 1px"><font size="2">$</font></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font
    size="2">(0.00)</font></td>
      </font>
    <td width="2%" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" align="right" style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font
    size="2">(0.13)</font></td>
    <td width="2%" align="right" style="height: 1px"><font size="2">$</font></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font
    size="2">(0.01)</font></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="40%" style="height: 1px"><font size="2">Weighted average shares outstanding</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="40%" bgcolor="#ffffff" style="height: 1px"><font size="2">Basic and diluted</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="border-bottom: 2px none rgb(0,0,0); height: 1px;"></td>
    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">
	4,682,407</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">1,695,126</font></td>
      </font>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"></td>
    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">
	4,682,407</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"></td>
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="13%" align="right" bgcolor="#ffffff"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">1,695,126</font></td>
      </font>
  </tr>
  <tr>
    <td width="100%" bgcolor="#FFFFFF" colspan="9" style="height: 1px"><font size="2">&nbsp; </font></td>
  </tr>
  <tr>
    <td width="100%" height="0" bgcolor="#FFFFFF" colspan="9"><font size="2">See notes to
    unaudited interim financial statements.</font></td>
  </tr>
</table>
	<font size="2" face="Times New Roman">

<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always; text-align: center;'>

<table cellSpacing="0" cellPadding="0" width="100%" border="0" height="1">
  <tr>
    <td width="101%" colspan="5" align="center" bgcolor="#ffffff" style="height: 1px"><font size="2"><b>Zaxis
    International Inc.</b></font></td>
  </tr>
  <tr>
    <td width="101%" colspan="5" align="center" style="height: 1px"><font size="2">
	<a name="Statements_of_Cash_Flows_">Statements of Cash Flows </a> </font></td>
  </tr>
  <tr>
    <td width="101%" colspan="5" align="center" style="height: 1px"><p align="center">
	<font size="1">
	<a href="#ITEM_1.&nbsp;FINANCIAL_STATEMENTS">Back to Table of Contents</a></font></td>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Six Months</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>&nbsp;Six Months</strong></font></td>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Ended</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>Ended</strong></font></td>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>June 30, 2015</strong></font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="1"><strong>June 30, 2014</strong></font></td>
  </tr>
  <tr>
    <td width="70%" style="height: 1px">&nbsp; </td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="1">(Unaudited)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="1">(Unaudited)</font></td>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">Cash flows from operating activities:</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
  </tr>
  <tr>
    <td width="70%" bgcolor="#ffffff" style="height: 1px"><font size="2">Net (loss)</font></td>
    <td width="2%" align="right" bgcolor="#ffffff" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" align="right" bgcolor="#ffffff" style="height: 1px"><font size="2">(627,533)</font></td>
    <td align="right" width="2%" bgcolor="#ffffff" style="height: 1px"><font size="2">$</font></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" bgcolor="#ffffff" style="height: 1px"><font size="2">(16,928)</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">Loss (gain) on debt settlement</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">528</font></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">Adjustments to reconcile net (loss) to
	net cash (used
    in) operating activities:</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
    <tr>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Imputed interest</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">4,113</font></td>
    <td align="right" width="2%" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    	</font>
	</tr>
	<tr>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; (Decrease) increase
	in accounts payable</font></td>
    	</font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">(7,500)</font></td>
    	</font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td align="right" width="2%" style="height: 1px"></td>
        </font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    	</font>
	</tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; (Decrease) increase in accrued
	expenses</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">(35,833)</font></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">9,178</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
	Net cash used in operating activities</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"></td>
    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">(666,245)</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 1px; height: 1px;" align="right" width="2%"
    bgcolor="#ffffff"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">(7,750)</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; </font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">Cash flows from financing activities:</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">&nbsp;&nbsp; Advances from related party</font></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td align="right" width="2%" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">7,500</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">&nbsp;&nbsp;
	Principal payments on debt</font></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="2%" align="right" style="height: 1px"></td>
      </font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	(52,375)</font></td>
      </font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td align="right" width="2%" style="height: 1px"></td>
      </font>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp; Proceeds from sale of
	common stock (net of issuance expenses)</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font
    size="2">1,185,000</font></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" bgcolor="#ffffff" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
	Net cash provided by financing activities</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"></td>
    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">1,132,625</font></td>
    <td align="right" width="2%" bgcolor="#ffffff" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font size="2">7,750</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">&nbsp; </font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Net
	increase (decrease) in cash</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">466,380</font></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">Cash and cash equivalents - beginning of period</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><font
    size="2">1,000</font></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" bgcolor="#ffffff" style="height: 1px"><font size="2">Cash
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	and cash equivalents </font>- end of period</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">
	467,380</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 2px; height: 1px;" align="right" width="2%"
    bgcolor="#ffffff"><font size="2">$</font></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="70%" style="height: 1px"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Non-cash transactions:</font></td>
    <td width="2%" align="right" style="height: 1px"></td>
    <td width="13%" align="right" style="height: 1px"></td>
    <td align="right" width="2%" style="height: 1px"></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" align="right" style="height: 1px"></td>
      </font>
  </tr>
  <tr>
    <td width="70%" bgcolor="#ffffff" style="height: 1px"><font size="2">Transfer of convertible note
    from related party to unrelated parties</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 2px; height: 1px;" align="right" width="2%"
    bgcolor="#ffffff"><font size="2">$</font></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">85,000</font></td>
      </font>
  </tr>
  <tr>
    <td width="70%" bgcolor="#ffffff" style="height: 1px"><font size="2">Transfer of advances from
    related party to unrelated party</font></td>
    <td width="2%" bgcolor="#ffffff" align="right" style="height: 1px"><font size="2">$</font></td>
    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;">
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">-</font></td>
    <td style="BORDER-BOTTOM: rgb(0,0,0) 2px; height: 1px;" align="right" width="2%"
    bgcolor="#ffffff"><font size="2">$</font></td>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="13%" bgcolor="#ffffff" align="right"
    style="border-bottom: 2px double rgb(0,0,0); height: 1px;"><font size="2">40,000</font></td>
      </font>
  </tr>
  <tr>
    <td width="100%" bgcolor="#FFFFFF" colspan="5" style="height: 1px"><font size="2">&nbsp; </font></td>
  </tr>
  <tr>
    <td width="100%" bgcolor="#FFFFFF" colspan="5" style="height: 1px"><font size="2">See notes to
    unaudited interim financial statements</font></td>
  </tr>
</table>
<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always; text-align: center;'>


<font size="2"><b>Zaxis International Inc.</b><br>
<a name="Notes_to_Unaudited_Interim_Financial_Statements_">Notes to Unaudited Interim
Financial Statements</a><br>
June 30, 2015<br>
<font size="1"><a href="#ITEM_1.&nbsp;FINANCIAL_STATEMENTS">Back to Table of Contents</a></font></p>

<p><font size="2"><b>Note 1. The Company</b></p>

<p><i>Organizational Background:</i>&nbsp;&nbsp; Emerald Medical Applications
Corp. (&quot;the Company&quot;) (f/k/a Zaxis International Inc.) was incorporated in Ohio
in 1989. On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene
Company (&quot;InFerGene&quot;) and InFerGene changed its name to Zaxis International Inc.
InFerGene was incorporated in California in 1984 and subsequently changed its
domicile in connection with the merger into Zaxis to Delaware in 1985.
Operations ceased operations in 2002. In November 2002, the Company and its
subsidiaries filed a petition for bankruptcy in the U.S. Bankruptcy Court
Northern District of Ohio. On October 13, 2004, the Company emerged from
bankruptcy. At present, the Company has no business operations and is deemed to
be a shell company.</p>
	<p><i>Basis of Presentation:</i>&nbsp;&nbsp; The accompanying financial
	statements have been prepared in conformity with accounting principles
	generally accepted in the United States of America, which contemplate
	continuation of the Company as a going concern. The Company has not
	established any source of revenue to cover its operating costs, and as such,
	has incurred an operating loss since inception. Further, as of June 30,
	2015, the cash resources of the Company were insufficient to meet its
	current business plan, and the Company had negative working capital. These
	and other factors raise substantial doubt about the Company's ability to
	continue as a going concern. The accompanying financial statements do not
	include any adjustments to reflect the possible future effects on the
	recoverability and classification of assets or the amounts and
	classification of liabilities that may result from the possible inability of
	the Company to continue as a going concern.</p>
	<p><i>Significant Accounting Policies</i></p>
	<p><i>Use of Estimates:</i>&nbsp;&nbsp; The preparation of financial statements
	in conformity with generally accepted accounting principles requires
	management to make estimates and assumptions that affect reported amounts of
	assets and liabilities and disclosure of contingent assets and liabilities
	at the date of the financial statement and the reported amounts of revenues
	and expenses during the reporting period. Actual results could differ from
	the estimates.</p>
	<p><i>Cash and Cash Equivalents:</i>&nbsp;&nbsp; For financial statement
	presentation purposes, the Company considers those short-term, highly liquid
	investments with original maturities of three months or less to be cash or
	cash equivalents. There were no cash equivalents as of June 30, 2015 and
	December 31, 2014.</p>
	<p><i>Property and Equipment:</i>&nbsp;&nbsp; New property and equipment are
	recorded at cost. Depreciation is computed using the straight-line method
	over the estimated useful lives of the assets, generally 5 years.
	Expenditures for renewals and betterments are capitalized. Expenditures for
	minor items, repairs and maintenance are charged to operations as incurred.
	Gain or loss upon sale or retirement due to obsolescence is reflected in the
	operating results in the period the event takes place.</p>
	<p><i>Valuation of Long-Lived Assets:</i>&nbsp;&nbsp; We review the
	recoverability of our long-lived assets including equipment, goodwill and
	other intangible assets, when events or changes in circumstances occur that
	indicate that the carrying value of the asset may not be recoverable. The
	assessment of possible impairment is based on our ability to recover the
	carrying value of the asset from the expected future pre-tax cash flows
	(undiscounted and without interest charges) of the related operations. If
	these cash flows are less than the carrying value of such asset, an
	impairment loss is recognized for the difference between estimated fair
	value and carrying value. Our primary measure of fair value is based on
	discounted cash flows. The measurement of impairment requires management to
	make estimates of these cash flows related to long-lived assets, as well as
	other fair value determinations.</p>
	<p><i>Stock Based Compensation:&nbsp;</i>&nbsp; Stock-based awards are accounted
	for using the fair value method in accordance with ASC 718,&nbsp;<i>Share-Based
	Payments</i>. Our primary type of share-based compensation consists of stock
	options. We use the Black-Scholes option pricing model in valuing options.
	The inputs for the valuation analysis of the options include the market
	value of the Company's common stock, the estimated volatility of the
	Company's common stock, the exercise price of the warrants and the risk free
	interest rate.</p>
	<p><i>Accounting For Obligations And Instruments Potentially To Be Settled
	In The Company's Own Stock:</i>&nbsp;&nbsp; We account for obligations and
	instruments potentially to be settled in the Company's stock in accordance
	with FASB ASC 815,&nbsp;Accounting for Derivative Financial Instruments.&nbsp;This
	issue addresses the initial balance sheet classification and measurement of
	contracts that are indexed to, and potentially settled in, the Company's own
	stock.</p>
	<p><i>Fair Value of Financial Instruments:</i>&nbsp;&nbsp; FASB ASC 825,
	<i>Financial Instruments</i>, requires entities to disclose the fair value of
	financial instruments, both assets and liabilities recognized and not
	recognized on the balance sheet, for which it is practicable to estimate
	fair value. FASB ASC 825 defines fair value of a financial instrument as the
	amount at which the instrument could be exchanged in a current transaction
	between willing parties. At June 30, 2015 and 2014, the carrying value of
	certain financial instruments (cash and cash equivalents, accounts payable
	and accrued expenses.) approximates fair value due to the short-term nature
	of the instruments or interest rates, which are comparable with current
	rates. </p>
	<p><i>Fair Value Measurements:</i>&nbsp;&nbsp; The Company measures fair
	value under a framework that utilizes a fair value hierarchy that
	prioritizes the inputs to valuation techniques used to measure fair value.
	The hierarchy gives the highest priority to unadjusted quoted prices in
	active markets for identical assets or liabilities (level 1 measurements)
	and the lowest priority to unobservable inputs (level 3 measurements). The
	three levels of inputs which prioritize the inputs used in measuring fair
	value are:</p>
	<p><i>Level 1:</i> Inputs to the valuation methodology are unadjusted quoted
	prices for identical assets or liabilities in active markets that the
	Company has the ability to access.<br><i>Level 2:</i> Inputs to the
	valuation methodology include:<br>- Quoted prices for similar assets or
	liabilities in active markets;<br>- Quoted prices for identical or similar
	assets or liabilities in inactive markets;<br>- Inputs other than quoted
	prices that are observable for the asset or liability;<br>- Inputs that are
	derived principally from or corroborated by observable market data by
	correlation or other means.<br>If the asset or liability has a specified
	(contractual) term, the level 2 input must be observable for substantially
	the full term of the asset or liability.<br><i>Level 3:</i> Inputs to the
	valuation methodology are unobservable and significant to the fair value
	measurement.</p>
	<p>The assets or liability's fair value measurement level within the fair
	value hierarchy is based on the lowest level of any input that is
	significant to the fair value measurement. Valuation techniques used need to
	maximize the use of observable inputs and minimize the use of unobservable
	inputs. The following table presents assets that were measured and recognize
	at fair value on March 31, 2015 and the year then ended on a recurring
	basis:</p>
<font face="Times New Roman" size="2">

    <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">

	</font>

<table BORDER="0" CELLSPACING="0" CELLPADDING="0" WIDTH="100%" HEIGHT="0">
  <tr>
      <td WIDTH="100%" VALIGN="top" colspan="9" style="text-align: center; height: 1px">
	  <font
    size="1">Fair Value Measurements at June 30, 2015</font></td>
  </tr>
  <tr>
      <td style="width: 36%; height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td VALIGN="BOTTOM" style="width: 17%; height: 1px; text-align: center;"><font size="1">Quoted Prices
    in Active</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="12%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Significant
    Other</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Significant</font></td>
  </tr>
  <tr>
      <td style="width: 36%; height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td VALIGN="BOTTOM" style="width: 17%; height: 1px; text-align: center;"><font size="1">Markets for
    Identical Assets</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="12%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Observable
    Inputs</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Unobservable
    Inputs</font></td>
  </tr>
  <tr>
      <td style="width: 36%; height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    align="center"><font size="1">Total</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td VALIGN="bottom" style="border-bottom: 1px solid rgb(0,0,0); width: 17%; height: 1px;"><p
    ALIGN="CENTER"><font size="1">(Level 1)</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="12%" VALIGN="bottom" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font size="1">(Level 2) </font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="bottom" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font size="1">(Level 3) </font></td>
  </tr>
  <tr>
      <td VALIGN="top" style="width: 36%; height: 1px"><font FACE="Times New Roman" SIZE="2">None</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="top" align="center" style="height: 1px"><font  FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" align="right" style="height: 1px"><font
    FACE="Times New Roman" SIZE="2">$</font></td>
    <td VALIGN="TOP" align="center" style="width: 17%; height: 1px"><font FACE="Times New Roman"
    SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="12%" VALIGN="TOP" style="text-align: center; height: 1px"><font FACE="Times New Roman"
    SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="TOP" style="height: 1px"><font FACE="Times New Roman"
    SIZE="2">-</font></td>
  </tr>
  <tr>
      <td VALIGN="top" style="width: 36%; height: 1px"><font FACE="Times New Roman" SIZE="2">Total
    assets at fair value</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="top" align="center"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); height: 1px;"><p
    ALIGN="center"><font FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" align="right" style="height: 1px"><font
    FACE="Times New Roman" SIZE="2">$</font></td>
    <td VALIGN="top" align="center"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); width: 17%; height: 1px;"><font
    FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="12%" VALIGN="top"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="top"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font FACE="Times New Roman" SIZE="2">-</font></td>
  </tr>
  <tr>
      <td VALIGN="top" HEIGHT="0" class="auto-style1" colspan="9">&nbsp; &nbsp;</td>
  </tr>
</table>

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<p>&nbsp;</p>

<table BORDER="0" CELLSPACING="0" CELLPADDING="0" WIDTH="100%" HEIGHT="0">
  <tr>
      <td colspan="9" style="height: 1px; text-align: center">
	  <font
    size="1">Fair Value Measurements at December&nbsp;31, 2014</font></td>
  </tr>
  <tr>
      <td style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td VALIGN="BOTTOM" style="width: 17%; height: 1px; text-align: center;"><font size="1">Quoted Prices
    in Active</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="12%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Significant
    Other</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Significant</font></td>
  </tr>
  <tr>
      <td style="width: 36%; height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td VALIGN="BOTTOM" style="width: 17%; height: 1px; text-align: center;"><font size="1">Markets for
    Identical Assets</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="12%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Observable
    Inputs</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="BOTTOM" style="text-align: center; height: 1px"><font size="1">Unobservable
    Inputs</font></td>
  </tr>
  <tr>
      <td style="width: 36%; height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    align="center"><font size="1">Total</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td VALIGN="bottom" style="border-bottom: 1px solid rgb(0,0,0); width: 17%; height: 1px;"><p
    ALIGN="CENTER"><font size="1">(Level 1)</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="12%" VALIGN="bottom" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font size="1">(Level 2) </font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="bottom" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font size="1">(Level 3) </font></td>
  </tr>
  <tr>
      <td VALIGN="top" style="width: 36%; height: 1px"><font FACE="Times New Roman" SIZE="2">None</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="top" align="center" style="height: 1px"><font
    FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" align="right" style="height: 1px"><font
    FACE="Times New Roman" SIZE="2">$</font></td>
    <td VALIGN="TOP" align="center" style="width: 17%; height: 1px"><font FACE="Times New Roman"
    SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="12%" VALIGN="TOP" style="text-align: center; height: 1px"><font FACE="Times New Roman"
    SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="TOP" style="height: 1px"><font FACE="Times New Roman"
    SIZE="2">-</font></td>
  </tr>
  <tr>
      <td VALIGN="top" style="width: 36%; height: 1px"><font FACE="Times New Roman" SIZE="2">Total
    assets at fair value</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="top" align="center"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); height: 1px;"><p
    ALIGN="center"><font FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" align="right" style="height: 1px"><font
    FACE="Times New Roman" SIZE="2">$</font></td>
    <td VALIGN="top" align="center"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); width: 17%; height: 1px;"><font
    FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="12%" VALIGN="top"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font FACE="Times New Roman" SIZE="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"><p style="text-align: right"><font FACE="Times New Roman"
    SIZE="2">$</font></td>
    <td WIDTH="13%" VALIGN="top"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 1px double rgb(0,0,0); height: 1px;"><p
    ALIGN="CENTER"><font FACE="Times New Roman" SIZE="2">-</font></td>
  </tr>
  <tr>
      <td VALIGN="top" HEIGHT="0" class="auto-style1" colspan="9">&nbsp; &nbsp;</td>
  </tr>
</table>

    </font>
</font>
	<p>When the Company changes its valuation inputs for measuring financial
	assets and liabilities at fair value, either due to changes in current
	market conditions or other factors, it may need to transfer those assets or
	liabilities to another level in the hierarchy based on the new inputs used.
	The Company recognizes these transfers at the end of the reporting period
	that the transfers occur. For the fiscal periods ended Jun e30, 2015 and
	December 31, 2014, there were no significant transfers of financial assets
	or financial liabilities between the hierarchy levels.</p>
	<p><i>Earnings per Common Share:</i>&nbsp;&nbsp; We compute net income (loss) per
	share in accordance with ASC 260,&nbsp;<i>Earning per Share</i>. ASC 260 requires
	presentation of both basic and diluted earnings per share (EPS) on the face
	of the income statement. Basic EPS is computed by dividing net income (loss)
	available to common shareholders (numerator) by the weighted average number
	of shares outstanding (denominator) during the period. Diluted EPS gives
	effect to all dilutive potential common shares outstanding during the period
	using the treasury stock method and convertible preferred stock using the
	if-converted method. In computing Diluted EPS, the average stock price for
	the period is used in determining the number of shares assumed to be
	purchased from the exercise of stock options or warrants. Diluted EPS
	excludes all dilutive potential shares if their effect is anti-dilutive. All
	per share disclosures retroactively reflect shares outstanding or issuable
	as though the reverse split had occurred January 1, 2012.</p>
	<p><i>Income Taxes:</i>&nbsp;&nbsp; We have adopted FASB ASC 740,&nbsp;<i>Accounting for
	Income Taxes</i>.&nbsp;Pursuant to ASC 740, we are required to compute tax asset
	benefits for net operating losses carried forward. The potential benefits of
	net operating losses have not been recognized in these financial statements
	because the Company cannot be assured it is more likely than not it will
	utilize the net operating losses carried forward in future years.</p>
	<p>We must make certain estimates and judgments in determining income tax
	expense for financial statement purposes. These estimates and judgments
	occur in the calculation of certain tax assets and liabilities, which arise
	from differences in the timing of recognition of revenue and expense for tax
	and financial statement purposes.</p>
	<p>Deferred tax assets and liabilities are determined based on the
	differences between financial reporting and the tax basis of assets and
	liabilities using the tax rates and laws in effect when the differences are
	expected to reverse. ASC 740 provides for the recognition of deferred tax
	assets if realization of such assets is more likely than not to occur.
	Realization of our net deferred tax assets is dependent upon our generating
	sufficient taxable income in future years in appropriate tax jurisdictions
	to realize benefit from the reversal of temporary differences and from net
	operating loss, or NOL, carryforwards. We have determined it more likely
	than not that these timing differences will not materialize and have
	provided a valuation allowance against substantially all of our net deferred
	tax asset. Management will continue to evaluate the realizability of the
	deferred tax asset and its related valuation allowance. If our assessment of
	the deferred tax assets or the corresponding valuation allowance were to
	change, we would record the related adjustment to income during the period
	in which we make the determination. Our tax rate may also vary based on our
	results and the mix of income or loss in domestic and foreign tax
	jurisdictions in which we operate.</p>
	<p>In addition, the calculation of our tax liabilities involves dealing with
	uncertainties in the application of complex tax regulations. We recognize
	liabilities for anticipated tax audit issues in the U.S. and other tax
	jurisdictions based on our estimate of whether, and to the extent to which,
	additional taxes will be due. If we ultimately determine that payment of
	these amounts is unnecessary, we will reverse the liability and recognize a
	tax benefit during the period in which we determine that the liability is no
	longer necessary. We will record an additional charge in our provision for
	taxes in the period in which we determine that the recorded tax liability is
	less than we expect the ultimate assessment to be.</p>
	<p>ASC 740 which requires recognition of estimated income taxes payable or
	refundable on income tax returns for the current period and for the
	estimated future tax effect attributable to temporary differences and
	carry-forwards. Measurement of deferred income tax is based on enacted tax
	laws including tax rates, with the measurement of deferred income tax assets
	being reduced by available tax benefits not expected to be realized.</p>
	<p><i>Uncertain Tax Positions:</i>&nbsp;&nbsp; When tax returns are filed,
	it is highly certain that some positions taken would be sustained upon
	examination by the taxing authorities, while others are subject to
	uncertainty about the merits of the position taken or the amount of the
	position that would be ultimately sustained. In accordance with the guidance
	of FASB ASC 740-10, <i>Accounting for Uncertain Income Tax Positions,</i> the
	benefit of a tax position is recognized in the financial statements in the
	period during which, based on all available evidence, management believes it
	is more likely than not that the position will be sustained upon
	examination, including the resolution of appeals or litigation processes, if
	any. Tax positions taken are not offset or aggregated with other positions.
	Tax positions that meet the more-likely-than-not recognition threshold are
	measured as the largest amount of tax benefit that is more than 50 percent
	likely of being realized upon settlement with the applicable taxing
	authority. The portion of the benefits associated with tax positions taken
	that exceeds the amount measured as described above should be reflected as a
	liability for unrecognized tax benefits in the accompanying consolidated
	balance sheets along with any associated interest and penalties that would
	be payable to the taxing authorities upon examination.</p>
	<p>Our federal and state income tax returns are open for fiscal years ending
	on or after December 31, 2011. We are not under examination by any
	jurisdiction for any tax year. At March 31, 2015 we had no material
	unrecognized tax benefits and no adjustments to liabilities or operations
	were required under FIN&nbsp;48.</p>
	<p><i>Recent Accounting Pronouncements</i></p>
	<p>On June 10, 2014, the FASB issued Accounting Standards Update ("ASU") No.
	2014-10 , which eliminates development stage reporting requirements under
	FASB ASC 915, as well as amends provisions of existing variable interest
	entity guidance under ASC 810. Additionally, the ASU indicates that the lack
	of commencement of principal operations represents a risk and uncertainty
	and, accordingly, is subject to the disclosure requirements of FASB ASC 275.
	As a result of the changes, existing development stage entity presentation
	and disclosure requirements are eliminated. The presentation and disclosure
	changes to FASB ASC 915 are effective for public entities for annual periods
	beginning after December 15, 2014, and the revisions to the consolidation
	standards are effective for annual periods beginning after December 15,
	2015. The Company has adopted these provisions and enhanced disclosure of
	risks and uncertainties as required. </p>
	<p>In April 2014, the FASB issued ASU 2014-08,<i> Presentation of Financial
	Statements (Topic 205) and Property, Plant, and Equipment (Topic 360):
	Reporting Discontinued Operations and Disclosures of Disposals of Components
	of an Entity</i>. The amendments in this ASU change the criteria for
	reporting discontinued operations while enhancing disclosures in this area.
	Under the new guidance, only disposals representing a strategic shift in
	operations should be presented as discontinued operations. Those strategic
	shifts should have a major effect on the organization's operations and
	financial results and include disposals of a major geographic area, a major
	line of business, or a major equity method investment. The new guidance
	requires expanded disclosures about discontinued operations that will
	provide financial statement users with more information about the assets,
	liabilities, income, and expenses of discontinued operations. Additionally,
	the new guidance requires disclosure of the pre-tax income attributable to a
	disposal of a significant part of an organization that does not qualify for
	discontinued operations reporting. The amendments in the ASU are effective
	for public business entities for annual periods, and interim periods within
	those annual periods, beginning after December 15, 2014. Early adoption is
	permitted. The Company is currently evaluating the impact of this
	pronouncement.</p>
	<p>In August 2014, the FASB issued ASU 2014-15, <i>Presentation of Financial
	Statements - Going Concern</i>. The new standard requires management of
	public and private companies to evaluate whether there is substantial doubt
	about the entity's ability to continue as a going concern and, if so,
	disclose that fact. Management will also be required to evaluate and
	disclose whether its plans alleviate that doubt. The standard requires
	management to evaluate, for each reporting period, whether there are
	conditions or events that raise substantial doubt about a company's ability
	to continue as a going concern within one year from the date the financial
	statements are issued. The new standard is effective for annual periods
	ending after December 15, 2016, and interim periods within annual periods
	beginning after December 15, 2016. Early adoption is permitted. We do not
	expect the adoption of the ASU to have a significant impact on our
	consolidated financial statements.</p>
	<p>Management does not anticipate that the adoption of these standards will
	have a material impact on the financial statements.</p>
	<p><b>Note 2. Going Concern</b></p>
	<p>The accompanying financial statements have been prepared assuming the
	Company will continue as a going concern. The Company has incurred losses,
	has negative operational cash flows and has no revenues. The future of the
	Company is dependent upon Management success in its efforts and limited
	resources to pursue and effect a business combination.</p>
	<p>These conditions raise substantial doubt about the Company's ability to
	continue as a going concern. These financial statements do not include any
	adjustments that might arise from this uncertainty.</p>
	<p><b>Note 3. Stockholders' Equity</b></p>
	<p>On January 8, 2015 the shareholders approved a resolution to increase the
	authorized common shares from 100,000,000 to 490,000,000 shares. All other
	provisions of the common shares remain unchanged. Also on that date, the
	Company declared a reverse split of common stock at the ration of 1:4. The
	stock split was effective January 8, 2015 for holders of record as of that
	date. Except as otherwise noted, all share, option and warrant numbers have
	been restated to give retroactive effect to this split. All per share
	disclosures retroactively reflect shares outstanding or issuable as though
	the reverse split had occurred at January 1, 2012.</p>
	<p><i>Recent Issuances of Common Stock</i></p>
	<p>During the period ended December 31, 2014 we issued 4,125,000 shares of
	our common stock (16,500,000 pre-reverse stock split) in exchange for
	converting $125,000 of promissory notes. </p>
	<p>Between January 15, 2015 and March 15, 2015 the Company sold a total of
	2,052,000 units for cash consideration of $780,000 at a price of $0.40 (the
	&quot;Units&quot;), each unit comprised of one share of common stock and one Class A
	warrant exercisable at $0.80 per share with a term 24 month. The relative
	fair value of the stock with embedded warrants was $351,419 for the common
	stock and $428,581 for the class A warrants. The warrants were valued using
	the Black-Scholes model with 216% volatility and discount rates ranging
	between 0.44% to 0.7%. The cash consideration is reflected in stock payable
	as shares will be issued after reverse merger is completed. </p>
	<p>Between April 1, 2015 and June 29, 2015 the Company sold a total of
	1,012,500 units for cash consideration of $405,000 at a price of $0.40 (the
	&quot;Units&quot;), each unit comprised of one share of common stock and one Class A
	warrant exercisable at $0.80 per share with a term 24 month. The relative
	fair value of the stock with embedded warrants was $158,123 for the common
	stock and $246,877 for the class A warrants. The warrants were valued using
	the Black-Scholes model with volatility ranging between163% - 177% and
	discount rates ranging between 0.54% to 0.71%. The cash consideration is
	reflected in stock payable as shares will be issued after reverse merger is
	completed. </p>
	<p><b>Note 4. Related Party Transactions Not Disclosed Elsewhere</b></p>
	<p>On March 25, 2014, our President and principal shareholder assigned
	accumulated advances and accruals totaling $124,229, to an unaffiliated
	third party. The advances carry no specific terms of repayment. On December
	15, 2014, $22,375 of the then outstanding balance was converted to a
	promissory note. A summary of transactions is as follows:</p>
<font face="Times New Roman" size="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

<table cellSpacing="0" cellPadding="0" width="100%" border="0" height="0">
  <tr>

      <td style="width: 68%; height: 1px;"><font size="2">&nbsp; </font></td>

    <td width="2%" bgcolor="#fffff" align="right" style="height: 1px"></td>

    <td width="13%" bgcolor="#fffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="1">
	June 30,
	2015</font></font></font></td>

    <td width="2%" bgcolor="#fffff" align="right" style="height: 1px"></td>

    <td bgcolor="#fffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); width: 15%; height: 1px;">

		<font size="1">	December 31,
	2014</font></td>

  </tr>
  <tr>

      <td style="width: 68%; height: 1px;"><font size="2">Beginning balance</font></td>

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="2%" align="right" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>

	<font size="2">

    <td width="13%" align="right" style="height: 1px"><font size="2">-</font></td>
    <td align="right" width="2%" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>
<font face="Times New Roman" size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td align="right" style="width: 15%; height: 1px;"><font size="2">161,729</font></td>
  	  </font>
	  </font>
</font>
  	  </font>
	  </font>
  </tr>
    <tr>

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

      <td style="width: 68%; height: 1px;"><font size="2">Increase due to payments made on
	  behalf of the company</font></td>

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td width="2%" align="right" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>

    <td width="13%" align="right" style="height: 1px"><font size="2">-</font></td>
    <td align="right" width="2%" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>
    	<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <td align="right" style="width: 15%; height: 1px;"><font size="2">21,625</font></td>
    	</font>
	    </font>
    	</font>

		</font>
      </font></font>
	</tr>
	<tr>

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

      <td style="width: 68%; height: 1px;"><font size="2">Less March 24, 2014 conversion
	  to convertible note</font></td>

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="2%" align="right" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">-</font></td>

    <td align="right" width="2%" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>

<font face="Times New Roman" size="2">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td align="right" style="width: 15%; height: 1px;"><font size="2">(40,000)</font></td>

  	  </font>
		</font>
</font>
  	  </font>
		</font>
		</font>
      </font></font>
	</tr>
  <tr>

      <td style="width: 68%; height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	  <font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	  Less December 15, 2014 conversion to promissory note</font></font></font></td>

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td width="2%" align="right" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>
    <td width="13%" align="right" style="height: 1px"><font size="2">-</font></td>

    <td align="right" width="2%" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></td>
<font face="Times New Roman" size="2">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td align="right" style="width: 15%; height: 1px;"><font size="2">(22,375)</font></td>
  	  </font>
		</font>

</font>
  	  </font>
		</font>

  </tr>
  <tr>

      <td style="width: 68%; height: 1px;"><font size="2">Obligation transferred to
	  unrelated party</font></td>

    <td width="2%" align="right" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></font></td>

    <td width="13%" align="right" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	-</font></font></font></font></font></td>

    <td align="right" width="2%" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></font></td>
<font face="Times New Roman" size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

    <td align="right" style="border-bottom: 1px solid rgb(0,0,0); width: 15%; height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	(120,979)</font></font></font></font></font></td>
      </font>
</font>
  </tr>
  <tr>

      <td bgcolor="#fffff" style="width: 68%; height: 1px;"><font size="2">Total</font></td>

    <td width="2%" bgcolor="#fffff" align="right" style="height: 1px"></td>

    <td width="13%" class="auto-style1" style="text-align: right; height: 1px;">

	<font size="2" face="Times New Roman">

    -</font></td>

    <td align="right" width="2%" bgcolor="#fffff" style="height: 1px"></td>

    <td bgcolor="#fffff" align="right" style="width: 15%; height: 1px;"><font size="2">
	-</font></td>
  </tr>
  <tr>

      <td bgcolor="#fffff" style="width: 68%; height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

      <font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	  Less current portion</font></font></font></td>

    <td width="2%" bgcolor="#fffff" align="right" style="height: 1px"></td>

    <td width="13%" bgcolor="#fffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    -</font></font></td>

    <td align="right" width="2%" bgcolor="#fffff" style="height: 1px"></td>

    <td bgcolor="#fffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); width: 15%; height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    <font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	-</font></font></font></td>
  </tr>
  <tr>

      <td bgcolor="#fffff" style="width: 68%; height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	  <font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	  Due after one year</font></font></font></td>

    <td width="2%" bgcolor="#fffff" align="right" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></font></td>

    <td width="13%" bgcolor="#fffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    -</font></font></td>

    <td align="right" width="2%" bgcolor="#fffff" style="height: 1px">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

	<font size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">$</font></font></font></td>

    <td bgcolor="#fffff" align="right"
    style="border-bottom: 1px solid rgb(0,0,0); width: 15%; height: 1px;">

	<font size="2" face="Times New Roman">

	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

    -</font></font></td>
  </tr>
</table>
	</font>
</font>
	<p>There was no stated term of interest associated with this obligation.
	Accordingly, the company imputed interest at an appropriate rate estimated
	at 8% as prescribed under FASB ASC 835. For the period ending December 31,
	2014 the resultant charge of $11,210 to interest expense was considered a
	contribution of capital. </p>
	<p><b>Note 5. Notes Payable</b></p>
	<p><i>Convertible Notes Payable</i></p>
	<p>On March 24, 2014, we issued a convertible promissory note in the amount
	of $40,000 to an unaffiliated party in consideration for past services
	provided to the Company. The Note bears interest at the rate of 1% per
	annum, is due and payable on March 24, 2015 and is convertible at a price of
	$0.005 per share. On March 24, 2014, the holder of the 2014 Note transferred
	and assigned the 2014 Note to five unaffiliated parties bearing the same
	interest rate and conversion price. In connection with the transfer and
	assignment of the 2014 Note, the Company agreed to extend the maturity date
	from March 24, 2015 to July 1, 2016. </p>
	<p>On December 10, 2014, upon the request of all fifteen note holders, all
	convertible promissory notes in the aggregate principal amount of $125,000
	were converted into 4,125,000 shares (16,500,000 pre-reverse stock split)
	consistent with the provisions of the notes. Related accrued interest of
	$35,295 was not included in the conversion and remains unpaid at June 30,
	2015.</p>
	<p>In accordance to ASC #815, Accounting for Derivative Instruments and
	Hedging Activities, we evaluated the holder's non-detachable conversion
	right provision and liquidated damages clause, contained in the terms
	governing the Note to determine whether the features qualify as an embedded
	derivative instruments at issuance. Such non-detachable conversion right
	provision and liquidated damages clause did not need to be accounted for as
	derivative financial instruments. Additionally, since the conversion price
	of the two notes represented the fair market value of the Company's common
	stock at the time of issuance, no beneficial conversion feature exists. We
	believe that the Company's shares of common stock is and have been very
	thinly traded during the last 3 years and that the fair value of the stock
	price was deemed not to be a fair value. Management decided that because the
	Company's ability to continue as a going concern was in question and that it
	has no revenue sources that the conversion price was a better measure of
	fair market value. Based on that decision, no beneficial conversion feature
	was reflected in the financial statements.</p>
	<p><i>Note Payable - Not Convertible</i></p>
	<p>On December 15, 2014, we issued a promissory note in the amount of
	$22,375 to an unaffiliated party in consideration for payments made on
	behalf of the Company for service provided to the Company (the &quot;December
	2014 Note&quot;). The December 2014 Note bears interest at the rate of 1% per
	annum, is due and payable on January 15, 2016 and is not convertible to
	common stock. </p>
	<p>On January 14 and 16, 2015, we issued two promissory notes in the amount
	of $15,000 each to two different unaffiliated party in consideration for
	cash transferred to the Company (the &quot;January 2015 Notes&quot;). The January 2015
	Notes bears interest at the rate of 1% per annum, are due and payable on
	January 14 and 16, 2016 and are not convertible to common stock. </p>
	<p>One of the notes was repaid in full during the first quarter with
	interest due waived the by the debtor, and the second note was repaid during
	the second quarter with interest due waived the by the debtor.</p>
	<p>During the second quarter the promissory note in the amount of $22,375
	with interest due was repaid in full. </p>
	<p>During the second quarter an agreement was reached with the holder of
	$120,979 advance payable note to settle the full amount due for $30,000 and
	interest due. The settlement with all note holders resulted in $528 loss on
	debt settlement as well as a charge of $90,979 considered a contribution of
	capital.</p>
	<p>We concluded that these notes have a stated rate of interest that is
	different from the rate of interest that is appropriate for this type of
	debt at the date of the transaction. Accordingly, the company imputed
	interest at an appropriate rate estimated at 8% as prescribed under FASB ASC
	835. The resultant charge of $6,280 for the period ending December 31, 2014
	and $4,113 for the period ending June 30, 2015 to interest expense was
	considered a contribution of capital.</p>
	<p>For the periods ending June 30, 2015 and December 31, 2014 the Company
	has recognized $4,699 and $3,255 respectively in accrued interest expense
	related to the stated interest rate on the notes and has recognized $4,113
	and $17,490 in imputed interest expense. </p>
	<p><b>Note 6. Income Taxes</b></p>
	<p>We have adopted ASC 740 which provides for the recognition of a deferred
	tax asset based upon the value the loss carry-forwards will have to reduce
	future income taxes and management's estimate of the probability of the
	realization of these tax benefits. Our net operating loss carryovers
	incurred prior to 2014 considered available to reduce future income taxes
	were reduced or eliminated through our recent change of control (I.R.C.
	Section 382(a)) and the continuity of business limitation of I.R.C. Section
	382(c). </p>
	<p>We have a current operating loss carry-forward of $784,725 resulting in
	deferred tax assets of $0. We have determined it more likely than not that
	these timing differences will not materialize and have provided a valuation
	allowance against substantially all our net deferred tax asset.</p>
	<p>Future utilization of currently generated federal and state NOL and tax
	credit carry forwards may be subject to a substantial annual limitation due
	to the ownership change limitations provided by the Internal Revenue Code of
	1986, as amended and similar state provisions. The annual limitation may
	result in the expiration of NOL and tax credit carry forwards before full
	utilization.</p>
<font face="Times New Roman" size="2">
<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">

<table BORDER="0" CELLSPACING="0" CELLPADDING="0" WIDTH="100%" HEIGHT="0">
  <tr>
      <td WIDTH="70%" VALIGN="middle" style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="middle" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="middle" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    ALIGN="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"
    size="1">June 30, 2015</font></td>
    <td WIDTH="2%" VALIGN="middle" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="middle" style="border-bottom: 1px solid rgb(0,0,0); height: 1px;"><p
    ALIGN="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"
    size="1">December 31, 2014</font></td>
  </tr>
  <tr>
      <td WIDTH="70%" VALIGN="top" style="height: 1px">
	  <font size="2" face="Times New Roman">Individual components giving rise to
	  the deferred tax assets are as follows:</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font size="2">$</font></td>
    <td WIDTH="13%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font size="2">$</font></td>
    <td WIDTH="13%" VALIGN="top" style="height: 1px"></td>
  </tr>
  <tr>
      <td WIDTH="70%" VALIGN="top" style="height: 1px">
<font size="2" face="Times New Roman">

	  Future tax benefit arising from net operating loss carryovers

	  </td>
    <td WIDTH="2%" VALIGN="top" align="right" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" align="right" style="height: 1px">
	<font size="2" face="Times New Roman">784,725</font></td>
    <td WIDTH="2%" VALIGN="top" align="right" style="height: 1px"></td>
<font face="Times New Roman" size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
    <td WIDTH="13%" VALIGN="top" align="right" style="height: 1px">
	<font size="2" face="Times New Roman">157,172</font></td>
</font>
  </tr>
  <tr>
      <td WIDTH="70%" VALIGN="top" style="height: 1px"><font size="2">
	  Less valuation
    allowance</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
    <td WIDTH="13%" VALIGN="top" style="text-align: right; height: 1px"><font size="2">
	(784,725)</font></td>
    <td WIDTH="2%" VALIGN="top" style="height: 1px"></td>
<font face="Times New Roman" size="2" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
    <td WIDTH="13%" VALIGN="top" style="text-align: right; height: 1px"><font size="2">
	(157,172)</font></td>
</font>
  </tr>
  <tr>
      <td WIDTH="70%" VALIGN="top" style="height: 1px"><font size="2">Net
    deferred asset</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font size="2">$</font></td>
    <td WIDTH="13%" VALIGN="top"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 2px double rgb(0,0,0); height: 1px;"><p
    ALIGN="RIGHT"><font size="2">-</font></td>
    <td WIDTH="2%" VALIGN="top" style="text-align: right; height: 1px"><font size="2">$</font></td>
    <td WIDTH="13%" VALIGN="top"
    style="border-top: 1px solid rgb(0,0,0); border-bottom: 2px double rgb(0,0,0); height: 1px;"><p
    ALIGN="RIGHT"><font size="2">-</font></td>
  </tr>
</table>

	</font>
</font>
	<p>The Company is not under examination by any jurisdiction for any tax
	year. Our federal and state income tax returns are open for fiscal years
	ending on or after December 31, 2011.</p>
	<p><b>Note 7. Advances to Related Party</b></p>
	<p>On February 3, 2015, March 23, 2015, 4 May, 2015, June 6, 2015 and June
	26, 2015, $90,000, $100,000, $100,000, $100,000, $100,000 respectively, were
	advanced to a company that Zaxis is in merger discussions with. These loans
	shall bear interest at the rate of one (1%) percent per annum (the &quot;Interest
	Rate&quot;) and shall be due and payable ninety (90) days from the date of the
	Loan (the &quot;Maturity Date&quot;). Since collectability is not reasonably assured
	this amount is being expensed in the statement of operations. </p>
	<p>The ability of the third party loanee Emerald Medical Applications Ltd to
	repay the loans as a standalone company is highly in doubt since it used the
	loan proceeds for ongoing business operations. If, for any reason, the
	merger with Zaxis, which is in advance stages of closing, does not close
	Emerald Medical Applications Ltd. will not have sufficient funds to repay
	the loan. </p>
	<p><b>Note 8. Subsequent Events</b></p>
	<p>In July 2015, the Company filed a Form 8-K/12G with the SEC for the
	merger between the Company and Emerald Medical Applications Ltd. On August
	5, 2015, the Company filed a registration statement on Form S-1 for selling
	<font size="2">security holders offering 19,361,758 shares of common stock
	</font> </p>
	</font>
	<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always'>

<font size="2">
<a name="ITEM_2._MANAGEMENTS_DISCUSSION_AND_ANALYSIS_AND_PLAN_OF_OPERATION">ITEM 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION</a> <font size="1">
<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font></font></p>

<p><i><font size="2">Some of the statements contained in this quarterly
report of Zaxis International Inc., Delaware corporation (hereinafter referred to as
&quot;we&quot;, &quot;us&quot;, &quot;our&quot;, &quot;Company&quot; and the
&quot;Registrant&quot;) discuss future expectations, contain projections of our plan of
operation or financial condition or state other forward-looking information.
Forward-looking statements give our current expectations or forecasts of future events. In
some cases, you can identify forward-looking statements by terminology such as
&quot;may,&quot; &quot;will,&quot; &quot;should,&quot; &quot;could,&quot;
&quot;would,&quot; &quot;expect,&quot; &quot;plan,&quot; &quot;anticipate,&quot;
&quot;believe,&quot; &quot;estimate,&quot; &quot;continue,&quot; or the negative of such
terms or other similar expressions.</font></i></p>
	<p>On December 30, 2014, the Registrant entered into a
	non-binding Memorandum of Understanding (&quot;MOU&quot;) with Emerald Medical
	Applications Ltd., a private limited liability company incorporated under
	the laws of the State of Israel (&quot;Emerald&quot;). Emerald develops and owns
	proprietary technologies and methods relating to detection and diagnosis of
	early-stage Melanoma. </p>
	<p>The MOU provides that the Registrant and Emerald will
	enter into a reverse merger (the &quot;Reverse Merger&quot;), subject to the execution
	of a definitive agreement (the &quot;Definitive Agreement&quot;). The execution of
	Definitive Agreement and the closing of the Reverse Merger will be subject
	to the Registrant's raise of $800,000 from third party investors, including
	but not limited to the Registrant's existing stockholders (the &quot;Investors&quot;),
	at terms and conditions to be agreed upon by the Registrant and Emerald. </p>
	<p>Upon the closing, the holders of Emerald's capital stock
	will receive in exchange a number of shares of the Registrant's common stock
	equal to 45% of the Registrant's issued and outstanding common stock on a
	fully-diluted basis as at immediately following the closing of the Reverse
	Merger, excluding Registrant's securities to be issued to the Investors upon
	exercise of warrants issued to the Investors within the framework of the
	Reverse Merger. In addition, Emerald's holders will be issued up to an
	additional 21% of the Registrant's common stock in three equal tranches of
	7% of the Registrant's issued and outstanding common stock as at immediately
	following the closing of the Reverse Merger, subject to Emerald's
	achievement of certain milestones to be set forth in the Definitive
	Agreement.</p>
	<p>The Definitive Agreement with Emerald closed on July 14, 2015 and Emerald
	became a wholly-owned subsidiary of the Company. </p>
	<i>

<p>Plan of Operations</p>
<b>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are a digital health startup company engaged in the development, sale and service of imaging solutions utilizing our proprietary
DermaCompare software that we developed for use in derma imaging and analytics (our &ldquo;DermaCompare&rdquo; or &ldquo;Product&rdquo;).
In our development of the DermaCompare technology, we utilized the knowledge learned from advanced military image processing and
data analytics to improve the analysis of medical images for the benefit of patients and the medical community. We believe that
our proprietary DermaCompare software represents an advancement in skin cancer screening that should enable physicians to more
readily identify and monitor changes in their patients&rsquo; skin characteristics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DermaCompare
is Emerald&rsquo;s first application of its technology, which we believe represents an advance in the early detection of skin
cancer. DermaCompare is based on automated image analytics software using advanced algorithms for alignment, anchoring, identifying
and detecting changes in the shapes, colors and sizes of skin lesions, which could potentially become Melanoma. We apply our DermaCompare
technology in image capture, correction and intelligent data extraction in the market for derma imaging products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare solution allows dermatologists and other medical care professionals, using a set of 25 total body photography (&ldquo;TBP&rdquo;),
to capture sets of skin lesion images with, among other devices, digital cameras, camera-equipped smart phones or tablets. These
images are then transmitted online and are remotely analyzed by professionals using our DermaCompare software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare imaging software has 2 main modules:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A
    SaaS cloud-based Dr. Module that can be launched on any desktop computer connected to the Internet; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mobile
    APP for mass population uses can be installed on smart phones or tablets with iOS or Android operating systems. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
future plans also contemplate the use of wearable computing and imaging devices such as Google glasses or other comparable devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales and marketing plan is to sell licenses for our DermaCompare imaging software to: NHSs, HMOs, health insurance companies,
hospitals and medical clinics through distributers, health care channel partners or directly through independent salespersons
and/or web purchase to dermatologists and other physicians (GPs) that we expect to purchase licenses based on the number of potential
numbers of patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</b></i>
	<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'">
	<p>


<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
	During the quarter ended March 31, 2015,</FONT></font> the Company sold a
	total of 2,052,000 units for cash consideration of $780,000 at a price of
	$0.40 (the &quot;Units&quot;), each unit comprised of one share of common stock and
	one Class A warrant exercisable at $0.80 per share with a term 24 month. </p>
	<p>


<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
	During the quarter ended June 30, 2015,</FONT></font> the Company sold a
	total of 1,012,500 units for cash consideration of $405,000 at a price of
	$0.40 (the &quot;Units&quot;), each unit comprised of one share of common stock and
	one Class A warrant exercisable at $0.80 per share with a term 24 month. </p>
	</font>
	<p><i>Results of Operations during the three and six months ended June 30,
	2015 as compared to the three and six months ended June 30, 2014</i></p>
	<p>We have not generated any revenues during the three and six months ended
	June 30, 2015 and 2014. We had operating expenses related to general and
	administrative expenses, being a public company and interest expenses.
	During the three and six month period ended June 30, 2015, we incurred
	$390,606 and $627,553, respectively, in net loss compared to $6,807 and
	$16,928 during the same period in the prior year. </p>
	<p>Our general and administrative expenses increased to $88,390 and $132,326
	for the three and six months ended June 30, 2015 as compared to $6,500 and
	$14,250 during the same period in the prior year. The significant increase
	was due to increased expenses relating to the merger between the Company and
	Emerald Medical Applications Ltd.</p>
	<p>Other expense increased to $300,000 and $490,000 for the three and six
	months ended June 30, 2015 as compared to $0 and $0 during the same period
	in the prior year, due to advances made to related parties. Interest expense
	increased to $1,698 and $4,699 for the three and six months ended June 30,
	2015 as compared to $307 and $2678 during the same period in the prior year
	and gain of debt settlement increased to $528 and $0 for the three and six
	months ended June 30, 2015 as compared to $0 and $0 during the same period
	in the prior year.</p>
	<p>On February 3, 2015, March 23, 2015, 4 May, 2015, June 6, 2015 and June
	26, 2015, $90,000, $100,000, $100,000, $100,000, $100,000 respectively, were
	advanced to a company that Zaxis is in merger discussions with. These loans
	shall bear interest at the rate of one (1%) percent per annum (the &quot;Interest
	Rate&quot;) and shall be due and payable ninety (90) days from the date of the
	Loan (the &quot;Maturity Date&quot;). Since collectability is not reasonably assured
	this amount is being expensed in the statement of operations. </p>
	<p>The ability of the third party loanee Emerald Medical Applications Ltd to
	repay the loans as a standalone company is highly in doubt since it used the
	loan proceeds for ongoing business operations. If, for any reason, the
	merger with Zaxis, which is in advance stages of closing, does not close
	Emerald Medical Applications Ltd will not have sufficient funds to repay the
	loan. </p>
	<p><i>Liquidity and Capital Resources</i></p>
	<p>At present, the Company has no business operations and no material cash
	resources. We are dependent upon interim funding provided by Management
	and/or affiliated parties to pay professional fees and expenses. Our
	Management and affiliated parties have agreed to provide funding as may be
	required to pay for accounting fees and other administrative expenses of the
	Company. If we require additional financing, we cannot predict whether
	equity or debt financing will become available at terms acceptable to us, if
	at all. The Company depends upon services provided by Management and
	affiliated consultants to fulfill its filing obligations under the Exchange
	Act. At present, the Company has limited financial resources to pay for such
	services and may be required to issue restricted shares in lieu of cash.</p>
	<p>On June 30, 2015, we have had current cash assets of $467,380 and had $0
	in current and long-term liabilities. </p>
	<p>On December 31, 2014, we have had current cash assets of $1,000 and had
	$163,874 in current liabilities consisting of $7,500 in accounts payable,
	$35,305 in accrued interest expenses and $120,979 in advances payable to
	unrelated parties. We had long-term liabilities of $22,375 in notes payable.</p>
	<p>During the period ended June 30, 2015, we had negative cash flow from
	operations of $666,245, which was the result of a net loss of $627,553
	decrease in accrued liabilities of $35,833 and decrease in accounts payable
	of $7,500 and offset by imputed interest of $4,113 and $528 loss on debt
	settlement. </p>
	<p>During the period ended June 30, 2015, we had positive cash flow from
	financing activities of $1,132,625 which was the result of $1,185,000 from
	proceeds from sale of common stock offset by $52,375 principal payments on
	debt. </p>
	<p>During the period ended June 30, 2014, we had negative cash flow from
	operations of $7,750 which was the result of a net loss of $16,928 offset by
	increase in accrued expenses of $9,178 and advances from related party of
	$7,750 due to loans made by former Management.</p>
	<p>There are no limitations in the Company's certificate of incorporation on
	the Company's ability to borrow funds or raise funds through the issuance of
	restricted common stock to effect a business combination. The Company's
	limited resources and lack of having cash-generating business operations may
	make it difficult to borrow funds or raise capital. The Company's
	limitations to borrow funds or raise funds through the issuance of
	restricted capital stock required to effect or facilitate a business
	combination may have a material adverse effect on the Company's financial
	condition and future prospects, including the ability to complete a business
	combination. To the extent that debt financing ultimately proves to be
	available, any borrowing will subject us to various risks traditionally
	associated with indebtedness, including the risks of interest rate
	fluctuations and insufficiency of cash flow to pay principal and interest,
	including debt of an acquired business.</p>
	<p>The Company has only limited capital. Additional financing is necessary
	for the Company to continue as a going concern. Our independent auditors
	have unqualified audit opinion for the period ended June 30, 2015 with an
	explanatory paragraph on going concern.</p>
	<p>In view of these matters, realization of a major portion of the assets in
	the accompanying balance sheet is dependent upon continued operations of the
	Company. Management believes that actions presently being taken to obtain
	additional equity financing will provide the opportunity to continue as a
	going concern.</p>
<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always'>

<font size="2">
<a name="ITEM_3._QUANTITATIVE_AND_QUALITATIVE_DISCLOSURES_ABOUT_MARKET_RISK">ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK <font size="1">
<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font></font></p>

<font
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have not entered
into, and do not expect to enter into, financial instruments for trading or hedging
purposes.</font><p><a name="ITEM_4._CONTROLS_AND_PROCEDURES">ITEM 4.
CONTROLS AND PROCEDURES</a> <font size="1"><a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font></p>

<p style="text-align: justify"><font size="2"><em>Evaluation of disclosure controls and
procedures.</em>  As of June 30, 2015, the Company's chief executive officer and chief
financial officer conducted an evaluation regarding the effectiveness of the Company's
disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under
the&nbsp; Exchange Act. Based upon the evaluation of these controls and procedures, our
chief executive officer and chief financial officer concluded that our disclosure controls
and procedures were</font> not effective as of the end of the period covered by
this report. </p>

<p style="text-align: justify"><font size="2"><i>Changes in internal controls.</i>
During the quarterly period covered by this report, no changes occurred in our internal
control over financial reporting that materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.</font></p>

	<div style="text-align: center">
		<b>PART II - OTHER INFORMATION</b></div>

	<a name="ITEM_1._LEGAL_PROCEEDINGS">ITEM 1. LEGAL
PROCEEDINGS</a><b> </b><font size="2" color="#000000"><font size="1">
	<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font><p>None.</font></p>

<font size="2" color="#000000"><a name="ITEM_1A._RISK_FACTORS">ITEM 1A.
RISK FACTORS</a> <font size="1"><a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font></font><p><font face="Times New Roman" size="2">See risk factors discussed
in the Company's registration statement on Form S-1 as filed with the SEC on
	August 5, 2015.</font></p>

	<a name="ITEM_2._UNREGISTERED_SALES_OF_EQUITY_SECURITIES_AND_USE_OF_PROCEEDS">ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
	<font size="1">
	<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font><p>


<font size="2" face="Times New Roman" style="display: inline; font-size: 10pt; font-family: 'Times New Roman'"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
	During the quarter ended June 30, 2015,</FONT> the Company sold a total of
	1,012,500 units for cash consideration of $405,000 at a price of $0.40 (the
	&quot;Units&quot;), each unit comprised of one share of common stock and one Class A
	warrant exercisable at $0.80 per share with a term 24 month. <font size="2">
	The issuances of these Warrants was made without registration under the Act
	in reliance upon the exemptions provided in Section 4(2) of the Act and Reg S.</font></font></p>

	<a name="ITEM_3.&nbsp;DEFAULTS_UPON_SENIOR_SECURITIES">ITEM
3.&nbsp;DEFAULTS UPON SENIOR SECURITIES</a><b> </b><font size="1">
	<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</font><p><font size="2">None.</font></p>

	<a name="ITEM_4.&nbsp;MINE_SAFETY_DISCLOSURE_">ITEM
4.&nbsp;MINE SAFETY DISCLOSURE</a><font size="1"> <a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font><p><font size="2">None.</font></p>

	<a name="ITEM_5.&nbsp;OTHER_INFORMATION">ITEM
5.&nbsp;OTHER INFORMATION</a><b> </b><font size="1">
	<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font><p><font size="2">None.</font></p>

	<a name="ITEM_6.&nbsp;EXHIBITS">ITEM 6.&nbsp;EXHIBITS</a> <font size="1">
	<a href="#TABLE_OF_CONTENTS">Back to Table of
Contents</a></font><p ALIGN="JUSTIFY" style="text-align: justify"><font size="2">(a) The following documents
are filed as exhibits to this report on Form 10-Q or incorporated by reference herein. </font></p>
	<font size="2" face="Times New Roman">

<table border="0" cellpadding="0" cellspacing="0" width="100%" height="0%">
  <tr>
    <td width="8%" bgcolor="#fffff" height="0%"><font size="1">Exhibit No.</font></td>
    <td width="92%" bgcolor="#fffff" height="0%"><font size="1">Description</font></td>
  </tr>
  <tr>
    <td width="8%" bgcolor="#FFFFFF" height="0%"><font size="2">31.1<td width="92%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">Certification of CEO pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act pursuant to Section
    302 of the Sarbanes-Oxley Act of 2002.</td>
  </tr>
    <tr>

    <td width="8%" bgcolor="#FFFFFF" height="0%"><font size="2">31.2</td>
    <td width="92%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">Certification of CFO pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act pursuant to Section
    302 of the Sarbanes-Oxley Act of 2002.</td>
	</tr>
	<tr>

    <td width="8%" bgcolor="#FFFFFF" height="0%"><font size="2">32.1</td>
    <td width="92%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">Certification of CEO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the
    Sarbanes-Oxley Act of 2002.</font></td>
	</tr>
  <tr>
    <td width="8%" bgcolor="#FFFFFF" height="0%"><font size="2">32.2</td>
    <td width="92%" bgcolor="#FFFFFF" style="height: 1px"><font size="2">Certification of CFO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the
    Sarbanes-Oxley Act of 2002.</font></td>
  </tr>
</table>

	</font>

<hr SIZE="4" NOSHADE COLOR="#000000">
<p Style='page-break-before:always'>

	<div style="text-align: center">
<font SIZE="2">SIGNATURES</font></div>
	<p><font size="2">Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned.<br>
<br>
ZAXIS INTERNATIONAL INC.</font></p>
	<p>By: /s/ Liron Carmel<br>
	Liron Carmel<br>
Chief Executive Officer and Chairman<br>
(Principal Executive Officer)<br>
Date: August 7, 2015<br>
<br>
By: /s/ Oded Gilboa<br>
	Oded Gilboa<br>
Chief Financial Officer<br>
(Principal Financial and Principal Accounting Officer)<br>
Date: August 7, 2015<br>
<br>
Pursuant to the requirements of the Securities Act of 1934, this report has been signed by
the following persons on behalf of the registrant and in the capacities and on the dates
indicated.<br>
<br>
By: /s/ Liron Carmel<br>
	Liron Carmel<br>
	Chairman<br>
(Principal Executive Officer)<br>
Date: August 7, 2015</p>
</div>
</font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>2
<FILENAME>exh31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>

<head>
<title>Exhibit 31</title>
</head>

<body>
<b><u><font SIZE="1">

<p align="center"></font><font size="2">CERTIFICATION</font></p>
</u>

<p></b><font size="2">I, Liron Carmel, certify that:</font> </p>

<p><font size="2">1. I have reviewed this quarterly report of Zaxis International Inc.;</font>
</p>

<p><font size="2">2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;</font></p>

<p><font size="2">3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the&nbsp; issuer as of, and for, the
periods presented in this report;</font></p>

<p><font size="2">4. The&nbsp; issuer's other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as 4efined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the&nbsp; issuer and have:</font>
</p>

<p><font size="2">(a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the&nbsp; issuer, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;</font></p>

<p><font size="2">(b) Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</font></p>

<p><font size="2">(c) Evaluated the effectiveness of the&nbsp; issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and</font></p>

<p><font size="2">(d) Disclosed in this report any change in the&nbsp; issuer's internal
control over financial reporting that occurred during the&nbsp; issuer's most recent
fiscal quarter (the&nbsp; issuer's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
issuer's internal control over financial reporting; and</font></p>

<p><font size="2">5. The&nbsp; issuer's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the
&nbsp; issuer's auditors and the audit committee of the&nbsp; issuer's board of directors
(or persons performing the equivalent functions):</font> </p>

<p><font size="2">(a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably likely to
adversely affect the&nbsp; issuer's ability to record, process, summarize and report
financial information; and</font></p>

<p><font size="2">(b) Any fraud, whether r not material, that involves management or other
employees who have a significant role in the&nbsp; issuer's internal control over
financial reporting.</font></p>

<p><font size="2">Date: August 7, 2015</font></p>

<p><font size="2">/s/ Liron Carmel<br>
CEO </font></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>3
<FILENAME>exh31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>

<head>
<title>Exhibit 31</title>
</head>

<body>
<b><u><font SIZE="1">

<p align="center"></font><font size="2">CERTIFICATION</font></p>
</u>

<p></b><font size="2">I, Oded Gilboa, certify that:</font> </p>

<p><font size="2">1. I have reviewed this quarterly report of Zaxis International Inc.;</font>
</p>

<p><font size="2">2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;</font></p>

<p><font size="2">3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the&nbsp; issuer as of, and for, the
periods presented in this report;</font></p>

<p><font size="2">4. The&nbsp; issuer's other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as 4efined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the&nbsp; issuer and have:</font>
</p>

<p><font size="2">(a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the&nbsp; issuer, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;</font></p>

<p><font size="2">(b) Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</font></p>

<p><font size="2">(c) Evaluated the effectiveness of the&nbsp; issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and</font></p>

<p><font size="2">(d) Disclosed in this report any change in the&nbsp; issuer's internal
control over financial reporting that occurred during the&nbsp; issuer's most recent
fiscal quarter (the&nbsp; issuer's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
issuer's internal control over financial reporting; and</font></p>

<p><font size="2">5. The&nbsp; issuer's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the
&nbsp; issuer's auditors and the audit committee of the&nbsp; issuer's board of directors
(or persons performing the equivalent functions):</font> </p>

<p><font size="2">(a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably likely to
adversely affect the&nbsp; issuer's ability to record, process, summarize and report
financial information; and</font></p>

<p><font size="2">(b) Any fraud, whether r not material, that involves management or other
employees who have a significant role in the&nbsp; issuer's internal control over
financial reporting.</font></p>

<p><font size="2">Date: August 7, 2015</font></p>

<p><font size="2">/s/ Oded Gilboa<br>
CFO </font></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>exh32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>

<body>

<p align="left"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">Exhibit 32.1</font></p>

<p align="center"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">CERTIFICATION
PURSUANT TO<br>
18 U.S.C. SECTION 1350,<br>
AS ADOPTED PURSUANT TO SECTION 906<br>
OF THE SARBANES-OXLEY ACT OF 2002</font></p>

<p style="text-align: justify"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">In
connection with the quarterly report of Zaxis International Inc. (the &#147;Company&#148;)
on Form 10-Q for the period ended June 30, 2015 (the &#147;Report&#148;), as filed with
the Securities and Exchange Commission on the date hereof, I, Liron Carmel, CEO of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:</font></p>

<p style="text-align: justify"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">1. The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and<br>
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.</font></p>

<p><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">/s/ Liron Carmel</font></p>

<p><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">Liron Carmel<br>
CEO<br>
Dated: August 7, 2015</font></p>

<p><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">A signed original of this written
statement required by Section 906 has been provided to Zaxis International Inc. and will
be retained by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.</font></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>exh32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>

<head>
<title>Exhibit 32</title>
</head>

<body>

<p align="left"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">Exhibit 32.2</font></p>

<p align="center"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">CERTIFICATION
PURSUANT TO<br>
18 U.S.C. SECTION 1350,<br>
AS ADOPTED PURSUANT TO SECTION 906<br>
OF THE SARBANES-OXLEY ACT OF 2002</font></p>

<p style="text-align: justify"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">In
connection with the quarterly report of Zaxis International Inc. (the &#147;Company&#148;)
on Form 10-Q for the period ended June 30, 2015 (the &#147;Report&#148;), as filed with
the Securities and Exchange Commission on the date hereof, I, Oded Gilboa, CFO of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:</font></p>

<p style="text-align: justify"><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">1. The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and<br>
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.</font></p>

<p><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">/s/ Oded Gilboa</font></p>

<p><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">Oded Gilboa<br>
CFO<br>
Dated: August 7, 2015</font></p>

<p><font face="TIMES NEW ROMAN, TIMES, SERIF" size="2">A signed original of this written
statement required by Section 906 has been provided to Zaxis International Inc. and will
be retained by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.</font></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>zxsi-20150630.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2015 [PPXM8K19K1334NYCARL5]. www.edgarsuite.com -->
<xbrl xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2015-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:fil='http://dermacompare.com/20150630' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<link:schemaRef xlink:type='simple' xlink:href='zxsi-20150630.xsd' />
	<dei:DocumentType contextRef='D150101_150630'>10-Q</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='D150101_150630'>2015-06-30</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='D150101_150630'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='D150101_150630'>Zaxis International Inc.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='D150101_150630'>0000797542</dei:EntityCentralIndexKey>
	<dei:TradingSymbol contextRef='D150101_150630'>zxsi</dei:TradingSymbol>
	<dei:CurrentFiscalYearEndDate contextRef='D150101_150630'>--12-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='E15Q2' unitRef='Shares'>6550602</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityPublicFloat decimals='INF' contextRef='E15Q2' unitRef='USD'>42000</dei:EntityPublicFloat>
	<dei:EntityFilerCategory contextRef='D150101_150630'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='D150101_150630'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='D150101_150630'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='D150101_150630'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='D150101_150630'>2015</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='D150101_150630'>Q2</dei:DocumentFiscalPeriodFocus>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E15Q2' unitRef='USD'>467380</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E14' unitRef='USD'>1000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E15Q2' unitRef='USD'>467380</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E14' unitRef='USD'>1000</us-gaap:AssetsCurrent>
	<us-gaap:Assets decimals='INF' contextRef='E15Q2' unitRef='USD'>467380</us-gaap:Assets>
	<us-gaap:Assets decimals='INF' contextRef='E14' unitRef='USD'>1000</us-gaap:Assets>
	<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent decimals='INF' contextRef='E15Q2' unitRef='USD'>0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
	<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent decimals='INF' contextRef='E14' unitRef='USD'>7500</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
	<fil:AdvancesPayable decimals='INF' contextRef='E15Q2' unitRef='USD'>0</fil:AdvancesPayable>
	<fil:AdvancesPayable decimals='INF' contextRef='E14' unitRef='USD'>120979</fil:AdvancesPayable>
	<fil:AccruedInterestPayable decimals='INF' contextRef='E15Q2' unitRef='USD'>0</fil:AccruedInterestPayable>
	<fil:AccruedInterestPayable decimals='INF' contextRef='E14' unitRef='USD'>35305</fil:AccruedInterestPayable>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E15Q2' unitRef='USD'>0</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E14' unitRef='USD'>163784</us-gaap:LiabilitiesCurrent>
	<us-gaap:NotesPayable decimals='INF' contextRef='E15Q2' unitRef='USD'>0</us-gaap:NotesPayable>
	<us-gaap:NotesPayable decimals='INF' contextRef='E14' unitRef='USD'>22375</us-gaap:NotesPayable>
	<fil:TotalLongTermLiabilities decimals='INF' contextRef='E15Q2' unitRef='USD'>0</fil:TotalLongTermLiabilities>
	<fil:TotalLongTermLiabilities decimals='INF' contextRef='E14' unitRef='USD'>22375</fil:TotalLongTermLiabilities>
	<us-gaap:Liabilities decimals='INF' contextRef='E15Q2' unitRef='USD'>0</us-gaap:Liabilities>
	<us-gaap:Liabilities decimals='INF' contextRef='E14' unitRef='USD'>186159</us-gaap:Liabilities>
	<us-gaap:PreferredStockValue id='us-gaap_PreferredStockValue_E15Q2_id' xsi:nil='true' contextRef='E15Q2' unitRef='USD' />
	<us-gaap:PreferredStockValue id='us-gaap_PreferredStockValue_E14_id' xsi:nil='true' contextRef='E14' unitRef='USD' />
	<us-gaap:CommonStockValue id='us-gaap_CommonStockValue_E15Q2_id' decimals='INF' contextRef='E15Q2' unitRef='USD'>655</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue id='us-gaap_CommonStockValue_E14_id' decimals='INF' contextRef='E14' unitRef='USD'>455</us-gaap:CommonStockValue>
	<fil:StockPayable decimals='INF' contextRef='E15Q2' unitRef='USD'>385000</fil:StockPayable>
	<fil:StockPayable decimals='INF' contextRef='E14' unitRef='USD'>0</fil:StockPayable>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E15Q2' unitRef='USD'>1283342</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E14' unitRef='USD'>388450</us-gaap:AdditionalPaidInCapital>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E15Q2' unitRef='USD'>-1201617</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E14' unitRef='USD'>-574064</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E15Q2' unitRef='USD'>467380</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E14' unitRef='USD'>-185159</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E15Q2' unitRef='USD'>467380</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E14' unitRef='USD'>1000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:Revenues decimals='INF' contextRef='Y15Q2' unitRef='USD'>0</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='Y14Q2' unitRef='USD'>0</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='D150101_150630' unitRef='USD'>0</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='D140101_140630' unitRef='USD'>0</us-gaap:Revenues>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y15Q2' unitRef='USD'>88390</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y14Q2' unitRef='USD'>6500</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D150101_150630' unitRef='USD'>132326</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D140101_140630' unitRef='USD'>14250</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:OtherGeneralExpense decimals='INF' contextRef='Y15Q2' unitRef='USD'>300000</us-gaap:OtherGeneralExpense>
	<us-gaap:OtherGeneralExpense decimals='INF' contextRef='Y14Q2' unitRef='USD'>0</us-gaap:OtherGeneralExpense>
	<us-gaap:OtherGeneralExpense decimals='INF' contextRef='D150101_150630' unitRef='USD'>490000</us-gaap:OtherGeneralExpense>
	<us-gaap:OtherGeneralExpense decimals='INF' contextRef='D140101_140630' unitRef='USD'>0</us-gaap:OtherGeneralExpense>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y15Q2' unitRef='USD'>388390</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y14Q2' unitRef='USD'>6500</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='D150101_150630' unitRef='USD'>622326</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='D140101_140630' unitRef='USD'>14250</us-gaap:OperatingExpenses>
	<us-gaap:IncomeLossFromContinuingOperations decimals='INF' contextRef='Y15Q2' unitRef='USD'>-388390</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:IncomeLossFromContinuingOperations decimals='INF' contextRef='Y14Q2' unitRef='USD'>-6500</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:IncomeLossFromContinuingOperations decimals='INF' contextRef='D150101_150630' unitRef='USD'>-622326</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:IncomeLossFromContinuingOperations decimals='INF' contextRef='D140101_140630' unitRef='USD'>-14250</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:InterestExpense decimals='INF' contextRef='Y15Q2' unitRef='USD'>-1688</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='Y14Q2' unitRef='USD'>-307</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='D150101_150630' unitRef='USD'>-4699</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='D140101_140630' unitRef='USD'>-2678</us-gaap:InterestExpense>
	<us-gaap:DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 decimals='INF' contextRef='Y15Q2' unitRef='USD'>-528</us-gaap:DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1>
	<us-gaap:DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 decimals='INF' contextRef='D150101_150630' unitRef='USD'>-528</us-gaap:DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1>
	<fil:FinancialIncomeExpense decimals='INF' contextRef='Y15Q2' unitRef='Pure'>-2216</fil:FinancialIncomeExpense>
	<fil:FinancialIncomeExpense decimals='INF' contextRef='Y14Q2' unitRef='Pure'>-307</fil:FinancialIncomeExpense>
	<fil:FinancialIncomeExpense decimals='INF' contextRef='D150101_150630' unitRef='Pure'>-5227</fil:FinancialIncomeExpense>
	<fil:FinancialIncomeExpense decimals='INF' contextRef='D140101_140630' unitRef='Pure'>-2678</fil:FinancialIncomeExpense>
	<fil:ProvisionForIncomeTaxes decimals='INF' contextRef='Y15Q2' unitRef='Pure'>0</fil:ProvisionForIncomeTaxes>
	<fil:ProvisionForIncomeTaxes decimals='INF' contextRef='Y14Q2' unitRef='Pure'>0</fil:ProvisionForIncomeTaxes>
	<fil:ProvisionForIncomeTaxes decimals='INF' contextRef='D150101_150630' unitRef='Pure'>0</fil:ProvisionForIncomeTaxes>
	<fil:ProvisionForIncomeTaxes decimals='INF' contextRef='D140101_140630' unitRef='Pure'>0</fil:ProvisionForIncomeTaxes>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y15Q2' unitRef='USD'>-390606</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y14Q2' unitRef='USD'>-6807</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D150101_150630' unitRef='USD'>-627553</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D140101_140630' unitRef='USD'>-16928</us-gaap:NetIncomeLoss>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y15Q2' unitRef='UsdPerShare'>-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y14Q2' unitRef='UsdPerShare'>-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D150101_150630' unitRef='UsdPerShare'>-0.13</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D140101_140630' unitRef='UsdPerShare'>-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y15Q2' unitRef='Shares'>4682407</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y14Q2' unitRef='Shares'>1695126</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D150101_150630' unitRef='Shares'>4682407</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D140101_140630' unitRef='Shares'>1695126</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<fil:NetLoss decimals='INF' contextRef='D150101_150630' unitRef='Pure'>-627553</fil:NetLoss>
	<fil:NetLoss decimals='INF' contextRef='D140101_140630' unitRef='Pure'>-16928</fil:NetLoss>
	<fil:LossGainOnDebtSettlement decimals='INF' contextRef='D150101_150630' unitRef='Pure'>528</fil:LossGainOnDebtSettlement>
	<fil:LossGainOnDebtSettlement decimals='INF' contextRef='D140101_140630' unitRef='Pure'>0</fil:LossGainOnDebtSettlement>
	<fil:ImputedInterest decimals='INF' contextRef='D150101_150630' unitRef='Pure'>4113</fil:ImputedInterest>
	<fil:ImputedInterest decimals='INF' contextRef='D140101_140630' unitRef='Pure'>0</fil:ImputedInterest>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF' contextRef='D150101_150630' unitRef='USD'>-7500</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF' contextRef='D140101_140630' unitRef='USD'>0</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D150101_150630' unitRef='USD'>-35833</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D140101_140630' unitRef='USD'>9178</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D150101_150630' unitRef='USD'>-666245</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D140101_140630' unitRef='USD'>-7750</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D150101_150630' unitRef='USD'>0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D140101_140630' unitRef='USD'>0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<fil:AdvancesFromRelatedParties decimals='INF' contextRef='D150101_150630' unitRef='Pure'>0</fil:AdvancesFromRelatedParties>
	<fil:AdvancesFromRelatedParties decimals='INF' contextRef='D140101_140630' unitRef='Pure'>7750</fil:AdvancesFromRelatedParties>
	<fil:PrincipalPayamentsOnDebt decimals='INF' contextRef='D150101_150630' unitRef='Pure'>-52375</fil:PrincipalPayamentsOnDebt>
	<fil:PrincipalPayamentsOnDebt decimals='INF' contextRef='D140101_140630' unitRef='Pure'>0</fil:PrincipalPayamentsOnDebt>
	<fil:ProceedFromSaleOfCommonStock decimals='INF' contextRef='D150101_150630' unitRef='Pure'>1185000</fil:ProceedFromSaleOfCommonStock>
	<fil:ProceedFromSaleOfCommonStock decimals='INF' contextRef='D140101_140630' unitRef='Pure'>0</fil:ProceedFromSaleOfCommonStock>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D150101_150630' unitRef='USD'>1132625</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D140101_140630' unitRef='USD'>7750</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF' contextRef='D150101_150630' unitRef='USD'>466380</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF' contextRef='D140101_140630' unitRef='USD'>0</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<fil:CashAndCashEquivalentsBeginningOfPeriod decimals='INF' contextRef='E14' unitRef='Pure'>1000</fil:CashAndCashEquivalentsBeginningOfPeriod>
	<fil:CashAndCashEquivalentsBeginningOfPeriod decimals='INF' contextRef='E13' unitRef='Pure'>0</fil:CashAndCashEquivalentsBeginningOfPeriod>
	<fil:CashAndCashEquivalentsEndOfPeriod decimals='INF' contextRef='E15Q2' unitRef='Pure'>467380</fil:CashAndCashEquivalentsEndOfPeriod>
	<fil:CashAndCashEquivalentsEndOfPeriod decimals='INF' contextRef='E14Q2' unitRef='Pure'>0</fil:CashAndCashEquivalentsEndOfPeriod>
	<fil:TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties decimals='INF' contextRef='E15Q2' unitRef='Pure'>0</fil:TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties>
	<fil:TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties decimals='INF' contextRef='E14Q2' unitRef='Pure'>85000</fil:TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties>
	<fil:TransferOfAdvancesFromRelatedPartyToUnrelatedParty decimals='INF' contextRef='D150101_150630' unitRef='Pure'>0</fil:TransferOfAdvancesFromRelatedPartyToUnrelatedParty>
	<fil:TransferOfAdvancesFromRelatedPartyToUnrelatedParty decimals='INF' contextRef='D140101_140630' unitRef='Pure'>40000</fil:TransferOfAdvancesFromRelatedPartyToUnrelatedParty>
	<us-gaap:NatureOfOperations contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p&gt;&lt;b&gt;Note 1. The Company&lt;/b&gt;&lt;/p&gt; &lt;p&gt;&lt;i&gt;Organizational Background:&lt;/i&gt;&amp;nbsp;&amp;nbsp; Emerald Medical Applications Corp. (&amp;quot;the Company&amp;quot;) (f/k/a Zaxis International Inc.) was incorporated in Ohio in 1989. On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company (&amp;quot;InFerGene&amp;quot;) and InFerGene changed its name to Zaxis International Inc. InFerGene was incorporated in California in 1984 and subsequently changed its domicile in connection with the merger into Zaxis to Delaware in 1985. Operations ceased operations in 2002. In November 2002, the Company and its subsidiaries filed a petition for bankruptcy in the U.S. Bankruptcy Court Northern District of Ohio. On October 13, 2004, the Company emerged from bankruptcy. At present, the Company has no business operations and is deemed to be a shell company.&lt;/p&gt; &lt;p&gt;&lt;i&gt;Basis of Presentation:&lt;/i&gt;&amp;nbsp;&amp;nbsp; The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of June 30, 2015, the cash resources of the Company were insufficient to meet its current business plan, and the Company had negative working capital. These and other factors raise substantial doubt about the Company&apos;s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.&lt;/p&gt; &lt;p&gt;&lt;i&gt;Significant Accounting Policies&lt;/i&gt;&lt;/p&gt; &lt;p&gt;&lt;i&gt;Use of Estimates:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Cash and Cash Equivalents:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents. There were no cash equivalents as of June 30, 2015 and December 31, 2014.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Property and Equipment:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;New property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Valuation of Long-Lived Assets:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We review the recoverability of our long-lived assets including equipment, goodwill and other intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference between estimated fair value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make estimates of these cash flows related to long-lived assets, as well as other fair value determinations.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Stock Based Compensation:&amp;nbsp;&lt;/i&gt;&amp;nbsp; &lt;/p&gt; &lt;p&gt;Stock-based awards are accounted for using the fair value method in accordance with ASC 718,&amp;nbsp;&lt;i&gt;Share-Based Payments&lt;/i&gt;. Our primary type of share-based compensation consists of stock options. We use the Black-Scholes option pricing model in valuing options. The inputs for the valuation analysis of the options include the market value of the Company&apos;s common stock, the estimated volatility of the Company&apos;s common stock, the exercise price of the warrants and the risk free interest rate.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Accounting For Obligations And Instruments Potentially To Be Settled In The Company&apos;s Own Stock:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We account for obligations and instruments potentially to be settled in the Company&apos;s stock in accordance with FASB ASC 815,&amp;nbsp;Accounting for Derivative Financial Instruments.&amp;nbsp;This issue addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially settled in, the Company&apos;s own stock.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Fair Value of Financial Instruments:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;FASB ASC 825, &lt;i&gt;Financial Instruments&lt;/i&gt;, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2015 and 2014, the carrying value of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair value due to the short-term nature of the instruments or interest rates, which are comparable with current rates. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Fair Value Measurements:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;The Company measures fair value under a framework that utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of inputs which prioritize the inputs used in measuring fair value are:&lt;/p&gt; &lt;p&gt;&lt;i&gt;Level 1:&lt;/i&gt; Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access. &lt;i&gt;Level 2:&lt;/i&gt; Inputs to the valuation methodology include: - Quoted prices for similar assets or liabilities in active markets; - Quoted prices for identical or similar assets or liabilities in inactive markets; - Inputs other than quoted prices that are observable for the asset or liability; - Inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability. &lt;i&gt;Level 3:&lt;/i&gt; Inputs to the valuation methodology are unobservable and significant to the fair value measurement.&lt;/p&gt; &lt;p&gt;The assets or liability&apos;s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. The following table presents assets that were measured and recognize at fair value on March 31, 2015 and the year then ended on a recurring basis:&lt;/p&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;100%&quot; colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;width:100.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Fair Value Measurements at June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Quoted Prices in Active&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Markets for Identical Assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Observable Inputs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Unobservable Inputs&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 1)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 2) &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 3) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total assets at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp; &amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td colspan=&quot;9&quot; style=&apos;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Fair Value Measurements at December&amp;nbsp;31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td style=&apos;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Quoted Prices in Active&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Markets for Identical Assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Observable Inputs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Unobservable Inputs&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 1)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 2) &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 3) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total assets at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it may need to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. For the fiscal periods ended Jun e30, 2015 and December 31, 2014, there were no significant transfers of financial assets or financial liabilities between the hierarchy levels.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Earnings per Common Share:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We compute net income (loss) per share in accordance with ASC 260,&amp;nbsp;&lt;i&gt;Earning per Share&lt;/i&gt;. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. All per share disclosures retroactively reflect shares outstanding or issuable as though the reverse split had occurred January 1, 2012.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Income Taxes:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We have adopted FASB ASC 740,&amp;nbsp;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;.&amp;nbsp;Pursuant to ASC 740, we are required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.&lt;/p&gt; &lt;p&gt;We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes.&lt;/p&gt; &lt;p&gt;Deferred tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect when the differences are expected to reverse. ASC 740 provides for the recognition of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.&lt;/p&gt; &lt;p&gt;In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be.&lt;/p&gt; &lt;p&gt;ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current period and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Uncertain Tax Positions:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, &lt;i&gt;Accounting for Uncertain Income Tax Positions,&lt;/i&gt; the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.&lt;/p&gt; &lt;p&gt;Our federal and state income tax returns are open for fiscal years ending on or after December 31, 2011. We are not under examination by any jurisdiction for any tax year. At March 31, 2015 we had no material unrecognized tax benefits and no adjustments to liabilities or operations were required under FIN&amp;nbsp;48.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/p&gt; &lt;p&gt;On June 10, 2014, the FASB issued Accounting Standards Update (&amp;quot;ASU&amp;quot;) No. 2014-10 , which eliminates development stage reporting requirements under FASB ASC 915, as well as amends provisions of existing variable interest entity guidance under ASC 810. Additionally, the ASU indicates that the lack of commencement of principal operations represents a risk and uncertainty and, accordingly, is subject to the disclosure requirements of FASB ASC 275. As a result of the changes, existing development stage entity presentation and disclosure requirements are eliminated. The presentation and disclosure changes to FASB ASC 915 are effective for public entities for annual periods beginning after December 15, 2014, and the revisions to the consolidation standards are effective for annual periods beginning after December 15, 2015. The Company has adopted these provisions and enhanced disclosure of risks and uncertainties as required. &lt;/p&gt; &lt;p&gt;In April 2014, the FASB issued ASU 2014-08,&lt;i&gt; Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity&lt;/i&gt;. The amendments in this ASU change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization&apos;s operations and financial results and include disposals of a major geographic area, a major line of business, or a major equity method investment. The new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. Additionally, the new guidance requires disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify for discontinued operations reporting. The amendments in the ASU are effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2014. Early adoption is permitted. The Company is currently evaluating the impact of this pronouncement.&lt;/p&gt; &lt;p&gt;In August 2014, the FASB issued ASU 2014-15, &lt;i&gt;Presentation of Financial Statements - Going Concern&lt;/i&gt;. The new standard requires management of public and private companies to evaluate whether there is substantial doubt about the entity&apos;s ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The standard requires management to evaluate, for each reporting period, whether there are conditions or events that raise substantial doubt about a company&apos;s ability to continue as a going concern within one year from the date the financial statements are issued. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.&lt;/p&gt; &lt;p&gt;Management does not anticipate that the adoption of these standards will have a material impact on the financial statements.&lt;/p&gt; </us-gaap:NatureOfOperations>
	<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 2. Going Concern&lt;/b&gt;&lt;/p&gt; &lt;p&gt;The accompanying financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses, has negative operational cash flows and has no revenues. The future of the Company is dependent upon Management success in its efforts and limited resources to pursue and effect a business combination.&lt;/p&gt; &lt;p&gt;These conditions raise substantial doubt about the Company&apos;s ability to continue as a going concern. These financial statements do not include any adjustments that might arise from this uncertainty.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 3. Stockholders&apos; Equity&lt;/b&gt;&lt;/p&gt; &lt;p&gt;On January 8, 2015 the shareholders approved a resolution to increase the authorized common shares from 100,000,000 to 490,000,000 shares. All other provisions of the common shares remain unchanged. Also on that date, the Company declared a reverse split of common stock at the ration of 1:4. The stock split was effective January 8, 2015 for holders of record as of that date. Except as otherwise noted, all share, option and warrant numbers have been restated to give retroactive effect to this split. All per share disclosures retroactively reflect shares outstanding or issuable as though the reverse split had occurred at January 1, 2012.&lt;/p&gt; &lt;p&gt;&lt;i&gt;Recent Issuances of Common Stock&lt;/i&gt;&lt;/p&gt; &lt;p&gt;During the period ended December 31, 2014 we issued 4,125,000 shares of our common stock (16,500,000 pre-reverse stock split) in exchange for converting $125,000 of promissory notes. &lt;/p&gt; &lt;p&gt;Between January 15, 2015 and March 15, 2015 the Company sold a total of 2,052,000 units for cash consideration of $780,000 at a price of $0.40 (the &amp;quot;Units&amp;quot;), each unit comprised of one share of common stock and one Class A warrant exercisable at $0.80 per share with a term 24 month. The relative fair value of the stock with embedded warrants was $351,419 for the common stock and $428,581 for the class A warrants. The warrants were valued using the Black-Scholes model with 216% volatility and discount rates ranging between 0.44% to 0.7%. The cash consideration is reflected in stock payable as shares will be issued after reverse merger is completed. &lt;/p&gt; &lt;p&gt;Between April 1, 2015 and June 29, 2015 the Company sold a total of 1,012,500 units for cash consideration of $405,000 at a price of $0.40 (the &amp;quot;Units&amp;quot;), each unit comprised of one share of common stock and one Class A warrant exercisable at $0.80 per share with a term 24 month. The relative fair value of the stock with embedded warrants was $158,123 for the common stock and $246,877 for the class A warrants. The warrants were valued using the Black-Scholes model with volatility ranging between163% - 177% and discount rates ranging between 0.54% to 0.71%. The cash consideration is reflected in stock payable as shares will be issued after reverse merger is completed. &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 4. Related Party Transactions Not Disclosed Elsewhere&lt;/b&gt;&lt;/p&gt; &lt;p&gt;On March 25, 2014, our President and principal shareholder assigned accumulated advances and accruals totaling $124,229, to an unaffiliated third party. The advances carry no specific terms of repayment. On December 15, 2014, $22,375 of the then outstanding balance was converted to a promissory note. A summary of transactions is as follows:&lt;/p&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp; &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;December 31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Beginning balance&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;161,729&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Increase due to payments made on behalf of the company&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;21,625&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less March 24, 2014 conversion to convertible note&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(40,000)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less December 15, 2014 conversion to promissory note&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(22,375)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Obligation transferred to unrelated party&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(120,979)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Due after one year&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;There was no stated term of interest associated with this obligation. Accordingly, the company imputed interest at an appropriate rate estimated at 8% as prescribed under FASB ASC 835. For the period ending December 31, 2014 the resultant charge of $11,210 to interest expense was considered a contribution of capital. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:LongTermDebtTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 5. Notes Payable&lt;/b&gt;&lt;/p&gt; &lt;p&gt;&lt;i&gt;Convertible Notes Payable&lt;/i&gt;&lt;/p&gt; &lt;p&gt;On March 24, 2014, we issued a convertible promissory note in the amount of $40,000 to an unaffiliated party in consideration for past services provided to the Company. The Note bears interest at the rate of 1% per annum, is due and payable on March 24, 2015 and is convertible at a price of $0.005 per share. On March 24, 2014, the holder of the 2014 Note transferred and assigned the 2014 Note to five unaffiliated parties bearing the same interest rate and conversion price. In connection with the transfer and assignment of the 2014 Note, the Company agreed to extend the maturity date from March 24, 2015 to July 1, 2016. &lt;/p&gt; &lt;p&gt;On December 10, 2014, upon the request of all fifteen note holders, all convertible promissory notes in the aggregate principal amount of $125,000 were converted into 4,125,000 shares (16,500,000 pre-reverse stock split) consistent with the provisions of the notes. Related accrued interest of $35,295 was not included in the conversion and remains unpaid at June 30, 2015.&lt;/p&gt; &lt;p&gt;In accordance to ASC #815, Accounting for Derivative Instruments and Hedging Activities, we evaluated the holder&apos;s non-detachable conversion right provision and liquidated damages clause, contained in the terms governing the Note to determine whether the features qualify as an embedded derivative instruments at issuance. Such non-detachable conversion right provision and liquidated damages clause did not need to be accounted for as derivative financial instruments. Additionally, since the conversion price of the two notes represented the fair market value of the Company&apos;s common stock at the time of issuance, no beneficial conversion feature exists. We believe that the Company&apos;s shares of common stock is and have been very thinly traded during the last 3 years and that the fair value of the stock price was deemed not to be a fair value. Management decided that because the Company&apos;s ability to continue as a going concern was in question and that it has no revenue sources that the conversion price was a better measure of fair market value. Based on that decision, no beneficial conversion feature was reflected in the financial statements.&lt;/p&gt; &lt;p&gt;&lt;i&gt;Note Payable - Not Convertible&lt;/i&gt;&lt;/p&gt; &lt;p&gt;On December 15, 2014, we issued a promissory note in the amount of $22,375 to an unaffiliated party in consideration for payments made on behalf of the Company for service provided to the Company (the &amp;quot;December 2014 Note&amp;quot;). The December 2014 Note bears interest at the rate of 1% per annum, is due and payable on January 15, 2016 and is not convertible to common stock. &lt;/p&gt; &lt;p&gt;On January 14 and 16, 2015, we issued two promissory notes in the amount of $15,000 each to two different unaffiliated party in consideration for cash transferred to the Company (the &amp;quot;January 2015 Notes&amp;quot;). The January 2015 Notes bears interest at the rate of 1% per annum, are due and payable on January 14 and 16, 2016 and are not convertible to common stock. &lt;/p&gt; &lt;p&gt;One of the notes was repaid in full during the first quarter with interest due waived the by the debtor, and the second note was repaid during the second quarter with interest due waived the by the debtor.&lt;/p&gt; &lt;p&gt;During the second quarter the promissory note in the amount of $22,375 with interest due was repaid in full. &lt;/p&gt; &lt;p&gt;During the second quarter an agreement was reached with the holder of $120,979 advance payable note to settle the full amount due for $30,000 and interest due. The settlement with all note holders resulted in $528 loss on debt settlement as well as a charge of $90,979 considered a contribution of capital.&lt;/p&gt; &lt;p&gt;We concluded that these notes have a stated rate of interest that is different from the rate of interest that is appropriate for this type of debt at the date of the transaction. Accordingly, the company imputed interest at an appropriate rate estimated at 8% as prescribed under FASB ASC 835. The resultant charge of $6,280 for the period ending December 31, 2014 and $4,113 for the period ending June 30, 2015 to interest expense was considered a contribution of capital.&lt;/p&gt; &lt;p&gt;For the periods ending June 30, 2015 and December 31, 2014 the Company has recognized $4,699 and $3,255 respectively in accrued interest expense related to the stated interest rate on the notes and has recognized $4,113 and $17,490 in imputed interest expense. &lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 6. Income Taxes&lt;/b&gt;&lt;/p&gt; &lt;p&gt;We have adopted ASC 740 which provides for the recognition of a deferred tax asset based upon the value the loss carry-forwards will have to reduce future income taxes and management&apos;s estimate of the probability of the realization of these tax benefits. Our net operating loss carryovers incurred prior to 2014 considered available to reduce future income taxes were reduced or eliminated through our recent change of control (I.R.C. Section 382(a)) and the continuity of business limitation of I.R.C. Section 382(c). &lt;/p&gt; &lt;p&gt;We have a current operating loss carry-forward of $784,725 resulting in deferred tax assets of $0. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all our net deferred tax asset.&lt;/p&gt; &lt;p&gt;Future utilization of currently generated federal and state NOL and tax credit carry forwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended and similar state provisions. The annual limitation may result in the expiration of NOL and tax credit carry forwards before full utilization.&lt;/p&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;December 31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Individual components giving rise to the deferred tax assets are as follows:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Future tax benefit arising from net operating loss carryovers &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;784,725&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;157,172&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less valuation allowance&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(784,725)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(157,172)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Net deferred asset&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company is not under examination by any jurisdiction for any tax year. Our federal and state income tax returns are open for fiscal years ending on or after December 31, 2011.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:ShortTermDebtDescription contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 7. Advances to Related Party&lt;/b&gt;&lt;/p&gt; &lt;p&gt;On February 3, 2015, March 23, 2015, 4 May, 2015, June 6, 2015 and June 26, 2015, $90,000, $100,000, $100,000, $100,000, $100,000 respectively, were advanced to a company that Zaxis is in merger discussions with. These loans shall bear interest at the rate of one (1%) percent per annum (the &amp;quot;Interest Rate&amp;quot;) and shall be due and payable ninety (90) days from the date of the Loan (the &amp;quot;Maturity Date&amp;quot;). Since collectability is not reasonably assured this amount is being expensed in the statement of operations. &lt;/p&gt; &lt;p&gt;The ability of the third party loanee Emerald Medical Applications Ltd to repay the loans as a standalone company is highly in doubt since it used the loan proceeds for ongoing business operations. If, for any reason, the merger with Zaxis, which is in advance stages of closing, does not close Emerald Medical Applications Ltd. will not have sufficient funds to repay the loan. &lt;/p&gt;</us-gaap:ShortTermDebtDescription>
	<us-gaap:SubsequentEventsTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;Note 8. Subsequent Events&lt;/b&gt;&lt;/p&gt; &lt;p&gt;In July 2015, the Company filed a Form 8-K/12G with the SEC for the merger between the Company and Emerald Medical Applications Ltd. On August 5, 2015, the Company filed a registration statement on Form S-1 for selling security holders offering 19,361,758 shares of common stock.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:UseOfEstimates contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p&gt;&lt;i&gt;Use of Estimates:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Cash and Cash Equivalents:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents. There were no cash equivalents as of June 30, 2015 and December 31, 2014.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
	<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Property and Equipment:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;New property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
	<us-gaap:PropertyPlantAndEquipmentBasisOfValuation contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Valuation of Long-Lived Assets:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We review the recoverability of our long-lived assets including equipment, goodwill and other intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference between estimated fair value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make estimates of these cash flows related to long-lived assets, as well as other fair value determinations.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentBasisOfValuation>
	<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Stock Based Compensation:&amp;nbsp;&lt;/i&gt;&amp;nbsp; &lt;/p&gt; &lt;p&gt;Stock-based awards are accounted for using the fair value method in accordance with ASC 718,&amp;nbsp;&lt;i&gt;Share-Based Payments&lt;/i&gt;. Our primary type of share-based compensation consists of stock options. We use the Black-Scholes option pricing model in valuing options. The inputs for the valuation analysis of the options include the market value of the Company&apos;s common stock, the estimated volatility of the Company&apos;s common stock, the exercise price of the warrants and the risk free interest rate.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
	<us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Accounting For Obligations And Instruments Potentially To Be Settled In The Company&apos;s Own Stock:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We account for obligations and instruments potentially to be settled in the Company&apos;s stock in accordance with FASB ASC 815,&amp;nbsp;Accounting for Derivative Financial Instruments.&amp;nbsp;This issue addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially settled in, the Company&apos;s own stock.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
	<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Fair Value of Financial Instruments:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;FASB ASC 825, &lt;i&gt;Financial Instruments&lt;/i&gt;, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2015 and 2014, the carrying value of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair value due to the short-term nature of the instruments or interest rates, which are comparable with current rates. &lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
	<us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Fair Value Measurements:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;The Company measures fair value under a framework that utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of inputs which prioritize the inputs used in measuring fair value are:&lt;/p&gt; &lt;p&gt;&lt;i&gt;Level 1:&lt;/i&gt; Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access. &lt;i&gt;Level 2:&lt;/i&gt; Inputs to the valuation methodology include: - Quoted prices for similar assets or liabilities in active markets; - Quoted prices for identical or similar assets or liabilities in inactive markets; - Inputs other than quoted prices that are observable for the asset or liability; - Inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability. &lt;i&gt;Level 3:&lt;/i&gt; Inputs to the valuation methodology are unobservable and significant to the fair value measurement.&lt;/p&gt; &lt;p&gt;The assets or liability&apos;s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. The following table presents assets that were measured and recognize at fair value on March 31, 2015 and the year then ended on a recurring basis:&lt;/p&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;100%&quot; colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;width:100.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Fair Value Measurements at June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Quoted Prices in Active&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Markets for Identical Assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Observable Inputs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Unobservable Inputs&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 1)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 2) &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 3) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total assets at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp; &amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td colspan=&quot;9&quot; style=&apos;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Fair Value Measurements at December&amp;nbsp;31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td style=&apos;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Quoted Prices in Active&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Markets for Identical Assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Observable Inputs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Unobservable Inputs&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 1)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 2) &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 3) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total assets at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it may need to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. For the fiscal periods ended Jun e30, 2015 and December 31, 2014, there were no significant transfers of financial assets or financial liabilities between the hierarchy levels.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Earnings per Common Share:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We compute net income (loss) per share in accordance with ASC 260,&amp;nbsp;&lt;i&gt;Earning per Share&lt;/i&gt;. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. All per share disclosures retroactively reflect shares outstanding or issuable as though the reverse split had occurred January 1, 2012.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:IncomeTaxPolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Income Taxes:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;We have adopted FASB ASC 740,&amp;nbsp;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;.&amp;nbsp;Pursuant to ASC 740, we are required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.&lt;/p&gt; &lt;p&gt;We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes.&lt;/p&gt; &lt;p&gt;Deferred tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect when the differences are expected to reverse. ASC 740 provides for the recognition of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.&lt;/p&gt; &lt;p&gt;In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be.&lt;/p&gt; &lt;p&gt;ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current period and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
	<us-gaap:IncomeTaxUncertaintiesPolicy contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Uncertain Tax Positions:&lt;/i&gt;&amp;nbsp;&amp;nbsp; &lt;/p&gt; &lt;p&gt;When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, &lt;i&gt;Accounting for Uncertain Income Tax Positions,&lt;/i&gt; the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.&lt;/p&gt; &lt;p&gt;Our federal and state income tax returns are open for fiscal years ending on or after December 31, 2011. We are not under examination by any jurisdiction for any tax year. At March 31, 2015 we had no material unrecognized tax benefits and no adjustments to liabilities or operations were required under FIN&amp;nbsp;48.&lt;/p&gt;</us-gaap:IncomeTaxUncertaintiesPolicy>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/p&gt; &lt;p&gt;On June 10, 2014, the FASB issued Accounting Standards Update (&amp;quot;ASU&amp;quot;) No. 2014-10 , which eliminates development stage reporting requirements under FASB ASC 915, as well as amends provisions of existing variable interest entity guidance under ASC 810. Additionally, the ASU indicates that the lack of commencement of principal operations represents a risk and uncertainty and, accordingly, is subject to the disclosure requirements of FASB ASC 275. As a result of the changes, existing development stage entity presentation and disclosure requirements are eliminated. The presentation and disclosure changes to FASB ASC 915 are effective for public entities for annual periods beginning after December 15, 2014, and the revisions to the consolidation standards are effective for annual periods beginning after December 15, 2015. The Company has adopted these provisions and enhanced disclosure of risks and uncertainties as required. &lt;/p&gt; &lt;p&gt;In April 2014, the FASB issued ASU 2014-08,&lt;i&gt; Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity&lt;/i&gt;. The amendments in this ASU change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization&apos;s operations and financial results and include disposals of a major geographic area, a major line of business, or a major equity method investment. The new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. Additionally, the new guidance requires disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify for discontinued operations reporting. The amendments in the ASU are effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2014. Early adoption is permitted. The Company is currently evaluating the impact of this pronouncement.&lt;/p&gt; &lt;p&gt;In August 2014, the FASB issued ASU 2014-15, &lt;i&gt;Presentation of Financial Statements - Going Concern&lt;/i&gt;. The new standard requires management of public and private companies to evaluate whether there is substantial doubt about the entity&apos;s ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The standard requires management to evaluate, for each reporting period, whether there are conditions or events that raise substantial doubt about a company&apos;s ability to continue as a going concern within one year from the date the financial statements are issued. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.&lt;/p&gt; &lt;p&gt;Management does not anticipate that the adoption of these standards will have a material impact on the financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;100%&quot; colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;width:100.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Fair Value Measurements at June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Quoted Prices in Active&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Markets for Identical Assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Observable Inputs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Unobservable Inputs&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 1)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 2) &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 3) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total assets at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp; &amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td colspan=&quot;9&quot; style=&apos;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Fair Value Measurements at December&amp;nbsp;31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td style=&apos;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Quoted Prices in Active&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Significant&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Markets for Identical Assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Observable Inputs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Unobservable Inputs&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;bottom&quot; style=&apos;width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 1)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;bottom&quot; style=&apos;width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 2) &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;bottom&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;(Level 3) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;36%&quot; valign=&quot;top&quot; style=&apos;width:36.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total assets at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;17%&quot; valign=&quot;top&quot; style=&apos;width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12%&quot; valign=&quot;top&quot; style=&apos;width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td colspan=&quot;9&quot; valign=&quot;top&quot; style=&apos;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
	<us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp; &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;December 31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Beginning balance&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;161,729&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Increase due to payments made on behalf of the company&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;21,625&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less March 24, 2014 conversion to convertible note&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(40,000)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less December 15, 2014 conversion to promissory note&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(22,375)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Obligation transferred to unrelated party&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(120,979)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;68%&quot; style=&apos;width:68.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Due after one year&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15%&quot; style=&apos;width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
	<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef='D150101_150630'>&lt;!--egx--&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%&apos;&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;June 30, 2015&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; style=&apos;width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;December 31, 2014&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Individual components giving rise to the deferred tax assets are as follows:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Future tax benefit arising from net operating loss carryovers &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;784,725&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;157,172&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Less valuation allowance&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(784,725)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(157,172)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:.75pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;top&quot; style=&apos;width:70.0%;padding:0;height:.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Net deferred asset&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.0%;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;13%&quot; valign=&quot;top&quot; style=&apos;width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
	<context id='E15Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<instant>2015-06-30</instant>
		</period>
	</context>
	<context id='D150101_150630'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<startDate>2015-01-01</startDate>
			<endDate>2015-06-30</endDate>
		</period>
	</context>
	<context id='E14'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<instant>2014-12-31</instant>
		</period>
	</context>
	<context id='Y15Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<startDate>2015-04-01</startDate>
			<endDate>2015-06-30</endDate>
		</period>
	</context>
	<context id='Y14Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<startDate>2014-04-01</startDate>
			<endDate>2014-06-30</endDate>
		</period>
	</context>
	<context id='D140101_140630'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<startDate>2014-01-01</startDate>
			<endDate>2014-06-30</endDate>
		</period>
	</context>
	<context id='E13'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<instant>2013-12-31</instant>
		</period>
	</context>
	<context id='E14Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000797542</identifier>
		</entity>
		<period>
			<instant>2014-06-30</instant>
		</period>
	</context>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='Shares'>
		<measure>shares</measure>
	</unit>
	<unit id='Pure'>
		<measure>pure</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>shares</measure>
			</unitDenominator>
		</divide>
	</unit>
	<link:footnoteLink xlink:type='extended' xlink:role='http://www.xbrl.org/2003/role/link'>
		<link:loc xlink:type='locator' xlink:label='us-gaap_PreferredStockValue_E15Q2_lab' xlink:href='#us-gaap_PreferredStockValue_E15Q2_id' />
		<link:footnote xlink:type='resource' xlink:label='footnote_55C4C3EC0' xlink:role='http://www.xbrl.org/2003/role/footnote' xml:lang='en-US'>$0.0001 par value; 10,000,000 shares authorized; none issued.</link:footnote>
		<link:footnoteArc xlink:type='arc' order='1.0' xlink:from='us-gaap_PreferredStockValue_E15Q2_lab' xlink:to='footnote_55C4C3EC0' xlink:arcrole='http://www.xbrl.org/2003/arcrole/fact-footnote' />
		<link:loc xlink:type='locator' xlink:label='us-gaap_PreferredStockValue_E14_lab' xlink:href='#us-gaap_PreferredStockValue_E14_id' />
		<link:footnoteArc xlink:type='arc' order='1.0' xlink:from='us-gaap_PreferredStockValue_E14_lab' xlink:to='footnote_55C4C3EC0' xlink:arcrole='http://www.xbrl.org/2003/arcrole/fact-footnote' />
		<link:loc xlink:type='locator' xlink:label='us-gaap_CommonStockValue_E15Q2_lab' xlink:href='#us-gaap_CommonStockValue_E15Q2_id' />
		<link:footnote xlink:type='resource' xlink:label='footnote_55C4C3EC1' xlink:role='http://www.xbrl.org/2003/role/footnote' xml:lang='en-US'>$0.0001 par value; 100,000,000 shares authorized; 6,550,602 and 4,550,602 issued and outstanding at June 30, 2015 and December 31, 2014, respectively.</link:footnote>
		<link:footnoteArc xlink:type='arc' order='1.0' xlink:from='us-gaap_CommonStockValue_E15Q2_lab' xlink:to='footnote_55C4C3EC1' xlink:arcrole='http://www.xbrl.org/2003/arcrole/fact-footnote' />
		<link:loc xlink:type='locator' xlink:label='us-gaap_CommonStockValue_E14_lab' xlink:href='#us-gaap_CommonStockValue_E14_id' />
		<link:footnoteArc xlink:type='arc' order='1.0' xlink:from='us-gaap_CommonStockValue_E14_lab' xlink:to='footnote_55C4C3EC1' xlink:arcrole='http://www.xbrl.org/2003/arcrole/fact-footnote' />
	</link:footnoteLink>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>zxsi-20150630.xsd
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2015 [PPXM8K19K1334NYCARL5]. www.edgarsuite.com -->
<schema xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2015-01-31' xmlns:fil='http://dermacompare.com/20150630' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' targetNamespace='http://dermacompare.com/20150630' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' elementFormDefault='qualified' attributeFormDefault='unqualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="zxsi-20150630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="zxsi-20150630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="zxsi-20150630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="zxsi-20150630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote3StockholdersEquity" id="idr_DisclosureNote3StockholdersEquity">
				<link:definition>000070 - Disclosure - Note 3. Stockholders&apos; Equity</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfOperations" id="idr_ZaxisInternationalIncStatementsOfOperations">
				<link:definition>000030 - Statement - Zaxis International Inc. - Statements of Operations</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote2GoingConcern" id="idr_DisclosureNote2GoingConcern">
				<link:definition>000060 - Disclosure - Note 2. Going Concern</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote7AdvancesToRelatedParty" id="idr_DisclosureNote7AdvancesToRelatedParty">
				<link:definition>000110 - Disclosure - Note 7. Advances To Related Party</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets" id="idr_ZaxisInternationalIncBalanceSheets">
				<link:definition>000020 - Statement - Zaxis International, Inc. - Balance Sheets</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies" id="idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies">
				<link:definition>000150 - Disclosure - Note 1. The Company: Property and Equipment (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies" id="idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies">
				<link:definition>000130 - Disclosure - Note 1. The Company: Use of Estimates (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables" id="idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables">
				<link:definition>000260 - Disclosure - Note 4. Related Party Transactions Not Disclosed Elsewhere: Schedule of Related Party Transactions (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies" id="idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies">
				<link:definition>000170 - Disclosure - Note 1. The Company: Stock Based Compensation (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables" id="idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables">
				<link:definition>000270 - Disclosure - Note 6. Income Taxes: Schedule of Deferred Tax Assets (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompany" id="idr_DisclosureNote1TheCompany">
				<link:definition>000050 - Disclosure - Note 1. The Company</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables" id="idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables">
				<link:definition>000250 - Disclosure - Note 1. The Company: Fair Value Measurements: Fair Value, Assets Measured on June 30, 2015 and December 31, 2014 (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyIncomeTaxesPolicies" id="idr_DisclosureNote1TheCompanyIncomeTaxesPolicies">
				<link:definition>000220 - Disclosure - Note 1. The Company: Income Taxes (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere" id="idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere">
				<link:definition>000080 - Disclosure - Note 4. Related Party Transactions Not Disclosed Elsewhere</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies" id="idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies">
				<link:definition>000180 - Disclosure - Note 1. The Company: Accounting For Obligations and Instruments Potentially To Be Settled in The Company&apos;s Own Stock (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfCashFlows" id="idr_ZaxisInternationalIncStatementsOfCashFlows">
				<link:definition>000040 - Statement - Zaxis International Inc. - Statements of Cash Flows</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxes" id="idr_DisclosureNote6IncomeTaxes">
				<link:definition>000100 - Disclosure - Note 6. Income Taxes</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies" id="idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies">
				<link:definition>000230 - Disclosure - Note 1. The Company: Uncertain Tax Positions (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies" id="idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies">
				<link:definition>000140 - Disclosure - Note 1. The Company: Cash and Cash Equivalents (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote8SubsequentEvents" id="idr_DisclosureNote8SubsequentEvents">
				<link:definition>000120 - Disclosure - Note 8. Subsequent Events</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote5NotesPayable" id="idr_DisclosureNote5NotesPayable">
				<link:definition>000090 - Disclosure - Note 5. Notes Payable</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies" id="idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies">
				<link:definition>000240 - Disclosure - Note 1. The Company: Recent Accounting Pronouncements (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies" id="idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies">
				<link:definition>000210 - Disclosure - Note 1. The Company: Earnings Per Common Share (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies" id="idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies">
				<link:definition>000200 - Disclosure - Note 1. The Company: Fair Value Measurements (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies" id="idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies">
				<link:definition>000190 - Disclosure - Note 1. The Company: Fair Value of Financial Instruments (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies" id="idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies">
				<link:definition>000160 - Disclosure - Note 1. The Company: Valuation of Long-lived Assets (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_AdvancesPayable' name='AdvancesPayable' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_AccruedInterestPayable' name='AccruedInterestPayable' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_TotalLongTermLiabilities' name='TotalLongTermLiabilities' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_StockPayable' name='StockPayable' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DocumentAndEntityInformationAbstract' name='DocumentAndEntityInformationAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_BalanceSheets1Abstract' name='BalanceSheets1Abstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LongTermLiabilities1Abstract' name='LongTermLiabilities1Abstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_StatementsOfOperationsAbstract' name='StatementsOfOperationsAbstract' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FinancialIncomeExpense' name='FinancialIncomeExpense' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ProvisionForIncomeTaxes' name='ProvisionForIncomeTaxes' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_NetLoss' name='NetLoss' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LossGainOnDebtSettlement' name='LossGainOnDebtSettlement' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ImputedInterest' name='ImputedInterest' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_AdvancesFromRelatedParties' name='AdvancesFromRelatedParties' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PrincipalPayamentsOnDebt' name='PrincipalPayamentsOnDebt' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ProceedFromSaleOfCommonStock' name='ProceedFromSaleOfCommonStock' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CashAndCashEquivalentsBeginningOfPeriod' name='CashAndCashEquivalentsBeginningOfPeriod' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CashAndCashEquivalentsEndOfPeriod' name='CashAndCashEquivalentsEndOfPeriod' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_NonCashTransactionAbstract' name='NonCashTransactionAbstract' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' name='TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' name='TransferOfAdvancesFromRelatedPartyToUnrelatedParty' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>zxsi-20150630_cal.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2015 [PPXM8K19K1334NYCARL5]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://dermacompare.com/20150630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncBalanceSheets"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AssetsCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' xlink:label='us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AdvancesPayable' xlink:label='fil_AdvancesPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='fil_AdvancesPayable' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AccruedInterestPayable' xlink:label='fil_AccruedInterestPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='fil_AccruedInterestPayable' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_PreferredStockValue' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_CommonStockValue' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_StockPayable' xlink:label='fil_StockPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='fil_StockPayable' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='5.0' weight='1.0'/>
	</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>zxsi-20150630_def.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2015 [PPXM8K19K1334NYCARL5]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://dermacompare.com/20150630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DocumentDocumentAndEntityInformation"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncBalanceSheets"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfOperations" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncStatementsOfOperations"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfOperations"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfCashFlows" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncStatementsOfCashFlows"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfCashFlows"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompany" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompany"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompany"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote2GoingConcern" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote2GoingConcern"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote2GoingConcern"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote3StockholdersEquity" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote3StockholdersEquity"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote3StockholdersEquity"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote5NotesPayable" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote5NotesPayable"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote5NotesPayable"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxes" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote6IncomeTaxes"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxes"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote7AdvancesToRelatedParty" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote7AdvancesToRelatedParty"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote7AdvancesToRelatedParty"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote8SubsequentEvents" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote8SubsequentEvents"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote8SubsequentEvents"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyIncomeTaxesPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyIncomeTaxesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyIncomeTaxesPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables"/>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>zxsi-20150630_lab.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2015 [PPXM8K19K1334NYCARL5]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://dermacompare.com/20150630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:label='us-gaap_FairValueMeasurementPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:to='lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:label='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Related Party Transactions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 3. Stockholders&apos; Equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_ProceedFromSaleOfCommonStock' xlink:label='fil_ProceedFromSaleOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProceedFromSaleOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceed from sale of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProceedFromSaleOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Proceed from sale of common stock, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ProceedFromSaleOfCommonStock' xlink:to='lab_fil_ProceedFromSaleOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_NetLoss' xlink:label='fil_NetLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Net loss, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetLoss' xlink:to='lab_fil_NetLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfCashFlowsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statements of Cash Flows</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='lab_us-gaap_StatementOfCashFlowsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpenses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total operating expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpenses' xlink:to='lab_us-gaap_OperatingExpenses'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AdvancesPayable' xlink:label='fil_AdvancesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Advances payable, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesPayable' xlink:to='lab_fil_AdvancesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtDescription' xlink:label='us-gaap_ShortTermDebtDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShortTermDebtDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 7. Advances To Related Party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShortTermDebtDescription' xlink:to='lab_us-gaap_ShortTermDebtDescription'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_NonCashTransactionAbstract' xlink:label='fil_NonCashTransactionAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NonCashTransactionAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Non-cash transaction:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NonCashTransactionAbstract' xlink:to='lab_fil_NonCashTransactionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Decrease) increase in accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherGeneralExpense' xlink:label='us-gaap_OtherGeneralExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherGeneralExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other expenses - advances to related parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherGeneralExpense' xlink:to='lab_us-gaap_OtherGeneralExpense'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_StockPayable' xlink:label='fil_StockPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Stock payable, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockPayable' xlink:to='lab_fil_StockPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Voluntary Filers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Deferred Tax Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Use of Estimates:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DisclosureTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='lab_us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_ImputedInterest' xlink:label='fil_ImputedInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ImputedInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Imputed interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ImputedInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Imputed interest, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ImputedInterest' xlink:to='lab_fil_ImputedInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:label='us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted per share amounts:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:to='lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash used in investing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted net loss</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasicAndDiluted' xlink:to='lab_us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_ProvisionForIncomeTaxes' xlink:label='fil_ProvisionForIncomeTaxes'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProvisionForIncomeTaxes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Provision for income taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProvisionForIncomeTaxes' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Provision for income taxes, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ProvisionForIncomeTaxes' xlink:to='lab_fil_ProvisionForIncomeTaxes'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' xlink:label='us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable and accrued liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net increase (decrease) in cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows from investing activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1' xlink:label='us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Gain) on debt settlement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1' xlink:to='lab_us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:to='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_TotalLongTermLiabilities' xlink:label='fil_TotalLongTermLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLongTermLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total long-term liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLongTermLiabilities' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Total long-term liabilities, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalLongTermLiabilities' xlink:to='lab_fil_TotalLongTermLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AccruedInterestPayable' xlink:label='fil_AccruedInterestPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterestPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued interest payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterestPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrued interest payable, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedInterestPayable' xlink:to='lab_fil_AccruedInterestPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 6. Income Taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxDisclosureTextBlock' xlink:to='lab_us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' xlink:label='fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Transfer of convertible note from related party to unrelated parties</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Transfer of convertible note from related party to unrelated parties, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' xlink:to='lab_fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AdvancesFromRelatedParties' xlink:label='fil_AdvancesFromRelatedParties'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesFromRelatedParties' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advances from related parties</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancesFromRelatedParties' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Advances from related parties, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancesFromRelatedParties' xlink:to='lab_fil_AdvancesFromRelatedParties'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows from operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current Reporting Status</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal Year End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central Index Key</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DocumentAndEntityInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and Entity Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:label='us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Assets Measured on June 30, 2015 and December 31, 2014</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:to='lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:label='us-gaap_CompensationRelatedCostsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting For Obligations and Instruments Potentially To Be Settled in The Company&apos;s Own Stock:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:to='lab_us-gaap_CompensationRelatedCostsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_LossGainOnDebtSettlement' xlink:label='fil_LossGainOnDebtSettlement'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossGainOnDebtSettlement' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss (gain) on debt settlement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossGainOnDebtSettlement' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Loss (gain) on debt settlement, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LossGainOnDebtSettlement' xlink:to='lab_fil_LossGainOnDebtSettlement'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_LongTermLiabilities1Abstract' xlink:label='fil_LongTermLiabilities1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermLiabilities1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermLiabilities1Abstract' xlink:to='lab_fil_LongTermLiabilities1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Period End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TableTextBlockSupplementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tables/Schedules</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='lab_us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:label='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 2. Going Concern</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:to='lab_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxUncertaintiesPolicy' xlink:label='us-gaap_IncomeTaxUncertaintiesPolicy'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxUncertaintiesPolicy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Uncertain Tax Positions:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxUncertaintiesPolicy' xlink:to='lab_us-gaap_IncomeTaxUncertaintiesPolicy'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 8. Subsequent Events</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsTextBlock' xlink:to='lab_us-gaap_SubsequentEventsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NatureOfOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 1. The Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NatureOfOperations' xlink:to='lab_us-gaap_NatureOfOperations'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_FinancialIncomeExpense' xlink:label='fil_FinancialIncomeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FinancialIncomeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Financial income (expense)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FinancialIncomeExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Financial income (expense), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FinancialIncomeExpense' xlink:to='lab_fil_FinancialIncomeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_BalanceSheets1Abstract' xlink:label='fil_BalanceSheets1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BalanceSheets1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance Sheets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BalanceSheets1Abstract' xlink:to='lab_fil_BalanceSheets1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Taxes:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxPolicyTextBlock' xlink:to='lab_us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_CashAndCashEquivalentsEndOfPeriod' xlink:label='fil_CashAndCashEquivalentsEndOfPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAndCashEquivalentsEndOfPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash equivalents - end of period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAndCashEquivalentsEndOfPeriod' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Cash and cash equivalents - end of period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAndCashEquivalentsEndOfPeriod' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Cash and cash equivalents - end of period, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CashAndCashEquivalentsEndOfPeriod' xlink:to='lab_fil_CashAndCashEquivalentsEndOfPeriod'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Decrease) increase in accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpensesAbstract' xlink:label='us-gaap_CostsAndExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostsAndExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Costs and expenses:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostsAndExpensesAbstract' xlink:to='lab_us-gaap_CostsAndExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenue</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Revenues' xlink:to='lab_us-gaap_Revenues'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; deficit:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerSharePolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Earnings Per Common Share:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerSharePolicyTextBlock' xlink:to='lab_us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PolicyTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='lab_us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_PrincipalPayamentsOnDebt' xlink:label='fil_PrincipalPayamentsOnDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrincipalPayamentsOnDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Principal payaments on debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrincipalPayamentsOnDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Principal payaments on debt, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrincipalPayamentsOnDebt' xlink:to='lab_fil_PrincipalPayamentsOnDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows from financing activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adjustments to reconcile net loss to cash used in operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recent Accounting Pronouncements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentBasisOfValuation' xlink:label='us-gaap_PropertyPlantAndEquipmentBasisOfValuation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentBasisOfValuation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Valuation of Long-lived Assets:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentBasisOfValuation' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentBasisOfValuation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 4. Related Party Transactions Not Disclosed Elsewhere</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:to='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations' xlink:label='us-gaap_IncomeLossFromContinuingOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Loss) from operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperations' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperations'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Liabilities and Stockholders&apos; Equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional paid in capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockValue' xlink:to='lab_us-gaap_PreferredStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermDebtTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 5. Notes Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermDebtTextBlock' xlink:to='lab_us-gaap_LongTermDebtTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' xlink:label='fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Transfer of advances from related party to unrelated party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Transfer of advances from related party to unrelated party, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' xlink:to='lab_fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_CashAndCashEquivalentsBeginningOfPeriod' xlink:label='fil_CashAndCashEquivalentsBeginningOfPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAndCashEquivalentsBeginningOfPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash equivalents - beginning of period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAndCashEquivalentsBeginningOfPeriod' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Cash and cash equivalents - beginning of period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashAndCashEquivalentsBeginningOfPeriod' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Cash and cash equivalents - beginning of period, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CashAndCashEquivalentsBeginningOfPeriod' xlink:to='lab_fil_CashAndCashEquivalentsBeginningOfPeriod'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows used by operating activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:to='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_StatementsOfOperationsAbstract' xlink:label='fil_StatementsOfOperationsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StatementsOfOperationsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statements of Operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='lab_fil_StatementsOfOperationsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable' xlink:label='us-gaap_NotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesPayable' xlink:to='lab_us-gaap_NotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:label='us-gaap_FairValueOfFinancialInstrumentsPolicy'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value of Financial Instruments:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:to='lab_us-gaap_FairValueOfFinancialInstrumentsPolicy'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:label='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Based Compensation:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:to='lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and Cash Equivalents:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:to='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash provided by financing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>General and administrative</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_GeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Stockholders&apos; equity (deficit)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total Stockholders&apos; equity (deficit)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current assets:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>zxsi-20150630_pre.xml
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2015 [PPXM8K19K1334NYCARL5]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://dermacompare.com/20150630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentType' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_TradingSymbol' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='15.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncBalanceSheets"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets">
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_BalanceSheets1Abstract' xlink:label='fil_BalanceSheets1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_AssetsAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_Assets' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' xlink:label='us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AdvancesPayable' xlink:label='fil_AdvancesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='fil_AdvancesPayable' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AccruedInterestPayable' xlink:label='fil_AccruedInterestPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='fil_AccruedInterestPayable' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='11.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_LongTermLiabilities1Abstract' xlink:label='fil_LongTermLiabilities1Abstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='fil_LongTermLiabilities1Abstract' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable' xlink:label='us-gaap_NotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_NotesPayable' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_TotalLongTermLiabilities' xlink:label='fil_TotalLongTermLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='fil_TotalLongTermLiabilities' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_Liabilities' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_PreferredStockValue' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_StockPayable' xlink:label='fil_StockPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='fil_StockPayable' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_StockholdersEquity' use='optional' order='22.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BalanceSheets1Abstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='23.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfOperations" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncStatementsOfOperations"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfOperations">
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_StatementsOfOperationsAbstract' xlink:label='fil_StatementsOfOperationsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_Revenues' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostsAndExpensesAbstract' xlink:label='us-gaap_CostsAndExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_CostsAndExpensesAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherGeneralExpense' xlink:label='us-gaap_OtherGeneralExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_OtherGeneralExpense' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_OperatingExpenses' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations' xlink:label='us-gaap_IncomeLossFromContinuingOperations'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperations' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_InterestExpense' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1' xlink:label='us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_FinancialIncomeExpense' xlink:label='fil_FinancialIncomeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='fil_FinancialIncomeExpense' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_ProvisionForIncomeTaxes' xlink:label='fil_ProvisionForIncomeTaxes'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='fil_ProvisionForIncomeTaxes' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract' xlink:label='us-gaap_EarningsPerShareBasicAndDilutedAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_EarningsPerShareBasicAndDilutedAbstract' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_EarningsPerShareBasicAndDiluted' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StatementsOfOperationsAbstract' xlink:to='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' use='optional' order='15.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfCashFlows" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_ZaxisInternationalIncStatementsOfCashFlows"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfCashFlows">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_NetLoss' xlink:label='fil_NetLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_NetLoss' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_LossGainOnDebtSettlement' xlink:label='fil_LossGainOnDebtSettlement'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_LossGainOnDebtSettlement' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_ImputedInterest' xlink:label='fil_ImputedInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_ImputedInterest' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayable' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_AdvancesFromRelatedParties' xlink:label='fil_AdvancesFromRelatedParties'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_AdvancesFromRelatedParties' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_PrincipalPayamentsOnDebt' xlink:label='fil_PrincipalPayamentsOnDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_PrincipalPayamentsOnDebt' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_ProceedFromSaleOfCommonStock' xlink:label='fil_ProceedFromSaleOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_ProceedFromSaleOfCommonStock' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_CashAndCashEquivalentsBeginningOfPeriod' xlink:label='fil_CashAndCashEquivalentsBeginningOfPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_CashAndCashEquivalentsBeginningOfPeriod' use='optional' order='17.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_CashAndCashEquivalentsEndOfPeriod' xlink:label='fil_CashAndCashEquivalentsEndOfPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_CashAndCashEquivalentsEndOfPeriod' use='optional' order='18.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_NonCashTransactionAbstract' xlink:label='fil_NonCashTransactionAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_NonCashTransactionAbstract' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' xlink:label='fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='zxsi-20150630.xsd#fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' xlink:label='fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty' use='optional' order='21.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompany" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompany"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompany">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_NatureOfOperations' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote2GoingConcern" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote2GoingConcern"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote2GoingConcern">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:label='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote3StockholdersEquity" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote3StockholdersEquity"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote3StockholdersEquity">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_StockholdersEquityNoteDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote5NotesPayable" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote5NotesPayable"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote5NotesPayable">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_LongTermDebtTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxes" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote6IncomeTaxes"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxes">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_IncomeTaxDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote7AdvancesToRelatedParty" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote7AdvancesToRelatedParty"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote7AdvancesToRelatedParty">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermDebtDescription' xlink:label='us-gaap_ShortTermDebtDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_ShortTermDebtDescription' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote8SubsequentEvents" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote8SubsequentEvents"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote8SubsequentEvents">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SubsequentEventsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_UseOfEstimates' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_CashAndCashEquivalentsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentBasisOfValuation' xlink:label='us-gaap_PropertyPlantAndEquipmentBasisOfValuation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentBasisOfValuation' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:label='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:label='us-gaap_CompensationRelatedCostsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_CompensationRelatedCostsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:label='us-gaap_FairValueOfFinancialInstrumentsPolicy'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_FairValueOfFinancialInstrumentsPolicy' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock' xlink:label='us-gaap_FairValueMeasurementPolicyPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_FairValueMeasurementPolicyPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_EarningsPerSharePolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyIncomeTaxesPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyIncomeTaxesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyIncomeTaxesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_IncomeTaxPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxUncertaintiesPolicy' xlink:label='us-gaap_IncomeTaxUncertaintiesPolicy'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_IncomeTaxUncertaintiesPolicy' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' xlink:label='us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:label='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables" xlink:type="simple" xlink:href="zxsi-20150630.xsd#idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0````(`.5>!T<L&7F%G0$``,P2```3````6T-O;G1E;G1?5'EP97-=
M+GAM;,V874_",!2&_PK9K6&E5?$CP(UXJR3Z!^IVQAK:M6G+@']O.]#H,@TH
M2\[-/GA/S_MNIWLNF+SN#+C!5LG*39/2>W-/B,M*4-REVD`5E$);Q7VXM4MB
M>+;B2R!L-!J33%<>*C_TL4<RFSS78*W(8?"P%V+O:<*-D2+C7NB*U%7>ZCK4
M12$RR'6V5F%)ZH,U7`0]&2RX]4]<A19D*TDC[(\TC3HYCZ$S%GCN2@"O9.K\
M3H+K\M\K'\YS*/A:^I.,#^\NM2";&E<*<[!ZW(8N+OPV38+JCG)H+_PMF5!Q
M:*9:?EL1[__X+*V76"LYMWPC6@9U;V.*YU1Q476-:J/MZDWKU3FW"<2GRB$?
M&AL*K1<=NR04+X+J2&C]+^^/G9)I"T<9QL(>/XJ26\A?O`WS[?XVOA;TER/.
MM;G^:>B-Z$ASZA$2)^5@2')<(LEQA23'-9(<8R0Y;I#DN$62XPY)#CK"$@0+
M42D6I%(L3*58H$JQ4)5BP2K%PE6*!:P4"UD9%K(R+&1E6,C*L)"582$KPT)6
MAH6L[).LI/D3:_8.4$L#!!0````(`.5>!T=(=07NQ0```"L"```+````7W)E
M;',O+G)E;'.MDLMNPD`,17\EFGUQ2B46$6'%AAU"_(`[XSR4S'CD,2+]^X[8
M@,)#K<32KWN/KKP.J:P.-*+V'%+7QU1,?@RIROW:=*JQ`DBV(X]IP9%"GC8L
M'C67TD)$.V!+L"S+%<BMCMFLY]K%SM5&=N[3%$>4EK0VTPAGEN&;>5ADZ3SX
MB?078VZ:WM*6[<E3T`?^LPT#SWF65Q['=B^<KRT+_8_H>13@2=&AXD7U(V8#
M$NTIO8+Z>@"%,;X[)9J4@B,WHX*[O]C\`E!+`P04````"`#E7@=';;-OU%X!
M``!^$0``&@```'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSQ=C);H,P$,;Q
M5T$\0,Q,]BC)*9=<V[Z`189%"8ML5VW>OI1#11>/>HCT74!@:?P__638MS[;
M/<G-AKIK?57W/GEO;JW?#>\/:15"OS/&YY4TUL^Z7MIAM>A<8\/PZ$K3V_QJ
M2S&<92OCIG/2X_[G[.1\.:3N?*$T>;&NE'!(WSIW]95(\&:\T6S88%B^]_*?
M[;NBJ',Y=?EK(VWXH\)\;9":>!#'@Q@2-(\'S2%!BWC0`A*TC`<M(4&K>-`*
M$K2.!ZTA09MXT`82M(T';2%!E"DR9I@D#6N,UJ1P31BO20&;,&*30C9AS"8%
M;<*H30K;A'&;%+@)(S<I=!/&;E+P)HS>K.C-&+U9T9M!9VWML(W1FQ6]&:,W
M*WHS1F]6]&:,WJSHS1B]6=&;,7KS1&]?62>7Y^#JMO2/KODV7"V:X.W#_2:/
M3QFGJI_8$ZW#L).8\?IP%,>IGR'FUZ^6XP=02P,$%`````@`Y5X'1_;@UG*(
M`@``I@@``!````!D;V-0<F]P<R]A<'`N>&ULO5;;;MLP#/T5P2][6>TTZV4(
M4@-=FEV`78K6[8"]#*S,Q$(5R1/E(-G7C[83UVGKPNG#\I!0]#FB>$C*&1L:
MC"Z=S=%YA216"VUHQ,ZS(/,^'T41R0P70"%###^=6;<`STLWC^QLIB1>6%DL
MT/AH.!B<1+CR:%),#_)FTR`>EU'.\UPK"5Y9$W]3TEFR,R^F*XEZ'#T&5`S>
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MQ"B/SE0HT&]Y*4-Q(#Z`[LO94JX]^%=PCI[E?+<>Q6$HD@S%9EJZ<<-0?+)<
M'48:R4&ZD>]"#FGE?69URFW]1DS_%"Q5-^$H%%>H>?Q2419Z+1('AD!ZU<TY
M#D7Y2\Q8PYW&;N1)6`IA%R@26"%U`T]#<9XN@;,CD=CVD;HY[SG7XH[P3U'V
MQ73)WR]$V-7ZM[@A%'8FIO1\39_E3("RJ@$G_3F;JWXMH#_G%G11-9+HSZG*
MSFU-+Y3C,>=<2EOP+)EY?\Y'OB&J`^X19\L9#OISIN`,'XR;K#_GH=?VZ(-R
MHCRH?;2^0EFV',OW"@V.]Q_&X4GO$>-&X-LX+32*)Z^)]GW_Z':/=O^5Q/\`
M4$L#!!0````(`.5>!T=LL]%C/P$``&D#```1````9&]C4')O<',O8V]R92YX
M;6S-DTU/PS`,AO\*ZKU+NVDP55T/@#@Q"8DA$+>0>%M8\Z'$4]=_3^9U+0,N
MNW&K:[^/7\=)*5PAK(<G;QUX5!"N]KHVH1!NGFP07<%8$!O0/(QBA8G)E?6:
M8PS]FCDNMGP-;)QEUTP#<LF1LP,P=3TQJ4HI"N&!H_4=7HH>[W:^)I@4#&K0
M8#"P?)2SI'HQ6V,;4[)!7Y71<<T#+JQ4*P7RMAW*?J=B9P2OPU$.LF]/?__T
M0!F6=)7[H/JJIFE&S83JXL`Y>UL\/M/9I,H$Y$9`5`558.M@GIPZOT[N[I</
M237.\FF:S=+L9IGGQ71:9+/WPV1G_@;#NAOBWSH^&:3MHL(:+MPM:20MESX)
M)"$(KQPJ:R["$>:;F&!A]_$)`B\'=4*Z;%MH&^MEJ.A^#='AY<25K:UOCZD?
MT=FKJKX`4$L#!!0````(`.5>!T>97)PC$`8``)PG```3````>&PO=&AE;64O
M=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8
MC6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;
MUKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?<D3$L/<@HL(2W@4R]9<X%L:
M+R/6ZK3;W5:$:6RA&$=D8'U>+&A`T%116F]?(+3E'S/X%<M4C66C`1-702:Y
MB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`
M@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP'`3@
M4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)
MQJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP=M;,
MT@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%,4'RO
M0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G
M[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E,L_O
M^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$X
MM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A6$G:
MA/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\'1,2
MS90+!D&&ER0F$JDY?DU($_XKI=K^G--`\)0O)/I*D8]ILR.G=";-Z#,:P4:O
M&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:<K46
M@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY`1OQZ&
M.$J:[:)Q6`3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR-`>CFED)
MO816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_+GW/
MI>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?P.S]
M:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH9%LE"<M4TV4WBA*>0AMN
MZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL<QP
M3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!O
MP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?
MF&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%
MZ'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT
M%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'<4Y3
MN!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!8/+]
M<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0!A,!
MS93)1/`"@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L`P%(1=RX^_O
MDVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+PWIN
MG2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D
M?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2
M!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5`Y3_;
MU`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@`Y5X'
M1Z6&!?XX`@``YP@```T```!X;"]S='EL97,N>&ULQ59M:]LP$/XK0AFCA1';
M&?7H:AM&(3#8RJ#YT&]%MF5;H!=/EC.[OWYZ<>PX$-)ES98O.CVZ>^ZYLWQQ
MU*B>XL<*8P4Z1GD3PTJI^K/G-5F%&6J6HL9<GQ1",J3T5I9>4TN,\L8$,>JM
M?#_T&"(<)A%OV9JI!F2BY2J&JQ$"+OY>Y#B&SU?O?[9"W;T#;EU\6"S\Y^N[
M0_S*'EQ#X#B^YC$,PAOHO9YTZ1_GU6<'U*&A]H8:DJ@0?%Z*`9*H>0%;1+5_
M8-PS084$2O=*:[`(1PP[CWM$22J)`0O$".T=O#*`;>_@QP@7TN9V&0[S+/TI
MDRS3&/K#[_7ITHG=+J8\0NF\/`TD48V4PI*O]08,]J:O=7%<<.Q$6K\3WJ5$
M?;"ZV0NPB\Z;"IEC.68.X`Y*(HH+I0,D*2NS*E$;Z4(IP;21$U0*CJBAW$4,
MAJ;-,*6/YC(_%3/NK@#.QSQC'P*C8F?J1@SF=`UL4[U]-L>]1WM[%BWHBI%?
M1Z.ZIOT72DK.L-/JH+48=J?H@R/T281VK*`2DKQH?W,/,@U@"<$62T6R?>27
M1/4&=VJXP%Y7'%-X;LF7U/3V79O4Z!OXK]MS=G(+/;0LQ7)MY^*?2_KXZ?0C
MLR\G/)!Y<65F[E]"VEM?Z/_5G?`OI7G#B-N;H[,I.J(@;0E5A.\T(/._]V!T
MT]F$FR:HYLR[:7C:4X52_=4QRZ+)<ER@EJH?9"N4/8SA9'\S\H-P]-J,%#&<
M[.\X)RV[M0JF3YOD-U!+`P04````"`#E7@='[^UT5$<#```;"@``#P```'AL
M+W=O<FMB;V]K+GAM;)6674_;,!1`_XJ5E[UL:6+Z`15!@E(8TL80=$S:"W(3
MEUHX=F8[;>'7[SJE]#:KI>ZEC9/<$_OZV+ZG=KC4YF6J]0M9E5+9H<FBN7/5
ML-.Q^9R7S,:ZX@J>S;0IF8.F>>[HV4SD_%+G=<F5Z]`DZ7<,E\P)K>Q<5#9Z
MI]E#:+8RG!5VSKDKY1I6,J&BLU,[G`G)'[FQ`":LJFY9R;-H)2,BF77C0CA>
M9%$7FGK)=VZ8NKJHA?2-7M*+.AZV&>J=(;DN^!HVF0O[Z_U!1`H^8[5T$^CL
MYKM9E-(NI?TUP[_V*/C28J"_05CNQ()/V#2+DHBPVNDK(1TWE\SQ:Z/K2JAG
M8$5D)HQU#WZXS9NE4*(4;[[?T+)SO?RJC7C3RC'YD!LM91/E'S1!\`7[<0?Z
MZ$2^\Z)CTWL_$UG43P"X$%9,A13N-8N::\G]2#JMH33IWUX1U21G,\6$J8*,
ME0,*N5'KR8/4^#[`RS=%\V$S%'!A;HITG2H,^LU6PD(HY$,UH4Q^AF8>DR_D
M@DD$H@A$#P)M.`^..00Z0J"C_P5U$:B+0-U_0;?:<9+&!)PA(UU63+VBX!X*
M[@6":4RN-=@!X2J'[J#P/@KO!\*/8NBQSE_F6A:@["<R_E/#1"'*`%$&`4HW
M)O=^"?."W#$#\SPQ3%DO-0(=(]!Q`-2+B?^W@'EEWK9M^`D*/PF$]V,_#;KD
M9,)6W&+%$NQ8$H@?Q.2\6#!(I"43C<>$43NZ[O&U01U#8NNIY7]JOP3&"_C=
MZ0]6-=WCZAXSGLA/RXF>D;'%KJ98UG2/K7M1(V;GS<H<8136-3W,UR=R9V!C
M]K/.,`K+FX;L;:,>F:R;!44P"HN<ADQNHQJM87^P6*(4VYR&=&ZCSO-<U["!
MJ6>,PCZG(:';J"LF3#/*G5YAM].0W"$43?`.B#VG(<_;J#$S"D8'RPZCL.<T
MY'D;M5U_&+6S,1]LN]_0')SF6`:*;:>'VG[/<[\,82(Q"MM.#[7](^T]C,*V
MTY#MH6T2Z@.$PK;3D.VMG0YTAQJIJ"7?R16VG0[>C^[M:0T%BU"\\+6,;3X#
MQ4#N"QSX6V]2W9YWT[>_0]&31;XR@2*DEG($]WZH;YHUY_>:O"EISOX"4$L#
M!!0````(`.5>!T=])-["50(``+L(```8````>&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL=9;?DIL@%,9?Q?$!5B#^23+&F68[G?:B,SM[T5Z3A$1G42R0N'W[
M`AKKP/%&!;_O_`[(`<M!R`]5,Z:CSY9WZA#76O?[)%'GFK54O8B>=>;-5<B6
M:M.4MT3UDM&+,[4\(0CE24N;+JY*U_<FJU+<-6\Z]B8C=6];*O\>&1?#(<;Q
ML^.]N=7:=B15F<R^2].R3C6BBR2['N(O>'_$A94XQ:^&#6KQ'-GD3T)\V,:/
MRR%&-@?&V5G;$-3<'NR5<6XC&?*?*>A_IC4NGY_1O[GAFO1/5+%7P7\W%UV;
M;%$<7=B5WKE^%\-W-HTALP'/@BMWC<YWI47[M,112S_'>].Y^S"^R;:3#3:0
MR4!F`\E=XB/(I?F5:EJ54@R1'.>VI_83XCTQ$W&VG7;<)D5EWEE%53XJ5"8/
M&V92')<*XA1X5B0F]@P@((`L[!MG)[!]`]HW"WOJ[!LOOU"1PH`4!*2!/?,`
MH2*'`1D(R`)[X0%"Q18&Y"`@#^P[#Q`J,(()!4@H0C_V$(!DY3MO0<0V]/L?
M>I1T3I*-$[DKLG0%LP,QNQ"3>AA`DL$(6^Y02:$P0NX7%0H&DV<9RM'*:/!*
M]>(0Y:^N23.B\K%`S*:\L@`P7,68A*"M#P(TNQ4*7.PXK&42;$>`9F5#PG#%
MX["@"?$I@&:S0H'+'H=53?RE!FG6*'#MX["TB;]_39KE6B-H=4W#.P`.ZYL$
M:WJI*49-X5&2Q;G4TQO[2>6MZ51T$MH<<>Z0N@JAF8F'7LSLU.9/8FYP=M7V
ML3#/<CQ;QX86_?-78?Y?J?X!4$L#!!0````(`.5>!T>B=J/@60,``/\.```8
M````>&PO=V]R:W-H965T<R]S:&5E=#(N>&ULC5?+CILP%/T5Q+X#?@&)"%(S
M4=4N*HUFT:Z9Q$G0`$[!F4S_ON81AO&]3KH!;)]CG^O'P3>]J.:U/4JIO?>J
MK-N5?]3ZM`R"=GN45=X^J).L3<M>-56N3;$Y!.VID?FN)U5E0,,P"JJ\J/TL
M[>N>FBQ59UT6M7QJO/9<57GS=RU+=5GYQ+]6/!>'H^XJ@BP-)MZNJ&3=%JKV
M&KE?^5_)<D-%!^D1OPIY:6??7B?^1:G7KO!CM_+#3H,LY59W7>3F]28?95EV
M/9F1_XR=?HS9$>??U]Z_]>$:^2]Y*Q]5^;O8Z:-1&_K>3N[S<ZF?U>6['&/H
M%6Y5V?9/;WMNM:JN%-^K\O?A7=3]^S*T"#;2<`(="70B).%-`AL);"(0?I/`
M1P*W",$02C\1FUSG6=JHB]<,JW?*NTU"EMQ,];:K[&;63$)KVCI$EKYE-$F#
MMZZ?$?(XA]`!LO@,V4`("R=(8`1,*BBJ@L[X;.`3G,]0/IOQ^<"G5A0#I.XA
M40_A4<R2T(H$PD@8.F+AJ!8.M3!+"Y\-(MQ:(,RM1:!:!-3"+2WB_[1`F%M+
MA&J)X!H+G!^C_!C&$EFQQ$"D'09$Q,(51H+*2*",V)*1W)4!$82&BWB!"UF@
M0A90B'UR%W>%0`03+'2L2V>@F(6$4,G"]I#PKA0$0B(6)]PAQN%G!&PS[EA?
M@GL1H2`<3NQPZ/UP((12%KNF%O<U`HV-V\9&V'TM$')+"^YK!!H;MXV-<&"?
M0`N$D"0BPK'W"6YL1,!E=FT4W(Y(!,,1G[6N,4SD&`4W+0)=B\?V*`@&_(-C
M,&N1$/;40A`7KD7&W8U`>^/@+$/W8HF8_PU&.;=\\+,8W.$(M#@1VF*@@Q&:
M,&8?DPT"9$G"A>N>@GL=A5XG;'.@T,B^&'LG$;%6?H,A1<S#R+&5*>YYE$!1
MMDN,F+O_>03WA23">3ZIXT('35389D$IW*ZH)(ASWSTH;J3TZH`8!?<[BOB=
M=>%8(QCA6CO<R"B\HMF'?XU@P+$.9A?^2C:'/G-JO:TZUWH@3;53=K;N<RF[
MGK+E(V5(BXG6M'"T19B6/I$*/@;/TE-^D#_SYE#4K?>BM$EB^C1DKY26)K#P
MP01V--GH5"CE7G>?L?ENAOQL*&AUNJ:;4\Z;_0-02P,$%`````@`Y5X'1T[B
M'A-B`P``00\``!@```!X;"]W;W)K<VAE971S+W-H965T,RYX;6R-5TUSFS`0
M_2N,[PE((`$>[)GXH],>.I/IH3T36[:9`')!CM-_7PDP`>WZ(X<8Q'NK?;M8
MSYN<9?5>'X10SF>1E_5L<E#J.'7=>G,015H_RZ,H]9.=K(I4Z=MJ[];'2J3;
MAE3D+O4\[A9I5D[F2;/V6LT3>5)Y5HK7RJE/19%6_Q8BE^?9A$PN"[^R_4&9
M!7>>N#UOFQ6BK#-9.I78S28O9+HFD8$TB-^9.->#:\<D_R;EN[GYL9U-/).#
MR,5&F1"I_O@02Y'G)I+>^6\7]&M/0QQ>7Z)_:^3J]-_26BQE_B?;JH/.UILX
M6[%+3[GZ)<_?1:>!F8`;F=?-?V=SJI4L+I2)4Z2?[6=6-I_G]@FC'0TGT(Y`
M>X(?WB3X'<%_E!!TA.!1`NL(S"*XK?:F<JM4I?.DDF>G:MM]3,U;1:9,]V9C
M%DTK=-5J_<P@YLG'G/'$_3!Q.LAB"*$M)!Q#5@@DZB&N3J#/@F)9+"CDQ^,M
MEA#"/2N+^U'6-Z.,$O71<OD#OM_R"<X/4'XPX`<MGUKE;B%E`^$-Q-*YO(M8
MW46L;R%&.ABJ@\$Z^#B?HWP.ZQ!8=>"##%D#B2(_MFL!49QY=CD@B/C4I]:+
MOD9@`657ZA*BND*HBUFZ0K"+[YD_2QB$V:H@(HAAH/6M0"-%$:HH@HKL`R*"
MBK!601C2*@1$D59!V(U6Q:BP&`JSCK5%#'9Y0I4A.$0:AL*T(;@;XHP-8N>Z
M!^5%EKP.,]Z)1Q9L.8+QK@P>L``D6,!C^P#&@E$>7G$+<L6T"!07V^((W(C1
MR,[Z#FJ<#6I>+X2";$+/SH;"ZE!*N%UJ!(:4&D$Q2D.[U-B>UTN-&Q[QH3AB
MB_/OG57+^Y#5?<CZ)F2L!K=?`OTWM/V70&M\TE]Y[H%F(4`>P6YA,!HRYMOJ
M$"#A\=6W$7=F`JTYO&+-!/=F`LTYM,V9#+TR:G/UGCUP='`@";0=C41`<?`-
MK_SX(K@[DQ#6AEV)@+LA@788@M_+T)P"'M'`?C.6"%#WFQ';$5:/1EP_$+%5
MZ0[F@T)4^V8RJYV-/)6J+4V_VD]_+\V,9*TOR'1)D/65F1:;>>0K_#PYIGOQ
M,ZWV65D[;U+IJ::92W92*J'S]Y[URWO0\VQ_DXN=,I>AOJ[:":^]4?)X&5C[
MJ7G^'U!+`P04````"`#E7@='!7022RD#``!^#0``&````'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;(V736^C,!"&_PKBWH)M,+@B2$U6J]W#2E4/NV>:.`DJ
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M(;Y7%^_#O6SZ^VGXDM`Q#`^@8P"=`BBY&<#&`.8$!(.S/J]OA2[RK%4GKQTF
MXU#8.2</S%1N;1MMH4Q.G?EF%7GVEB=)%KS9?D;)\E)">TF<3I+`]#X-0;$A
MEA3$)^GU$"M$(O`A&)H%NXAG?7P:XO$1&A]=Q$=#/'&J,$B:7A+WDCM.DSAF
M3BJ(CG!!9RH6HW9B:(<Z=F(P3$S=JD+-3%$XZH+#HC(\/D'C$YA%Y&21`(<1
M(6Y%H6@FC12UD4(;L6,CO1B!#W.6Q&'H^("J&1\"]2&@#^[X$'#ML#AE;D&@
M3)!D9H%9AF&_?0C=@/\^1)8\YS1RRK?"A(DIX(RC&1`1N-SF<D(Y\T@HS$FX
M.=$;DSAF<TMR[0.'$8$T$G,]X#@BD$?"Y1&!H`&90,F-:<%11""+A,LB`D%S
M%U.6@'7R92`1G$B$0S/,-</!((2DYF\&U8'".3<XWP@$G'`!1Q*PF`S@**>@
M-E!X8ZYPTA&(.N&BCD"*19RS%%3GR[0C..X(Y)UP>4<@R0@R45`U8X7BL*,0
M=L*%'84,BW@"ZX+HYLS@G*.0<V)N.X5SCD+."9=SE'Y*!T1R_9M<>\%91QGP
M0MP)7(ZBFV:@)`JAF>!B6UO+=M=O]SMOK8Z-'G:.4^MTI'CL-]Y.^](<-8;M
M\D<W>78H=O)7T>[*IO->E#:;[G[;O%5*2^,RO#<`VYO#T/12R:VVCXEY;H?C
MP?"BU>%\VIF.7/E_4$L#!!0````(`.5>!T<O<!_2HP$``+,#```8````>&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL=5/;;MP@$/T5Q`<$F]UMTY774C95U#Y4
MBO+0/K/VV$8!Q@&\3O^^@+V.U;HOP`SGG#G#I1C1OKH.P)-WK8P[T<[[_LB8
MJSK0PMUA#R;L-&BU\"&T+7.]!5$GDE:,9]DGIH4TM"Q2[MF6!0Y>20//EKA!
M:V%_GT'A>*(YO25>9-OYF&!EP19>+348)]$0"\V)/N3'\SXB$N"GA-&MUB1Z
MOR"^QN![?:)9M``**A\51)BN\`A*1:%0^&W6_"@9B>OU3?TI=1O<7X2#1U2_
M9.V[8#:CI(9&#,J_X/@-YA8.4;!"Y=)(JL%YU#<*)5J\3[,T:1ZG'9[-M&T"
MGPE\(=PG`IL*)9M?A1=E87$D=CK:7L0;S(\\'$05D['O8-&%O8@HBVN99WG!
MKE%HQIS7&)XPA_L%PH+\4H-OU3CS?_C\RS9_M^EQM^+O9H]\6V"_*;!?">S_
MT^069O=7$;8Z50VV38_'D0H'XZ?C6[++^WS@Z58^X&71BQ9^"-M*X\@%?;C;
M=#L-HH=@);L[4-*%'[0$"AH?EY_#VDZ/:@H\]K<OLOS3\@]02P,$%`````@`
MY5X'1SGFXV:C`0``LP,``!@```!X;"]W;W)K<VAE971S+W-H965T-BYX;6QU
M4]MNW"`0_17$!P0OZVW3E==2-E74/E2*\M`^L_;81@'&`;Q._[Z`O8[5NB_`
M#.><.<.E&-&^N@[`DW>MC#O1SOO^R)BK.M#"W6$/)NPT:+7P(;0M<[T%42>2
M5HQGV2>FA32T+%+NV98%#EY)`\^6N$%K87^?0>%XHCMZ2[S(MO,QP<J"+;Q:
M:C!.HB$6FA-]V!W/>40DP$\)HUNM2?1^07R-P??Z1+-H`114/BJ(,%WA$92*
M0J'PVZSY43(2U^N;^E/J-KB_"`>/J'[)VG?!;$9)#8T8E'_!\1O,+1RB8(7*
MI9%4@_.H;Q1*M'B?9FG2/$X[G,^T;0*?"7PAW&?)^%0HV?PJO"@+BR.QT]'V
M(M[@[LC#050Q&?L.%EW8BXBRN):[+"_8-0K-F/,:PQ/F<+]`6)!?:O"M&F?^
M#Y]_V>;O-SWN5_S][)%O"^2;`OE*(/]/DUN8PU]%V.I4-=@V/1Y'*AR,GXYO
MR2[O\R%=(_N`ET4O6O@A;"N-(Q?TX6[3[32('H*5[.Y`21=^T!(H:'Q<?@YK
M.SVJ*?#8W[[(\D_+/U!+`P04````"`#E7@='O_:Z?*0!``"S`P``&````'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;'53VV[<(!#]%<0'!"^[F\O*:RF;J&H?
M*D5Y:)]9>VRC`.,`7J=_7\!>QTK=%V"&<\Z<X9(/:-]<"^#)AU;&'6GK?7=@
MS)4M:.%NL`,3=FJT6O@0VH:YSH*H$DDKQK/LEFDA#2WRE'NQ18Z]5]+`BR6N
MUUK8/R=0.!SIAEX3K[)I?4RP(F<SKY(:C)-HB(7Z2!\WA],N(A+@EX3!+=8D
M>C\COL7@1W6D6;0`"DH?%428+O`$2D6A4/A]TOPL&8G+]57]6^HVN#\+!T^H
M?LO*M\%L1DD%M>B5?\7A.TPM[*-@B<JED92]\ZBO%$JT^!AG:=(\C#O\8:*M
M$_A$X#/A/DO&QT+)YK/PHL@M#L2.1]N)>(.;`P\'4<9D[#M8=&$O(HK\4FRR
MVYQ=HM"$.2TQ/&'V]S.$!?FY!E^K<>+_\/G#.G^[ZG&[X&\GCWQ=8+<JL%L(
M[/[3Y!KF[DL1MCA5#;9)C\>1$GOCQ^.;L_/[?.3I5C[A1=Z)!GX*VTCCR!E]
MN-MT.S6BAV`EN]E3TH8?-`<*:A^7=V%MQT<U!AZ[ZQ>9_VGQ%U!+`P04````
M"`#E7@='#Z*:T*,!``"S`P``&````'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;'5376_;(!3]*X@?4!R2;&WD6&I:3=O#I*H/VS.QKVU4X+J`X^[?#[#C6)WW
M`MS+.>>>RT<^H'US+8`G'UH9=Z2M]]V!,5>VH(6[PPY,V*G1:N%#:!OF.@NB
M2B2M&,^R+TP+:6B1I]R++7+LO9(&7BQQO=;"_CF!PN%(-_2:>)5-ZV."%3F;
M>9748)Q$0RS41_JX.9QV$9$`OR0,;K$FT?L9\2T&/ZHCS:(%4%#ZJ"#"=($G
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MK.WXJ,;`8W?](O,_+?X"4$L#!!0````(`.5>!T<',BQ*I`$``+,#```8````
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL=5/;;MP@$/T5Q`<$F]UMTY774C95
MU#Y4BO+0/K/VV$8!Q@&\3O^^@+V.U;HOP`SGG#G#I1C1OKH.P)-WK8P[T<[[
M_LB8JSK0PMUA#R;L-&BU\"&T+7.]!5$GDE:,9]DGIH4TM"Q2[MF6!0Y>20//
MEKA!:V%_GT'A>*(YO25>9-OYF&!EP19>+348)]$0"\V)/N3'\SXB$N"GA-&M
MUB1ZOR"^QN![?:)9M``**A\51)BN\`A*1:%0^&W6_"@9B>OU3?TI=1O<7X2#
M1U2_9.V[8#:CI(9&#,J_X/@-YA8.4;!"Y=)(JL%YU#<*)5J\3[,T:1ZG'<YG
MVC:!SP2^$.ZS9'PJE&Q^%5Z4A<61V.EH>Q%O,#_R<!!53,:^@T47]B*B+*YE
MGF<%NT:A&7->8WC"'.X7"`OR2PV^5>/,_^'S+]O\W:;'W8J_FSQF?%M@ORFP
M7PGL_]/D%B;_JPA;G:H&VZ;'XTB%@_'3\2W9Y7T^I&MD'_"RZ$4+/X1MI7'D
M@C[<;;J=!M%#L)+='2CIP@]:`@6-C\O/86VG1S4%'OO;%UG^:?D'4$L#!!0`
M```(`.5>!T?P?56&I`$``+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;'53VV[<(!#]%<0'!)O=;=.5UU(V5=0^5(KRT#ZS]MA&`<8!O$[_OH"]
MCM6Z+\`,YYPYPZ48T;ZZ#L"3=ZV,.]'.^_[(F*LZT,+=80\F[#1HM?`AM"US
MO051)Y)6C&?9)Z:%-+0L4N[9E@4.7DD#SY:X06MA?Y]!X7BB.;TE7F3;^9A@
M9<$67BTU&"?1$`O-B3[DQ_,^(A+@IX31K=8D>K\@OL;@>WVB6;0`"BH?%428
MKO`(2D6A4/AMUOPH&8GK]4W]*74;W%^$@T=4OV3MNV`VHZ2&1@S*O^#X#>86
M#E&P0N722*K!>=0W"B5:O$^S-&D>IQV>S[1M`I\)?"'<9\GX5"C9_"J\*`N+
M(['3T?8BWF!^Y.$@JIB,?0>++NQ%1%E<RSSG!;M&H1ES7F-XPASN%P@+\DL-
MOE7CS/_A\R_;_-VFQ]V*OYL\9GQ;8+\IL%\)[/_3Y!9F]U<1MCI5#;9-C\>1
M"@?CI^-;LLO[?.#I5C[@9=&+%GX(VTKCR`5]N-MT.PVBAV`ENSM0TH4?M`0*
M&A^7G\/:3H]J"CSVMR^R_-/R#U!+`P04````"`#E7@='?H2#VZ4!``"S`P``
M&0```'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6QU4]MNG#`0_16+#XC!R[;I
MBD7*IHK:ATA1'M)G+PQ@Q?80VRS)W\<V+$$M?;$]XW/.G/&E&-&\V@[`D7<E
MM3TFG7/]@5);=:"XO<$>M-]IT"CN?&A::GL#O(XD)2E+TV]4<:&3LHBY)U,6
M.#@I-#P98@>EN/DX@<3QF&3)-?$LVLZ%!"T+NO!JH4!;@9H8:([)778XY0$1
M`2\"1KM:D^#]C/@:@M_U,4F#!9!0N:#`_72!>Y`R"/G";[/F5\E`7*^OZ@^Q
M6^_^S"W<H_PC:M=YLVE":FCX(-TSCK]@;F$?!"N4-HZD&JQ#=:4D1/'W:18Z
MSN.TL\MGVC:!S02V$&[3:'PJ%&W^Y(Z7A<&1F.EH>QYN,#LP?Q!52(:^O47K
M]P*B+"YEEN4%O02A&7-:8UC$[&\7"/7R2PVV5>/$_N&S']O\W:;'W8J_FSRF
M;%L@WQ3(5P+Y?YK<PNS_*D)7IZK`M/'Q6%+AH-UT?$MV>9]W+-[*%[PL>M["
M(S>MT):<T?F[C;?3(#KP5M*;?4(Z_X.60$+CPO*[7YOI44V!P_[Z199_6GX"
M4$L#!!0````(`.5>!T=YSWSDI0$``+,#```9````>&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;'53RV[D(!#\%>0/"#;S2#+R6,ID%>T>5HIR2,Z,W;91@'8`
MC[-_'\`>Q]KU7H!NJJJK>>0#FG?;`CCRJ:2VQZ1UKCM0:LL6%+<WV('V.S4:
MQ9T/34-M9X!7D:0D96FZIXH+G11YS#V;(L?>2:'AV1#;*\7-GQ-('(Y)EEP3
M+Z)I74C0(J<SKQ(*M!6HB8'ZF#QDA],V("+@5<!@%VL2O)\1WT/PJSHF:;``
M$DH7%+B?+O`(4@8A7_ACTOPN&8C+]57]*7;KW9^YA4>4;Z)RK3>;)J2"FO?2
MO>#P$Z86=D&P1&GC2,K>.E172D(4_QQGH>,\C#ML/]'6"6PBL)EPET;C8Z%H
M\P=WO,@-#L2,1]OQ<(/9@?F#*$,R].TM6K\7$$5^*;)LG]-+$)HPIR6&1<SN
M;H90+S_78&LU3NP?/KM?YV]6/6X6_,WH,67K`MM5@>U"8/N?)M<PMW\5H8M3
M56":^'@L*;'7;CR^.3N_SP<6;^4;7N0=;^`W-XW0EIS1^;N-MU,C.O!6TIM=
M0EK_@^9`0NW"\M:OS?BHQL!A=_TB\S\MO@!02P,$%`````@`Y5X'1Y?"<]^F
M`0``LP,``!D```!X;"]W;W)K<VAE971S+W-H965T,3,N>&UL=5/;;IPP$/T5
MBP^(P<NVR8I%RB:JVH=*41[:9R\,8,7V$-LLZ=_7-BR+4OIB>\;GG#GC2S&B
M>;,=@",?2FI[3#KG^@.EMNI`<7N'/6B_TZ!1W/G0M-3V!G@=24I2EJ9?J.)"
M)V41<R^F+'!P4FAX,<0.2G'SYP02QV.2)=?$JV@[%Q*T+.C"JX4";05J8J`Y
M)H_9X90'1`3\$C#:U9H$[V?$MQ#\J(])&BR`A,H%!>ZG"SR!E$'(%WZ?-6\E
M`W&]OJI_B]UZ]V=NX0GE;U&[SIM-$U)#PP?I7G'\#G,+^R!8H;1Q)-5@':HK
M)2&*?TRST'$>IYW\8:9M$]A,8`OA/HW&IT+1YC-WO"P,CL1,1]OS<(/9@?F#
MJ$(R].TM6K\7$&5Q*;/LOJ"7(#1C3FL,BYC]#4*]_%*#;=4XL7_X[&&;O]OT
MN%OQ=[/'_PCDFP+Y2B"?!%CZJ<DM3/:I"%V=J@+3QL=C286#=M/Q+=GE?3ZR
M>"LW>%GTO(6?W+1"6W)&Y^\VWDZ#Z,!;2>_V">G\#UH""8T+RZ]^;:9'-04.
M^^L76?YI^1=02P,$%`````@`Y5X'1V2[F="G`0``LP,``!D```!X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL=5/;;IPP$/T5BP^(P<NVVQ6+E$T5M0^5HCRT
MSUX8P(KM(;99TK^O;5B"$OIB>\;GG#GC2S&B>;$=@"-O2FI[2CKG^B.EMNI`
M<7N'/6B_TZ!1W/G0M-3V!G@=24I2EJ9?J.)")V41<T^F+'!P4FAX,L0.2G'S
M]PP2QU.2);?$LV@[%Q*T+.C"JX4";05J8J`Y)??9\9P'1`3\%C#:U9H$[Q?$
MEQ#\K$])&BR`A,H%!>ZG*SR`E$'(%WZ=-=]+!N)Z?5-_C-UZ]Q=NX0'E'U&[
MSIM-$U)#PP?IGG'\`7,+^R!8H;1Q)-5@':H;)2&*OTVST'$>IYW]8:9M$]A,
M8`OAD$;C4Z%H\SMWO"P,CL1,1]OS<(/9D?F#J$(R].TM6K\7$&5Q+3/&"GH-
M0C/FO,:PB-D?%@CU\DL-ME7CS#[QV;=M_F[3XV[%WTT>L_\(Y)L"^4H@GYO<
M?6AR"Y-_*$)7IZK`M/'Q6%+AH-UT?$MV>9_W+-[*.[PL>M["+VY:H2VYH/-W
M&V^G073@K:1W^X1T_@<M@83&A>57OS;3HYH"A_WMBRS_M/P'4$L#!!0````(
M`.5>!T>UAE`%I@$``+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM
M;'53RT[D,!#\%<L?@!//!-A1)A(#0G!8"7'8/7N23F+A1["="?OW:SL/(@@7
MV]VNJJ[V(Q^T>;,M@$,?4BA[Q*USW8$06[8@F;W2'2B_4VLCF?.A:8CM#+`J
MDJ0@-$FNB61<X2*/N1=3Y+IW@BMX,<CV4C+S[P1"#T><XCGQRIO6A00I<K+P
M*BY!6:X5,E`?\5UZ..T#(@+^<!CL:HV"][/6;R%XKHXX"19`0.F"`O/3!>Y!
MB"#D"[]/FI\E`W&]GM4?8[?>_9E9N-?B+Z]<Z\TF&%50LUZX5ST\P=1"%@1+
M+6P<4=E;I^5,P4BRCW'F*L[#N)/-M&T"G0AT(=PFT?A8*-I\8(X5N=$#,N/1
M=BS<8'J@_B#*D`Q]>XO6[P5$D5^*E&8YN02A"7-:8VC$9+<+A'CYI0;=JG&B
MW_CTUS9_M^EQM^+O1H_I#P+[38']2F`_-7G]I<DMS,V7(F1UJA),$Q^/1:7N
ME1N/;\DN[_..QEOYA!=YQQKXS4S#E45G[?S=QMNIM7;@K217&4:M_T%+(*!V
M87GCUV9\5&/@=#=_D>6?%O\!4$L#!!0````(`.5>!T<-]YI,IP$``+,#```9
M````>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;'53VVZ<,!#]%8L/B,'LILF*
M1<JFJMJ'2E$>VF<O#&#%]E#;+.G?US8LBQ+Z8GO&YYPYXTLQHGFS'8`C[TIJ
M>TPZY_H#I;;J0'%[ASUHO].@4=SYT+34]@9X'4E*4I:F]U1QH9.RB+D74Q8X
M."DTO!AB!Z6X^7L"B>,QR9)KXE6TG0L)6A9TX=5"@;8"-3'0').G['#:!40$
M_!(PVM6:!.]GQ+<0_*B/21HL@(3*!07NIPL\@Y1!R!?^,VO>2@;B>GU5_Q:[
M]>[/W,(SRM^B=ITWFR:DAH8/TKWB^!WF%O9!L$)IXTBJP3I45TI"%'^?9J'C
M/$X[]_E,VR:PF<`6PD,:C4^%HLVOW/&R,#@2,QUMS\,-9@?F#Z(*R="WMVC]
M7D"4Q:7,V$-!+T%HQIS6&!8Q^QN$>OFE!MNJ<6*?^.QQFY]O>LQ7_'SRF/U'
M8+<IL%L)[.8F'S\TN8')TP]%Z.I4%9@V/AY+*ARTFXYOR2[O\XG%6[G!RZ+G
M+?SDIA7:DC,Z?[?Q=AI$!]Y*>K=/2.=_T!)(:%Q8?O%K,SVJ*7#87[_(\D_+
M?U!+`P04````"`#E7@='QP3+:J<!``"S`P``&0```'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6QU4]MNG#`0_16+#XC![#;IBD7*IJJ2ATI1'M)G+PQ@Q?90
MVRSIW\<V+$$I?;$]XW/.G/&E&-&\V0[`D7<EM3TFG7/]@5);=:"XO<$>M-]I
MT"CN?&A::GL#O(XD)2E+TV]4<:&3LHBY9U,6.#@I-#P;8@>EN/E[`HGC,<F2
M:^)%M)T+"5H6=.'50H&V`C4QT!R3^^QPV@5$!+P*&.UJ38+W,^);")[J8Y(&
M"R"A<D&!^^D"#R!E$/*%_\R:GR4#<;V^JO^,W7KW9V[A`>5O4;O.FTT34D/#
M!^E><'R$N85]$*Q0VCB2:K`.U962$,7?IUGH.(_3SOYVIFT3V$Q@"^$NC<:G
M0M'F#^YX61@<B9F.MN?A!K,#\P=1A63HVUNT?B\@RN)29GE6T$L0FC&G-89%
MS/YN@5`OO]1@6S5.[!\^^[[-SS<]YBM^/GG,_B.PVQ38K01V<Y/L2Y-;F/Q+
M$;HZ506FC8_'D@H'[:;C6[++^[QG\58^X671\Q9^<=,*;<D9G;_;>#L-H@-O
M);W9)Z3S/V@))#0N+&_]VDR/:@H<]M<OLOS3\@-02P,$%`````@`Y5X'1QI:
MNT^E`0``LP,``!D```!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL=5/;;IPP
M$/T5BP^(P<NFZ8I%RB:JVH=*41[:9R\,8,7V$-LLZ=_7-BQ!6_IB>\;GG#GC
M2S&B>;,=@",?2FI[3#KG^@.EMNI`<7N'/6B_TZ!1W/G0M-3V!G@=24I2EJ;W
M5'&AD[*(N1=3%C@X*32\&&('I;CY<P*)XS')DFOB5;2="PE:%G3AU4*!M@(U
M,=`<D\?L<,H#(@)^"1CM:DV"]S/B6PA^U,<D#19`0N6"`O?3!9Y`RB#D"[_/
MFI\E`W&]OJI_B]UZ]V=NX0GE;U&[SIM-$U)#PP?I7G'\#G,+^R!8H;1Q)-5@
M':HK)2&*?TRST'$>IYV'=*9M$]A,8#<$.A6*-I^YXV5A<"1F.MJ>AQO,#LP?
M1!62H6]OT?J]@"B+2YGM\H)>@M",.:TQ+&+V#PN$>OFE!MNJ<6+_\-G7;?YN
MT^-NQ=]-'K/_".2;`OE*()^;W-\TN86YORE"5Z>JP+3Q\5A2X:#=='Q+=GF?
MCRS>RB>\+'K>PD]N6J$M.:/S=QMOIT%TX*VD=_N$=/X'+8&$QH7E%[\VTZ.:
M`H?]]8LL_[3\"U!+`P04````"`#E7@='CBN=`*8!``"S`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970Q.2YX;6QU4]MNXR`0_17$!Q0;)TT:.9::KJK=AY6J
M/K3/Q![;J%Q<P''W[PO8<:W6^P+,<,Z9,USR09LWVP(X]"&%LD?<.M<="+%E
M"Y+9&]V!\CNU-I(Y'YJ&V,X`JR))"D*3Y)9(QA4N\IA[,D6N>R>X@B>#;"\E
M,_].(/1PQ"F^)IYYT[J0($5.9E[%)2C+M4(&ZB.^3P^G34!$P`N'P2[6*'@_
M:_T6@C_5$2?!`@@H75!@?KK``P@1A'SA]TGSJV0@+M=7]<?8K7=_9A8>M'CE
ME6N]V02C"FK6"_>LA]\PM;`-@J46-HZH[*W3\DK!2+*/<>8JSL.X<[N?:.L$
M.A'H3-AET?A8*-K\Q1PK<J,'9,:C[5BXP?1`_4&4(1GZ]A:MWPN((K\4:;;+
MR24(39C3$D,C9KN?(<3+SS7H6HT3_<&G=^O\;-5CMN!GH\?T/P*;58'-0F`S
M-;G_UN0:YGL1LCA5"::)C\>B4O?*C<<W9^?W>4_CK7S!B[QC#?QEIN'*HK-V
M_F[C[=1:._!6DILM1JW_07,@H'9AN?-K,SZJ,7"ZNWZ1^9\6GU!+`P04````
M"`#E7@='%39CY*<!``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6QU4]MNG#`0_16+#XC!RZ;IBD7*IJK:ATA1'M)G+PQ@Q?90VRS)W\<V+$$I
M?;$]XW/.G/&E&-&\V@[`D3<EM3TFG7/]@5);=:"XO<$>M-]IT"CN?&A::GL#
MO(XD)2E+TUNJN-!)6<3<DRD+')P4&IX,L8-2W+R?0.)X3++DFG@6;>="@I8%
M77BU4*"M0$T,-,?D/CN<\H"(@!<!HUVM2?!^1GP-P>_ZF*3!`DBH7%#@?KK`
M`T@9A'SAO[/F9\E`7*^OZC]CM][]F5MX0/E'U*[S9M.$U-#P0;IG''_!W,(^
M"%8H;1Q)-5B'ZDI)B.)OTRQTG,=I9W\[T[8);":PA7"71N-3H6CS!W>\+`R.
MQ$Q'V_-P@]F!^8.H0C+T[2U:OQ<097$ILSPMZ"4(S9C3&L,B9G^W0*B77VJP
MK1HG]@^??=_F[S8][E;\W>0Q^X]`OBF0KP3RN<GL2Y-;&/:E"%V=J@+3QL=C
M286#=M/Q+=GE?=ZS>"N?\++H>0N/W+1"6W)&Y^\VWDZ#Z,!;26_V">G\#UH"
M"8T+RV]^;:9'-04.^^L76?YI^0%02P,$%`````@`Y5X'1Q($2N*G`0``LP,`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,C$N>&UL=5/+;J0P$/P5RQ\0@P>R
MLR,&*9,HRAY6BG+8/7N@`2M^$-L,V;]?VS`$)>1BN]M5U=5^%*,VK[8#<.A=
M"F6/N'.N/Q!BJPXDLS>Z!^5W&FTD<SXT+;&]`59'DA2$)LDMD8PK7!8Q]VS*
M0@].<`7/!ME!2F;^G4#H\8A3?$V\\+9S(4'*@BR\FDM0EFN%##1'?)<>3EE`
M1,`?#J-=K5'P?M;Z-02_ZB-.@@404+F@P/QT@7L0(@CYPF^SYD?)0%ROK^J/
ML5OO_LPLW&OQE]>N\V83C&IHV"#<BQZ?8&XA#X*5%C:.J!JLT_)*P4BR]VGF
M*L[CM)/O9]HV@<X$NA#V230^%8HV'YAC96'TB,QTM#T+-Y@>J#^(*B1#W]ZB
M]7L!41:7,LUV!;D$H1ES6F-HQ.3[!4*\_%*#;M4XT2]\^G.;O]OTN%OQ=Y/'
M]!N!;%,@6PED<Y/9IR:W,/FG(F1UJA),&Q^/194>E)N.;\DN[_..QEOY@)=%
MSUKXS4S+E45G[?S=QMMIM';@K20W.4:=_T%+(*!Q8?G#K\WTJ*;`Z?[Z199_
M6OX'4$L#!!0````(`.5>!T?QW!GFI0$``+,#```9````>&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;'53R6[D(!#]%<0'!)MV9VFY+:4SBF8.(T4Y)&?:+MLH
M+`[@=N;O`WB)E7@N0!7OO7K%D@_:O-D6P*$/*90]XM:Y[D"(+5N0S%[I#I3?
MJ;61S/G0-,1V!E@525(0FB371#*N<)''W),I<MT[P14\&61[*9GY=P*AAR-.
M\9QXYDWK0H(4.5EX%9>@+-<*&:B/^#X]G+*`B(`7#H-=K5'P?M;Z+01_JB-.
M@@404+J@P/QT@0<0(@CYPN^3YE?)0%RO9_7'V*UW?V86'K1XY95KO=D$HPIJ
MU@OWK(??,+6P#X*E%C:.J.RMTW*F8"39QSAS%>=AW,EFVC:!3@2Z$&Z3:'PL
M%&W^8HX5N=$#,N/1=BS<8'J@_B#*D`Q]>XO6[P5$D5^*-+O.R24(39C3&D,C
M9G^[0(B77VK0K1HG^H-/[[;YNTV/NQ5_-WI,_R.0;0ID*X%L:O+F6Y-;F.]=
MDM6I2C!-?#P6E;I7;CR^);N\SWL:;^4+7N0=:^`O,PU7%IVU\W<;;Z?6VH&W
MDESM,6K]#UH"`;4+RQN_-N.C&@.GN_F++/^T^`102P,$%`````@`Y5X'1]3.
M$#>G`0``LP,``!D```!X;"]W;W)K<VAE971S+W-H965T,C,N>&UL=5-=3Z0P
M%/TK37^`A0ZX.F%('(W1ATV,#[O/';A`8S^P+8/[[[<M#!+%E[;W]IQSS^U'
M,6KS9CL`ASZD4/:`.^?Z/2&VZD`R>Z5[4'ZGT48RYT/3$ML;8'4D24%HDEP3
MR;C"91%S+Z8L].`$5_!BD!VD9.;?$80>#SC%E\0K;SL7$J0LR,*KN01EN5;(
M0'/`=^G^F`5$!/SA,-K5&@7O)ZW?0O!<'W`2+("`R@4%YJ<SW(,00<@7?I\U
M/TL&XGI]47^,W7KW)V;A7HN_O':=-YM@5$/#!N%>]?@$<PMY$*RTL'%$U6"=
MEA<*1I)]3#-7<1ZGG?QZIFT3Z$R@"^$FB<:G0M'F`W.L+(P>D9F.MF?A!M,]
M]0=1A63HVUNT?B\@RN)<IMEM0<Y!:,8<UQ@:,?G-`B%>?JE!MVH<Z3<^O=WF
M[S8][E;\W>0Q_4$@VQ3(5@+9))`G7YK<PJ1?BI#5J4HP;7P\%E5Z4&XZOB6[
MO,\[&F_E$UX6/6OA-S,M5Q:=M/-W&V^GT=J!MY)<Y1AU_@<M@8#&A>4OOS;3
MHYH"I_O+%UG^:?D?4$L#!!0````(`.5>!T?)'4_OI@$``+,#```9````>&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;'53VV[<(!#]%<0'!)OUING*:RF;JFH?
M*D5Y:)]9>WQ1@'$!K]._+^!+K-1]`68XY\P9+OF(YM6V`(Z\*:GMF;;.]2?&
M;-F"$O8.>]!^IT:CA/.A:9CM#8@JDI1D/$GNF1*=ID4><\^FR'%PLM/P;(@=
ME!+FSP4DCF>:TB7QTC6M"PE6Y&SE59T";3O4Q$!]IH_IZ9(%1`3\[&"TFS4)
MWJ^(KR'X7IUI$BR`A-(%!>&G&SR!E$'(%_X]:[Z7#,3M>E'_&KOU[J_"PA/*
M7UWE6F\VH:2"6@S2O>#X#>86CD&P1&GC2,K!.E0+A1(EWJ:YTW$>IYW[A;9/
MX#.!KX2')!J?"D6;7X0316YP)&8ZVEZ$&TQ/W!]$&9*A;V_1^KV`*/);D1YY
MSFY!:,9<MA@>,<>'%<*\_%J#[]6X\'_X_/,^_[#K\;#A'R:/Z7\$LEV!;".0
MS4T>/C2YA\D^%&&;4U5@FOAX+"EQT&XZOC6[OL]''F_E'5[DO6C@AS!-IRVY
MHO-W&V^G1G3@K21W1TI:_X/60$+MPO*37YOI44V!PW[Y(NL_+?X"4$L#!!0`
M```(`.5>!T>QD\"'HP$``+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#(U
M+GAM;&U3VV[C(!#]%>0/*`Z)VV[D6&JZJMJ'E:H^=)^)/;91@7$!Q]V_+V#'
MM;)^`68XY\P9+OF`YL.V`(Y\*:GM(6F=Z_:4VK(%Q>T-=J#]3HU&<>=#TU#;
M&>!5)"E)69K>4L6%3HH\YEY-D6/OI-#P:HCME>+FWQ$D#H=DDUP2;Z)I74C0
M(J<SKQ(*M!6HB8'ZD#QL]L==0$3`NX#!+M8D>#\A?H3@I3HD:;``$DH7%+B?
MSO`(4@8A7_ASTOPI&8C+]47]*7;KW9^XA4>4?T7E6F\V34@%->^E>\/A&:86
MLB!8HK1Q)&5O':H+)2&*?XVST'$>QIW[=**M$]A$8%<$.A:*-G]SQXO<X$#,
M>+0=#S>XV3-_$&5(AKZ]1>OW`J+(S\4FRW)Z#D(3YKC$L(C)[F<(]?)S#;96
MX\C^X[-?Z_SMJL?M@K^=/-ZN"^Q6!78+@=TD<'?5Y!KFNDNZ.%4%IHF/QY(2
M>^W&XYNS\_M\8/%6?N!%WO$&_G#3"&W)"9V_VW@[-:(#;R6]R1+2^A\T!Q)J
M%Y9W?FW&1S4&#KO+%YG_:?$-4$L#!!0````(`.5>!T=X]H16I`$``+,#```9
M````>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;&U3RV[D(!#\%>0/"#;SV&3D
ML93):K5[6"G*(3DS=MM&`=H+>)S\?0!['&O6%Z";JNIJ'OF`YMVV`(Y\**GM
M,6F=ZPZ4VK(%Q>T==J#]3HU&<>=#TU#;&>!5)"E)69KNJ>)")T4><\^FR+%W
M4FAX-L3V2G'S>0*)PS')DFOB132M"PE:Y'3F54*!M@(U,5`?D\?L<-H&1`2\
M"ACL8DV"]S/B>PC^5,<D#19`0NF"`O?3!9Y`RB#D"_^;-+]+!N)R?57_%;OU
M[L_<PA/*-U&YUIM-$U)!S7OI7G#X#5,+NR!8HK1Q)&5O':HK)2&*?XRST'$>
MQIW[=**M$]A$8#<$.A:*-G]RQXO<X$#,>+0=#S>8'9@_B#(D0]_>HO5[`5'D
MER+;/>3T$H0FS&F)81&SNY\AU,O/-=A:C1/[C\\>UOF;58^;!7\S>=RO"VQ7
M!;8+@>THL$]OFES#9#=%Z.)4%9@F/AY+2NRU&X]OSL[O\Y'%6_F&%WG'&_C+
M32.T)6=T_F[C[=2(#KR5]&Z7D-;_H#F04+NP_.'79GQ48^"PNWZ1^9\67U!+
M`P04````"`#E7@='N8D:!*<!``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970R-RYX;6QM4]MNG#`0_17+'Q"SAMVF*Q8IFRI*'RI%>6B?O3"`%9NAMEG2
MOZ]M6((27FS/^)PS9WS)1S1OM@5PY%VKSIYHZUQ_9,R6+6AA[["'SN_4:+1P
M/C0-L[T!44625HPGR8%I(3M:Y#'W8HH<!Z=D!R^&V$%K8?Z=0>%XHCMZ2[S*
MIG4AP8J<+;Q*:NBLQ(X8J$_T87<\9P$1`;\EC':U)L'[!?$M!#^K$TV"!5!0
MNJ`@_'2%1U`J"/G"?V?-CY*!N%[?U)]BM][]15AX1/5'5J[U9A-**JC%H-PK
MCL\PM[`/@B4J&T=2#M:AOE$HT>)]FF47YW':.:0S;9O`9P)?"/=)-#X5BC9_
M"">*W.!(S'2TO0@WN#MR?Q!E2(:^O47K]P*BR*_%[L!S=@U",^:\QO"(V=\O
M$.;EEQI\J\:9?^'S[]O\=--CNN*GD\?]85L@VQ3(5@+9W&3ZJ<DM3/:I"%N=
MJ@;3Q,=C28E#YZ;C6[++^WS@\58^X$7>BP9^"=/(SI(+.G^W\79J1`?>2G*W
MIZ3U/V@)%-0N++_YM9D>U10X[&]?9/FGQ7]02P,$%`````@`Y5X'1\D^\I0`
M(0``C)H``!0```!X;"]S:&%R9613=')I;F=S+GAM;.U=Z7,;QY7_G/TKIK14
MA:P"(0`D>,5QE4Y'B:Z84ES9K?W0F&D`8PUFX#D(PI4_?M_5QUP@%#MV#I1*
M*A+H\_4[?N_HUE=%40;WJR0M?O]H69;KFR=/BG"I5ZH89FN=PC?S+%^I$G[-
M%T^*=:Y55"RU+E?)D\EH=/%DI>+T45"E\0^5?IY5:?G[1^.+Z:.OORKBK[\J
MOWZ1A=5*IV6@TBAXF99QN0U>ISQFG*7!:?#'*AT&9Z-!,!F-I_#[I]L7P?'1
MR5=/RJ^_>H*#\$`?LU(ES0\?&/VFV5Z:?*L7<5'F"CJ^4RO=;/4_ZCXN8)Q2
MYRF-HQ+X+1SVSOYQNVX-,AZ=_KFWPP>=QQFN.`I>J++5UY#DOW[S&R1*BQ2Y
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M85RVEO,AUW,-6XN"`MLWO_[?\?^USHPU2W?S2:LY+:/W#*(H%INP5C&>11"J
M==QAG."TJE65@-:)S%ZZ*5+?MOZA0E$_EB[=AM!G/^*N^A@O:8QFSZ/1<#0:
MC6'=>7"GDDK_+AB/!O`1_@T*5KBJ*I=9'O^HH]\%*2B8($;]$K6,7^=@.T>[
M&$RGH\'%:$(+/K>_\03T8>:T?:!*A`;:00-L`-I`KV:@K(U&&`0PS5J'97RG
MDVUKE7VF')01*FV-BJ\(LGGP?JUS:M!BRK/@;9:6RP*MFHZ:WU[L_+:FV43[
M'05/A#K\[ZX^YWOVV7<OW^H[G58MGGZ>%26SD;X'T%=TZ(!O=*H1!Y`FBU9Q
M2@`*J=YL^;Y<POF8@8#0RFBU,H/#8GD`KNG7$!FO'WC`C-)L=_PF*XJ38)YG
M*].Z8[>OC9J485JC?`/8]20`S1#I61F`MB\3HF*SX:LXA1W$L+0X#;.5#HYE
MQ)9P?LBSN[A`8`L@U+0NU7U["^]T&1PGN(WF-\]4`7@&"1W%2474`H+2P0=J
M18:E=3SM/BF,C\,'?PL<]S2[?:?CQ1);JSL@XD(;L<WZ45=[IK_U#+ZW[*&9
M1ORVV2D+TSW0PWE/&YIACC/4>`:U#&J.'K,G%&P;3:#J\6)/WGD:?5\5)>^5
M!"#,@)4`$]@#@D]#7%]5D&G?;W&O5VLBOH$"+=X&30F^&K`H<B']A&.K!C+9
MOQL!CSYY].A+NYAM.W?QT+'$Z1ULY8&=/_=IU=7CH5GF+,V[9[%0C+H\H+8^
MY$"L>$V08*N$KYDS.A1$J&$D&K90P`<@`.$.?$*K7Z-:B9BP7<OO8EU[?H`D
MW)D2JW7.@2)-?(@`!"PZ[>(TF(&OG*8X'2QT3;[!EW37:-7[.K[+TE/J@[YX
M@=OI\-D_XG<`^)A0<-YP!(BI4T"E[=/9HCA5Z4-VQAM3]9YTQU@M3(78.!@/
M@X]+W><V$GS>HU_P/E^H-/[1Z,IG*OR\R$%<HYL`M2[I2@"_!9"6PQO!;;Q(
M8X")&,D0IP-/ZD,&'C$BPT\%\==+$)$5[*&XH?G6N8:]</P%OIU;ZU8XM8R<
MDE$D!<'H)BZ7P8(A0+)%=:#79#;<G&N6@01FS9$%T(RL5`I&A9Q+H.1*?=:!
M-DMA)`'0;[4FXQV42T!\:CX'+`<CH&N-$["]HW,B=XRZ)0WP&X'G"JJTRD6:
M:$7.O6OW@?4`'2)8!W;`GSN(0-WPNZ[5Y(RDZJ@IB*H<:>$Z$66(]X=P0&4%
MXP-AJ@0&`<HEN/0Y\B'Q'G:S]!D&5JSHAY=.K&[`.<\[5[SVN"-85_DZ@U4-
M:&##9$"=(D8O`3Z%;\%VPS+)=1L$2T`#<+Q)#'-%HEN9'8@!`,B#+H`)88&P
M42(ED2_7.E@Q#(:%`0N049MI5@CP45,Q$-_#:6WPGS1K*PY%(^^!_X<@$6AJ
M@$DI!@ACK'')-\$[O4&]Z;[3YKL`D10:XAQ5*C!#"/AW"&,#^8"@1+P8#TAL
M;%680T7,BXCI-(EA92L-)`3U!BJI=G;80\\K='7O#(FT\.+`$Z-IL-4J!V*\
M1/X!M[)"H4'@"'Z[WJB$N6L&V`*.A^F2:^-NHE/5T16@.2)/8(@"?2/P47,>
M!@.UI4XI(D/#`&A;P%KAI!R$1L*#'&/D``9'?$PGBC"E6J.)(HN%"RQ!PHF8
M4:5IC%F1P<F'&L>/40G,$Q!E-M.X?P<(C`3(%RP?3,$[TA6@*`"A)"K4P^`O
MX%M:547QBC=`U4BB,S?!=WB4=S$<-DM=B,?!HK[%+EF5<W0BH6ZB$6"/245N
MIN4*.)DLBS9QPDY.1FX,D$RE"[(WYOPV2YWR0HG;@8R@:UAAQCEX_`B<T9QD
MX/[GK-5B.*$0E0W]ANL,59YO<7IRG6LL`@>U1>.&\F.WDV@V%=BB*(CN:%7A
M7&AM\0K/F3X&TL\4HB.D&"S`D$*PI^'570MPRNA^S4<XKY#!4+V<@C/#XLJ(
MZAC,$VA?U(OBPZ.J`/_!!:F8T<!=DTF,/75<-PQ>TU>%]H=&)F5=`B3N6711
MA4M>]0`F]^E`/$M\&&9@)'_$762\=]:YQ*@@6QN-YVE%=PX#R/@,:?PIA\%[
M("F8NA4&;U<`JL3F>+W\`_!(XS;&)RF=S5%Z*]_/?&8=%#.4A=8MEA^@:&\T
M<G<AS.TM.M*H8N+4G`>'P)[1/M!R@'DSD`._.>4=JHW*(SXH00)"9:<QO3E$
M78H7DD>DB<BP/+U]'ER.KR3H?\K3?E!;UGD>L$&[]WZ6Q`O15D_AA%ZGH)4K
M;OH!4!6T).WZ,0N>Z>"6'#-LY4.MWQ;!^XVD&DB%R/)I\9DW`;)`[$VP]B9@
M$U?(!*+,W`2$YKMV^^KI[3/:\M5X.O!WAY._`&5X1W&5P$4=O"TB\\0%Q\P`
MND88$L+0RA+]M!A7!MS'87=*TP5A`N=/&)&4*%F".NLA7LH!?!L(EN-0D;XG
M1AI0#W_;;L.#QHXQ+4&['@:O\-C_8J2T<R<W'B$F0(C.1OY`;]VR!<@:3",;
M*GQN`[T$+*Y`F8%#MLGRS[R[JHS1<A;XC6N\C$$5Y>%RRXU`P#/$-S]:R@(0
M($QS9ZU1J<,E)3W%Y44)%7W@!F91=Z,O"!"4]-EB21%\GDI<#47!`ACMARHC
MER./0[8MY.N!#*G\,]HOBBY%>":8LA&CAI;:0[G'"5BI)!C[YPU:V*!:T!CM
M!8`5U_D=Y2QDTS+*67T4WA@C/VI`"DFZ;)9QN/2(Z-/0..X\&G&]IW!S?1.\
MX56;'R;FA[,;:P'K>T76JZD9Q]V\=I0Z$<_.,_<UMD<9[HR>![`8+5^L.<BV
MYW<!W5J*SJ[`QR]-CDFUL(VZCU>&3!5[;.US(,$%$6^V[#@S/IQYEL!&2`_3
M=^(;%(:"M!<"X+)>-M_67B(P]C8%&WB+Y#+(>VH9"4$L_I"BL\]45#@,@$B<
M?8:NZTV?(+?#_']FUO]@6?\IL[[OZW*,V?_DK2<8KZU@,$@$DV$I])JI^<FG
MFGS&P>=CX;\3\]/$_G1V$KS#C,A1<%K[RQV-KUFC6K/I#BJT7)M_;TI\APQ3
M<TP-D(:N3LT*]Y-GXU2&-17]#KZ;>A#HF*@DGHJ/V"5%RFH5+2$G]TB_&)`4
MEED.\"D69"Y26YH0$KO1W2H8VJF4QV%M(FK(Z9Z:X@&GS]>3]>B0%<Q"@)]9
M@8UG2*RM*_K@/`_7BQR4(6$JCH!0^I_;%R++()J!?B@#5]9\^9IN=)/-VZ=6
M"V+X9#.HO$XJMC/@\JH<XY$%I45,T<B2;`<@.?':*;QNLC649O&R*#T0='(!
M&Y71J36-BCD+'.4C9G%HBJ6Z0^R540C,@IC+\U$+S?E=L><*K#L#^5#G)7K7
M]7C8]U6TL/$W@\EQ,)=),L$F&K\S!B1A'^*>HAEQ<S.P?QH;SRH),54M?K99
M'<[7+6(#L?(JCPL)PSJWRKKV,+-$CH5[S002/O.C9^R>X83PV>Z-O3`%`/WK
M(QAK*(B!<U_._)4:7G,S.MDQ%@ZGF9D(;,]\SN7!UKDE>*(V1`[-D<V-47O^
M&G"MUM<F1QW<]`+0H_"5B?\7UH5MD#/J($B,5,8PD3U5YRR39[S*T,&./^MD
MRRXV!ATPDL-ZX=MZ9XPEH$QU3E7`QQB'PF.B.!&VYD`7$;*HYEC,P,&=>X$J
MQ-%`&0DN4"R,1'.-8;L\IH`)3/(]*/TBBD,)$V>R+73>4SV/O7@%TTT1:`.F
M@6-$-[U&Z512+[@5%Y%"!3%`??3N_9L!^_Q`:?)NAU;B/6Y"6]!)/=&RA65]
M?W**+6$S%$?8'VT"5T3#VQR/\LR?0@S'(3M,.(+V**H91IC$&8-_=A_.$/"`
MC2+0`C@\SJ90\TQ:J$<'[D)GQ*:M$=DG+EVTH6.U%-"AZ%,M7M4](!D"4D)9
MCL4<&==_=!&!;(PUX:"#X",*HW,TMQ9>4C;QBCV$W;P`O1A&8#C69!O-FID7
MZ85#..ACI)I`@$H*]`7S;3W69@*;1F^LXGMVBVAN$TA%U0Z_@UKF/#IPF@:;
MV<'K_MJ869&R*?K])/J#+MV=R6)]Y12G=UF"KF>$9PP$()M7I:+GI0V'`-?K
MQ`0+.#6Y3O0];U\O9!Z6"N<J^'.ABD+^Q(1H:<ZY@@5ST,).]&EX._0BK>W=
MUTAKK!BN"70H=N'0A+A?^KZ4DR:*#2R-0!M0_04S_PQ9@-D3:`J'18."(%GA
ME@@`!Y]<E,VD?D#556D*&*@HX/B9`W%@4=GL/QK'M.E0L2$1K;6;%1OKJ0\+
MBT@YQ*=1[F4Q=":R&)(&E?I4X#`L%1A0#-,O5&$*U>/Q#ZS&YD]\7J.EN9CM
MQI@U=EB%VKY2H!B:LW,\H0V`-JR<"]+ZA36VR)+2$O,JC?BWU`=-N08;DSK[
M:8"_[%7$L)'%$<-$H(NMMRK+/)Y5[%`CY_4:&;(AI\Z(O*W'W*P6]-;HAR%T
MJD(C/((@3,+"PHL!2W'9#B9WC2ZJ=J8Y`Q-5(9<3J#L5)[P?QYP%F2D?DLR,
M?4"WY)-1'(AL@P]9P4[3C3AU'KT1V<SC1$?D/\$.)<5H`2:R4X%K7)M1*/V3
MBE['`"MH<456EY"%OE=&,>/R!7`16N-:0XM.D0E03_`JP&Y^3YR8>7H/MC_+
MJE)HF,>ES=:9Y<AJA#=8"[3;4"C%+-C3*G;MK+8;/@>.L:AB_@3#I)XK<3IN
M>Q..[,ZO<-0?D)F:Z\C6Z1%T[I("I`?>[A`?@OP^AE^:;6]&.U9SD/J6PS<F
M/:/(V2LES-HX%'17?5TN-F%+B\")0.++9CAI@S`K0L5FX!'57MCL38T]<7O0
M4M6+JWPSA`Z\2VL2<!"]$LFB7[U^%YQ?(=`-=:-^(L_2#+F$1WZ?<HAJ//(\
M7CXMJ5WU^MYBW1RE13ZMJ<#@^-'3VT^/,&`RI-YPLH'QGG02$]W(,H-WFW%^
M&@YNX?OPLG!>C2S>\,HU)A&\U`Z6'\'D5K\31^O[F*ND`+/$`K]-;23?++!\
MR,-S>F($YV0-2++E?<-N;$*S\*R3"C^;6B8MI*,<I:V-\HXCURX:&0"??*8#
MK<EE"BJ#!0;6C7-CV-7),+M0MNRC1B%?E":74]@$34/@S,BN!($&CC3M`Q#2
MU(HJ&N4FM7G)C3,G*M&;79U-(`JVXQ\GCT,&!Z-]*#MKON-""W(8*ZV\>(VK
MTVJ(+?('<ZVK9S&L(83$FI`L`0:@51:6@]L+^<))I_40UA+Y4^(F#*L\-J50
M0+I$)FQ6]""'%`T6(1_?UAJQ@GT*S);TB2BP+8G?Z&I0JZ*J)ZB\RM3CC]D:
MB#X933EI8@I-H'NBTG)0+S@QS<\N1B<WWMV@%Y@"9H\K\BJS.99F=TE,"[^"
M25&<2T&:9:GA9P!3]GI;\+1:8!SI@7WB$>RUS]/@FXQO/2%Q4]]AC#+-4,`!
M>B?Q=)(R,)^FXQR"H1PG<^H<<]P@O1*$Z2H[:]7O4YG<9%A?X5Z-.%D4ALQZ
M]:BQ5^=&:YQA`(BKXK04I1EH;EBW[CHC'P<+FB[DZ=J,;LIHR.E#38,?IGK!
MR5VK#!&9>S4/%`T@>&\JS"2;PUA4M)>9IQUX\0ZOJ$+T#*A,%G8*@@PL:0)7
MJQB%$-@#G`&IS5]7>6%"<@)W@QF&M7`0H./,^L,<6/2BY;G"**`7F@#.J6:E
MAZY<EM@K2'F(GD4WE\#@Q)2,B34ABQH20`Y=89V6'YXLE^2[61/3S6MGPWVN
MTN"-V9L"N%G__A%I^/Q./]HY`($(!<H3?(4K03Q4488A9FG+D2\JV:"322I&
MEYFKY26YLW=J;.$P5^W3-OU+.-#S_+IY)P?,(0:-R.FNHP0V!?Z(8-D0;@+5
MR%1A$2-&/@SD17Q3KRZ,=)BP$%F/N%C#<3>KG$W*PE6ACF_.F=/Y>^ZU485G
M@)KT0X-D2"<A9O1Z92^R/BR1PVI56_:R08[`XF$$&$`)VNH@$%U&%4S@NV'V
M(JW0EODZ`A&3J;#!7#XBZCR3W+P(#=E4!"NX`R:VRSQ$GL;W^B9;4R_7<0,#
MH2PJ=[Y)2'6;U6+I!3P-C1$^4_`VY[)&0R]&V!.+=/'&J-2HS6NW;H,7K9@$
MIX':N<F-N1@6G`_&DZE_YTMB4+7C/AY?#*;"AEA%9A?N#INJT_4]<QJ=K:GV
MAA4=F3D(468KF#O+J4P.&?J9Q/#MAJ=>PHK=#/N1SZT@8LBI)=\ZF@>3P6@Z
MH6FJ-):L(REG4S1KN?7H\HHW@P4S7*9!'X^&YZ/@&.=X]`F'>'0""%.%2QJ0
M@FFHD"A-A_E39HJ6;&!0#+Y]CJ4[P5/+C_I>YV%<,!^4.-G5R.,M\BEA-W@+
M<W+.!;DL4A02)0CGY?-9WGE&ZHHG'.%IRWP%B=_1V70\.!]?N]!)<ZE'YY.K
MP?1J[%K4URT6S(V*OA@MPB^M?88.Q.EMN,0J4EA\)(4;P61\\3BXRW`'-J9F
MZNHDSY)CC2:6&@@?P"F</T9!'`TO'_/L'<?8+%(M_&N?*&C"SR9P:.XI$M(U
M#+S2.0;AI%PXT03\#3\R'O7K)<B/G%SOP8OC`8@LRLS#O'@^FOZ'\.)X>@7:
MYFP'+T[.+P97EY?_(%[TV+#!<^.+L\>`I,>7EX_WX]"IY=#QK\&BG>#G'$T$
M9T\^T/V7C^Y>3A%`$^.Q0(.72:$WF/C?'QK]7<,C<&(5/K&.+)H7=&VH`HX+
M%&V4P0-4B.3C1<KW5.Q5;'O?QU[*1X^+Y$XLS?E@@B)*Q1M8E#>?PY&SV5_&
MN5P$DGIL,QC%>ZG\8:U#+'\@WA=<(MF$(>ZEPR\_FDP&9Y=3(P942N7;?U/0
MB2(@-I$AB&K:0H`;@,)75)V,H_GTC<E?YJJPXJ91=-4V\,^L:V^FY\J=\<5X
M<#FYQA`D0U*IJEF;<MV5BBCZ/M-+E<P]7$EJC@>9C`<7DVGP!CT+.=QSF9<W
M6`CP;5WXXO['YV1]3WB$%DD;@S2(9,9@JI]X!<6V7B5G^C;N?IF.X\EH<'UY
M?2+E3J?PA]9ADPKH^M/;-J>`J+2((VI1*I6SQ5)<-L/>GL&5J#`I92CA.6#A
M+&3FDY@Q5B'8%0\I]&AC9#ZEX\8-43(/]>PZY3-=O@,:7#U&)D&Y#?-XYD*E
MME+W;.HJAAQ$I$!'BX48H6+4#2V&Y)_0,HW'@\EXQ(Y-_8JVX7'2@>1&4'4R
MYEQ,0I)OO_1H,%@=OU;QH?-^ZP[EU.R)<03+>O5OG$8Z-R+LX+"J\6R3]4R2
MU>81CLZMJ]94-LQS?!'/LPD4#U18"0"KI\I`6SD@X3R!%*RA:',SJ:UPG"#.
M%YW'^#%9;HSMK2C.&DD8P&;6&AMF+!,7M:VVT,=H-'6(8-A%-:KO8E4M:H+X
MAI;LBZ)<%61=WFB6!7-$$RW*<1V9LOY,H59>U)NV3GDZIREH[11'A`]3S9D+
MFZBQ]7YN,7Y9@UU1W1]6BUSJ!2E!+64!?'UNRQ<0R6MOD!?:_[%*C.=VT3`<
M-@U!$1^6,BPKIL6@2SN/0>/HE%E./&1V=G?PIJL`6,"B%[@T9U4]AC6>&$$G
M9XZ`M%G;%]S+[R/^+DJN4!%RMR,3XNL9!*&:;^'@VLZF@\GU5'2J#1#9RQG>
M87-F'J,;&!2BEUR:E<C-G!WL#U7@?S]P;<._O8"S_$%'!/V>VMO:I"Y,Z4WD
M2<%O<=GI::1+@.DD>=Z*<PIHN;P]Q_'PIB:_,*-6"I,)`'BK`K@0]2:G34TM
M'N&1!=X`2XU0&!%R^7VIK>`(K59\K_`'@$CQ?$MANM1A\\AMVK\CH[C2@^N`
M;K'F[&?:%(#JB,[5U.#.FO>.5.$O:NX]V^%=H*FGM`#TA[K)'5:-$>$VF0B(
M35O)J9$+([7#-4_&13N[@EY@;ZFEH=(``0"G-FFUWD+D"#A+Q54W,YW$($4N
M#N]=.;(!F-JTL8DKFS`6C(Z9\SC%VK5<T5FZR$^"QN5,$L*<,Y*9^EPV)M>&
MJ*]7.C*5A'@^M=LP?FH!8#+9+!Q\ID,ZX+\G4DSS`H^3!C0\Q!<URD8L/;#1
M;GL/LWGF&YJ`K]RV+OCY1SV4VW$V%@K[*:@FZ\'#W*B.Z[&=Z1`64(,[3LE'
M\G%)MS_A@Y&'`8@X'U\*0':B?6/^L*G`E#Z4(A$*NPUK2!_)):/V-S\#G&E$
M"B\,H$'&]6TDL9X3I:$?QH?58"^P<&0N?+JCRN@UKYXI95M)01FD"O0R=43E
MWD?A'M!PCDN;OF;1!"\(SAKZMK_Y(OI25'L'@6M$8CJ;VI$'"*UKEE^DQKRY
M-J\`S7A*:Q[GL%(P5#D*+L$(NWY<WD;175AL*E5#^#I+EKNL>($O\T0L)=Y<
MWAS2XLLG&?J!]<8H`G;V$]*N*9M4V349^G^(2+D:F+H"[SG?TH?C1^+FFAB'
M/=U40`-?!&7JXVG(<G%5R)='9Q(A3Z/:DB7+8Q],DE@AET9;N"J.(^O'H^GD
MBFMGV^\MU6I??"?SFE>_GS-)%T<,6O2JN)GU))$M/KJ1`[LI<RO0R:ZK2.]K
MZ[OA'*N$#\OM6G/]WJSL>J3$B^?\*H[_QSZ'_F(PN1K9F.M#<0%.&@S&X[.>
M+O78U$\+$]2#%47W%)T7FVI:=*EJ3PG`\B^NKWDG9X/)=%I[AM!_,JNU=.^2
M/B,H53LLYIC44WRF)J`^/5*/IA]?#LZO1Y3E;QZ\3-D3*[D8UNXG[=.F=?NI
M7KC[T#45U76=@&M>K2O+\))P*`I\O8[6JRNA>R!8Q6I*(VHUP?S@B0&;@"7]
M^G%1N;/&58?&;1E6`'[5(5\$:-\<X46B8^55?=#U9URE"4A:7G4%MSNW("6+
M7*@+0[G*,EA:3BE@OG-`.5U)FYKK_%D2'+\>?CM\#AZ81#+.KB;'ZL3=_Q9(
M+02PA1Y4&F*)T#%&>.*NQ"@;\^RBB#DV29B>#RXG4]$??*>M^S((!8_^^6_=
M[+AR\XJ/D]\:<%<IF%307VY&H=/:*M=]]_X-'Q&^LP+C8JJ.<@M6!O`"RJQ6
MT*QJI3=2H^<=I(3H\=2S#4Q=+..UX1C7S`LD"GJ1MQN30-X-!6T8,02\OKH8
MV&I3B=`5,%*B<MF'"^!(IJ2U*MR'%&4*X`%]%;N\YL.4F&F\.\/HPR/V\,'D
MQFLP`K#3BOPS6V>W@,^PVA8+1$R):==-PUS7,BE'\.>5NRI@[G=@Z1&%A[JO
MF_E*P\C&>'HY&%]..)O0Q8['TO(D.):V)\$[GPE9I7H9!K]4[*?4:_]2M>6=
M5N@2@S:2:/N8U9.(^T?X_5'*QBCHU[W2LYQ\EC/CT$E4UOY^#I]LS2_$8Q>M
MW+[U!H^D\@HL]&B/GVH`8L#:7Y"WY/H,OB-UQX^KQ@6_I4$)7DPY5P7'3!%3
MFQ*Z)`/4B+$ARA&KO->QPPS5\?@QW90.Y78,NWGB1-H'=;]5Z)\S(\BX+2<P
M!9V-[UA?CTX`Q&X+!XI]2/L&%B>COS5A\1>*O?];"LV%(&=`E]K=)WPD"9^_
MAXFV5*^9<W*V,$Y(;&ZZ"`2R819WG1@W[+U`13JJ#@B\;"\14>O@Y0HE(`K>
MZHB?57"WY8K@32FW=X$$@F`4/ZFFI#0V01*'3B+E-@S=",1Z20Y&@O+@)V5D
M"-2E^&@HXZHLY?"7M=CU=[0&5GB91.P;"(N0JT6L8VX@,`<9%X_JWCF`"#H*
M9AFX$F!*S#](@*&SMV1?O9N_>#6K:!.H!YU>8>QX5F!B`_J^I/?6]FZ(D7M*
MH+`HUD)2>!L)#@3\@E5P=?JG)^/)-\[]O7WYW()7H9G_&(%-ZV#E]X.4>&]+
MM:>#'2O)Y7\C,<7WAC]37N/MZ5CB:`D5*!3XL@IRJ2M]!.6/WXRO!V>8G9]>
M]42"N[5K_172F]:CH<&Q>4^T_=RU?-'\O/7NZ(,-#@^3_LL\3+H7$_4^7KJ#
MF_H?/-V_Y>%I5/<TZEX'U?U\ZBZ9[WYO=<]FAV=9_RV>9=V+M=I/MR;>TZT[
M6&QWQQ:K'9Z(/3P1>W@B]A=^(G8O#=#WC.P.V>]]>7;OAK_\$[5[T6+',[9J
M[V=LX]YG;'>0]!\\<]]_?W9XL-?@N7_^!WOWXN`]'O7=P87[/`G\]_39YQGA
M+]U>[6W.O;94>YQXWW:'1XP/CQ@?'C'.#H\8_VL]W7MXQ/CPB/'R\(CQ3WG$
M>"]`8A\Z_M!XZ'@').GMT_Z_T'_99Y3WVG&MUJA_D[47F7=^>7BN^?!<\^&Y
MYL-SS?],A6.'YYH/SS4?GFL^/-=\>*[Y\%SS+_%<\WY%/]U/.N\`X7V/0._;
M[O!8].&QZ'^YQZ+WDJ4''Y3N%ZJ'NGYI^\/;U?'A[>K#V]6'MZL/;U?_.F]7
M[YED]K\8F#S'6Y/2RM*][JL>?T3UV#8J_/&36[SI727M:NV?/O5>EW`.V;-#
M]JSV]^=[@_(F,,R-`KVC?Y^([-=]/S8_O*SX*[^LN,]-]CK'V`P%.DFF/'D/
M5NGH]_/PR'_&!55'JR=%47[]_U!+`0(4`Q0````(`.5>!T<L&7F%G0$``,P2
M```3``````````````"``0````!;0V]N=&5N=%]4>7!E<UTN>&UL4$L!`A0#
M%`````@`Y5X'1TAU!>[%````*P(```L``````````````(`!S@$``%]R96QS
M+RYR96QS4$L!`A0#%`````@`Y5X'1VVS;]1>`0``?A$``!H`````````````
M`(`!O`(``'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!`A0#%`````@`
MY5X'1_;@UG*(`@``I@@``!```````````````(`!4@0``&1O8U!R;W!S+V%P
M<"YX;6Q02P$"%`,4````"`#E7@=';+/18S\!``!I`P``$0``````````````
M@`$(!P``9&]C4')O<',O8V]R92YX;6Q02P$"%`,4````"`#E7@='F5R<(Q`&
M``"<)P``$P``````````````@`%V"```>&PO=&AE;64O=&AE;64Q+GAM;%!+
M`0(4`Q0````(`.5>!T>EA@7^.`(``.<(```-``````````````"``;<.``!X
M;"]S='EL97,N>&UL4$L!`A0#%`````@`Y5X'1^_M=%1'`P``&PH```\`````
M`````````(`!&A$``'AL+W=O<FMB;V]K+GAM;%!+`0(4`Q0````(`.5>!T=]
M)-["50(``+L(```8``````````````"``8X4``!X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"%`,4````"`#E7@='HG:CX%D#``#_#@``&```````````
M````@`$9%P``>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!`A0#%`````@`
MY5X'1T[B'A-B`P``00\``!@``````````````(`!J!H``'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+`0(4`Q0````(`.5>!T<%=!)+*0,``'X-```8````
M``````````"``4`>``!X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"%`,4
M````"`#E7@='+W`?TJ,!``"S`P``&```````````````@`&?(0``>&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L!`A0#%`````@`Y5X'1SGFXV:C`0``LP,`
M`!@``````````````(`!>",``'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+
M`0(4`Q0````(`.5>!T>_]KI\I`$``+,#```8``````````````"``5$E``!X
M;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"%`,4````"`#E7@='#Z*:T*,!
M``"S`P``&```````````````@`$K)P``>&PO=V]R:W-H965T<R]S:&5E=#@N
M>&UL4$L!`A0#%`````@`Y5X'1P<R+$JD`0``LP,``!@``````````````(`!
M!"D``'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+`0(4`Q0````(`.5>!T?P
M?56&I`$``+,#```9``````````````"``=XJ``!X;"]W;W)K<VAE971S+W-H
M965T,3`N>&UL4$L!`A0#%`````@`Y5X'1WZ$@]NE`0``LP,``!D`````````
M`````(`!N2P``'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"%`,4````
M"`#E7@='><]\Y*4!``"S`P``&0``````````````@`&5+@``>&PO=V]R:W-H
M965T<R]S:&5E=#$R+GAM;%!+`0(4`Q0````(`.5>!T>7PG/?I@$``+,#```9
M``````````````"``7$P``!X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L!
M`A0#%`````@`Y5X'1V2[F="G`0``LP,``!D``````````````(`!3C(``'AL
M+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"%`,4````"`#E7@='M890!:8!
M``"S`P``&0``````````````@`$L-```>&PO=V]R:W-H965T<R]S:&5E=#$U
M+GAM;%!+`0(4`Q0````(`.5>!T<-]YI,IP$``+,#```9``````````````"`
M`0DV``!X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L!`A0#%`````@`Y5X'
M1\<$RVJG`0``LP,``!D``````````````(`!YS<``'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"%`,4````"`#E7@='&EJ[3Z4!``"S`P``&0``````
M````````@`'%.0``>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+`0(4`Q0`
M```(`.5>!T>.*YT`I@$``+,#```9``````````````"``:$[``!X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L!`A0#%`````@`Y5X'1Q4V8^2G`0``LP,`
M`!D``````````````(`!?CT``'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"%`,4````"`#E7@='$@1*XJ<!``"S`P``&0``````````````@`%</P``
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+`0(4`Q0````(`.5>!T?QW!GF
MI0$``+,#```9``````````````"``3I!``!X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L!`A0#%`````@`Y5X'1]3.$#>G`0``LP,``!D`````````````
M`(`!%D,``'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"%`,4````"`#E
M7@='R1U/[Z8!``"S`P``&0``````````````@`'T1```>&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+`0(4`Q0````(`.5>!T>QD\"'HP$``+,#```9````
M``````````"``=%&``!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L!`A0#
M%`````@`Y5X'1WCVA%:D`0``LP,``!D``````````````(`!JT@``'AL+W=O
M<FMS:&5E=',O<VAE970R-BYX;6Q02P$"%`,4````"`#E7@='N8D:!*<!``"S
M`P``&0``````````````@`&&2@``>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM
M;%!+`0(4`Q0````(`.5>!T?)/O*4`"$``(R:```4``````````````"``61,
L``!X;"]S:&%R9613=')I;F=S+GAM;%!+!08`````)``D`*X)``"6;0``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344820907168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Fair Value Measurements: Fair Value, Assets Measured on June 30, 2015 and December 31, 2014 (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on June 30, 2015 and December 31, 2014</a></td>
<td class="text"><!--egx--><p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="100%" colspan="9" valign="top" style='width:100.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Fair Value Measurements at June 30, 2015</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Quoted Prices in Active</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant Other</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Markets for Identical Assets</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Observable Inputs</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Unobservable Inputs</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>Total</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 1)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 2) </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 3) </p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>None</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total assets at fair value</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> </tr> <tr align="left"> <td colspan="9" valign="top" style='padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp; &nbsp;</p> </td> </tr> </table> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td colspan="9" style='padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Fair Value Measurements at December&nbsp;31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td style='padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Quoted Prices in Active</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant Other</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Markets for Identical Assets</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Observable Inputs</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Unobservable Inputs</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>Total</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 1)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 2) </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 3) </p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>None</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total assets at fair value</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> </tr> <tr align="left"> <td colspan="9" valign="top" style='padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19190-110258<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344630545264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5. Notes Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Note 5. Notes Payable</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 5. Notes Payable</b></p> <p><i>Convertible Notes Payable</i></p> <p>On March 24, 2014, we issued a convertible promissory note in the amount of $40,000 to an unaffiliated party in consideration for past services provided to the Company. The Note bears interest at the rate of 1% per annum, is due and payable on March 24, 2015 and is convertible at a price of $0.005 per share. On March 24, 2014, the holder of the 2014 Note transferred and assigned the 2014 Note to five unaffiliated parties bearing the same interest rate and conversion price. In connection with the transfer and assignment of the 2014 Note, the Company agreed to extend the maturity date from March 24, 2015 to July 1, 2016. </p> <p>On December 10, 2014, upon the request of all fifteen note holders, all convertible promissory notes in the aggregate principal amount of $125,000 were converted into 4,125,000 shares (16,500,000 pre-reverse stock split) consistent with the provisions of the notes. Related accrued interest of $35,295 was not included in the conversion and remains unpaid at June 30, 2015.</p> <p>In accordance to ASC #815, Accounting for Derivative Instruments and Hedging Activities, we evaluated the holder's non-detachable conversion right provision and liquidated damages clause, contained in the terms governing the Note to determine whether the features qualify as an embedded derivative instruments at issuance. Such non-detachable conversion right provision and liquidated damages clause did not need to be accounted for as derivative financial instruments. Additionally, since the conversion price of the two notes represented the fair market value of the Company's common stock at the time of issuance, no beneficial conversion feature exists. We believe that the Company's shares of common stock is and have been very thinly traded during the last 3 years and that the fair value of the stock price was deemed not to be a fair value. Management decided that because the Company's ability to continue as a going concern was in question and that it has no revenue sources that the conversion price was a better measure of fair market value. Based on that decision, no beneficial conversion feature was reflected in the financial statements.</p> <p><i>Note Payable - Not Convertible</i></p> <p>On December 15, 2014, we issued a promissory note in the amount of $22,375 to an unaffiliated party in consideration for payments made on behalf of the Company for service provided to the Company (the &quot;December 2014 Note&quot;). The December 2014 Note bears interest at the rate of 1% per annum, is due and payable on January 15, 2016 and is not convertible to common stock. </p> <p>On January 14 and 16, 2015, we issued two promissory notes in the amount of $15,000 each to two different unaffiliated party in consideration for cash transferred to the Company (the &quot;January 2015 Notes&quot;). The January 2015 Notes bears interest at the rate of 1% per annum, are due and payable on January 14 and 16, 2016 and are not convertible to common stock. </p> <p>One of the notes was repaid in full during the first quarter with interest due waived the by the debtor, and the second note was repaid during the second quarter with interest due waived the by the debtor.</p> <p>During the second quarter the promissory note in the amount of $22,375 with interest due was repaid in full. </p> <p>During the second quarter an agreement was reached with the holder of $120,979 advance payable note to settle the full amount due for $30,000 and interest due. The settlement with all note holders resulted in $528 loss on debt settlement as well as a charge of $90,979 considered a contribution of capital.</p> <p>We concluded that these notes have a stated rate of interest that is different from the rate of interest that is appropriate for this type of debt at the date of the transaction. Accordingly, the company imputed interest at an appropriate rate estimated at 8% as prescribed under FASB ASC 835. The resultant charge of $6,280 for the period ending December 31, 2014 and $4,113 for the period ending June 30, 2015 to interest expense was considered a contribution of capital.</p> <p>For the periods ending June 30, 2015 and December 31, 2014 the Company has recognized $4,699 and $3,255 respectively in accrued interest expense related to the stated interest rate on the notes and has recognized $4,113 and $17,490 in imputed interest expense. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344862586032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4. Related Party Transactions Not Disclosed Elsewhere<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Note 4. Related Party Transactions Not Disclosed Elsewhere</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 4. Related Party Transactions Not Disclosed Elsewhere</b></p> <p>On March 25, 2014, our President and principal shareholder assigned accumulated advances and accruals totaling $124,229, to an unaffiliated third party. The advances carry no specific terms of repayment. On December 15, 2014, $22,375 of the then outstanding balance was converted to a promissory note. A summary of transactions is as follows:</p> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp; </p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>June 30, 2015</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>December 31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Beginning balance</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>161,729</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Increase due to payments made on behalf of the company</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>21,625</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less March 24, 2014 conversion to convertible note</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(40,000)</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less December 15, 2014 conversion to promissory note</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(22,375)</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Obligation transferred to unrelated party</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(120,979)</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less current portion</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Due after one year</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>There was no stated term of interest associated with this obligation. Accordingly, the company imputed interest at an appropriate rate estimated at 8% as prescribed under FASB ASC 835. For the period ending December 31, 2014 the resultant charge of $11,210 to interest expense was considered a contribution of capital. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph b<br><br><br><br> -Article 3A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624246144">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Zaxis International, Inc. - Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 467,380<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">467,380<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">467,380<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesPayable', window );">Advances payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">120,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccruedInterestPayable', window );">Accrued interest payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,305<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">163,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermLiabilities1Abstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalLongTermLiabilities', window );">Total long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 186,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 655<span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockPayable', window );">Stock payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">385,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,283,342<span></span>
</td>
<td class="nump">388,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,201,617)<span></span>
</td>
<td class="num">(574,064)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">467,380<span></span>
</td>
<td class="num">(185,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 467,380<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">$0.0001 par value; 10,000,000 shares authorized; none issued.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">$0.0001 par value; 100,000,000 shares authorized; 6,550,602 and 4,550,602 issued and outstanding at June 30, 2015 and December 31, 2014, respectively.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccruedInterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrued interest payable, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccruedInterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Advances payable, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AdvancesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongTermLiabilities1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongTermLiabilities1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Stock payable, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalLongTermLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Total long-term liabilities, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalLongTermLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.16)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.16)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 13, 16<br><br><br><br> -Article 9<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20, 22<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344640628800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2. Going Concern<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Note 2. Going Concern</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 2. Going Concern</b></p> <p>The accompanying financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses, has negative operational cash flows and has no revenues. The future of the Company is dependent upon Management success in its efforts and limited resources to pursue and effect a business combination.</p> <p>These conditions raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments that might arise from this uncertainty.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 205<br><br><br><br> -SubTopic 40<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51888302&amp;loc=SL51888449-203568<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 205<br><br><br><br> -SubTopic 40<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51888302&amp;loc=SL51888443-203568<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344820907168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Income Taxes (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Income Taxes:</i>&nbsp;&nbsp; </p> <p>We have adopted FASB ASC 740,&nbsp;<i>Accounting for Income Taxes</i>.&nbsp;Pursuant to ASC 740, we are required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.</p> <p>We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes.</p> <p>Deferred tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect when the differences are expected to reverse. ASC 740 provides for the recognition of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.</p> <p>In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be.</p> <p>ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current period and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 19<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6423966&amp;loc=d3e40913-109327<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 954<br><br><br><br> -SubTopic 740<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 17<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32247-109318<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32280-109318<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624688672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Recent Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Recent Accounting Pronouncements</i></p> <p>On June 10, 2014, the FASB issued Accounting Standards Update (&quot;ASU&quot;) No. 2014-10 , which eliminates development stage reporting requirements under FASB ASC 915, as well as amends provisions of existing variable interest entity guidance under ASC 810. Additionally, the ASU indicates that the lack of commencement of principal operations represents a risk and uncertainty and, accordingly, is subject to the disclosure requirements of FASB ASC 275. As a result of the changes, existing development stage entity presentation and disclosure requirements are eliminated. The presentation and disclosure changes to FASB ASC 915 are effective for public entities for annual periods beginning after December 15, 2014, and the revisions to the consolidation standards are effective for annual periods beginning after December 15, 2015. The Company has adopted these provisions and enhanced disclosure of risks and uncertainties as required. </p> <p>In April 2014, the FASB issued ASU 2014-08,<i> Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity</i>. The amendments in this ASU change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization's operations and financial results and include disposals of a major geographic area, a major line of business, or a major equity method investment. The new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. Additionally, the new guidance requires disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify for discontinued operations reporting. The amendments in the ASU are effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2014. Early adoption is permitted. The Company is currently evaluating the impact of this pronouncement.</p> <p>In August 2014, the FASB issued ASU 2014-15, <i>Presentation of Financial Statements - Going Concern</i>. The new standard requires management of public and private companies to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The standard requires management to evaluate, for each reporting period, whether there are conditions or events that raise substantial doubt about a company's ability to continue as a going concern within one year from the date the financial statements are issued. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.</p> <p>Management does not anticipate that the adoption of these standards will have a material impact on the financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344870769696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3. Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Note 3. Stockholders' Equity</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 3. Stockholders' Equity</b></p> <p>On January 8, 2015 the shareholders approved a resolution to increase the authorized common shares from 100,000,000 to 490,000,000 shares. All other provisions of the common shares remain unchanged. Also on that date, the Company declared a reverse split of common stock at the ration of 1:4. The stock split was effective January 8, 2015 for holders of record as of that date. Except as otherwise noted, all share, option and warrant numbers have been restated to give retroactive effect to this split. All per share disclosures retroactively reflect shares outstanding or issuable as though the reverse split had occurred at January 1, 2012.</p> <p><i>Recent Issuances of Common Stock</i></p> <p>During the period ended December 31, 2014 we issued 4,125,000 shares of our common stock (16,500,000 pre-reverse stock split) in exchange for converting $125,000 of promissory notes. </p> <p>Between January 15, 2015 and March 15, 2015 the Company sold a total of 2,052,000 units for cash consideration of $780,000 at a price of $0.40 (the &quot;Units&quot;), each unit comprised of one share of common stock and one Class A warrant exercisable at $0.80 per share with a term 24 month. The relative fair value of the stock with embedded warrants was $351,419 for the common stock and $428,581 for the class A warrants. The warrants were valued using the Black-Scholes model with 216% volatility and discount rates ranging between 0.44% to 0.7%. The cash consideration is reflected in stock payable as shares will be issued after reverse merger is completed. </p> <p>Between April 1, 2015 and June 29, 2015 the Company sold a total of 1,012,500 units for cash consideration of $405,000 at a price of $0.40 (the &quot;Units&quot;), each unit comprised of one share of common stock and one Class A warrant exercisable at $0.80 per share with a term 24 month. The relative fair value of the stock with embedded warrants was $158,123 for the common stock and $246,877 for the class A warrants. The warrants were valued using the Black-Scholes model with volatility ranging between163% - 177% and discount rates ranging between 0.54% to 0.71%. The cash consideration is reflected in stock payable as shares will be issued after reverse merger is completed. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (SAB TOPIC 4.C)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Preferred Stock<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section C<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624648352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Zaxis International Inc. - Statements of Operations<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StatementsOfOperationsAbstract', window );"><strong>Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">88,390<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">132,326<span></span>
</td>
<td class="nump">14,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other expenses - advances to related parties</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">490,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">388,390<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">622,326<span></span>
</td>
<td class="nump">14,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) from operations</a></td>
<td class="num">(388,390)<span></span>
</td>
<td class="num">(6,500)<span></span>
</td>
<td class="num">(622,326)<span></span>
</td>
<td class="num">(14,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,688)<span></span>
</td>
<td class="num">$ (307)<span></span>
</td>
<td class="num">(4,699)<span></span>
</td>
<td class="num">$ (2,678)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1', window );">(Gain) on debt settlement</a></td>
<td class="num">$ (528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FinancialIncomeExpense', window );">Financial income (expense)</a></td>
<td class="num">(2,216)<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="num">(5,227)<span></span>
</td>
<td class="num">(2,678)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProvisionForIncomeTaxes', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss)</a></td>
<td class="num">$ (390,606)<span></span>
</td>
<td class="num">$ (6,807)<span></span>
</td>
<td class="num">$ (627,553)<span></span>
</td>
<td class="num">$ (16,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and diluted per share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss | $ / shares</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted | shares</a></td>
<td class="nump">4,682,407<span></span>
</td>
<td class="nump">1,695,126<span></span>
</td>
<td class="nump">4,682,407<span></span>
</td>
<td class="nump">1,695,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FinancialIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Financial income (expense), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_FinancialIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProvisionForIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Provision for income taxes, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ProvisionForIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StatementsOfOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StatementsOfOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net gain (loss) on settlement of other claims for entities in bankruptcy, reported as a reorganization item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 852<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49172455&amp;loc=d3e55730-112764<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 852<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34712771&amp;loc=d3e56145-112766<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 18<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=SL4613673-111683<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.6)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344871769040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Stock Based Compensation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Stock Based Compensation:&nbsp;</i>&nbsp; </p> <p>Stock-based awards are accounted for using the fair value method in accordance with ASC 718,&nbsp;<i>Share-Based Payments</i>. Our primary type of share-based compensation consists of stock options. We use the Black-Scholes option pricing model in valuing options. The inputs for the valuation analysis of the options include the market value of the Company's common stock, the estimated volatility of the Company's common stock, the exercise price of the warrants and the risk free interest rate.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b),(f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624569296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information - Jun. 30, 2015 - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zaxis International Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">zxsi<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000797542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">6,550,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="nump">$ 42,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344821327184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Accounting For Obligations and Instruments Potentially To Be Settled in The Company's Own Stock (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Accounting For Obligations and Instruments Potentially To Be Settled in The Company's Own Stock:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Accounting For Obligations And Instruments Potentially To Be Settled In The Company's Own Stock:</i>&nbsp;&nbsp; </p> <p>We account for obligations and instruments potentially to be settled in the Company's stock in accordance with FASB ASC 815,&nbsp;Accounting for Derivative Financial Instruments.&nbsp;This issue addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially settled in, the Company's own stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b),(f(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624193552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Zaxis International Inc. - Statements of Cash Flows<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetLoss', window );">Net loss</a></td>
<td class="num">(627,553)<span></span>
</td>
<td class="num">(16,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LossGainOnDebtSettlement', window );">Loss (gain) on debt settlement</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ImputedInterest', window );">Imputed interest</a></td>
<td class="nump">4,113<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">(Decrease) increase in accounts payable</a></td>
<td class="num">$ (7,500)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">(Decrease) increase in accrued expenses</a></td>
<td class="num">(35,833)<span></span>
</td>
<td class="nump">9,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows used by operating activities</a></td>
<td class="num">(666,245)<span></span>
</td>
<td class="num">(7,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash used in investing activities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancesFromRelatedParties', window );">Advances from related parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PrincipalPayamentsOnDebt', window );">Principal payaments on debt</a></td>
<td class="num">(52,375)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedFromSaleOfCommonStock', window );">Proceed from sale of common stock</a></td>
<td class="nump">1,185,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by financing activities</a></td>
<td class="nump">$ 1,132,625<span></span>
</td>
<td class="nump">$ 7,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash</a></td>
<td class="nump">$ 466,380<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CashAndCashEquivalentsBeginningOfPeriod', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CashAndCashEquivalentsEndOfPeriod', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">467,380<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NonCashTransactionAbstract', window );"><strong>Non-cash transaction:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties', window );">Transfer of convertible note from related party to unrelated parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty', window );">Transfer of advances from related party to unrelated party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancesFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Advances from related parties, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AdvancesFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CashAndCashEquivalentsBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Cash and cash equivalents - beginning of period, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CashAndCashEquivalentsBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CashAndCashEquivalentsEndOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Cash and cash equivalents - end of period, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CashAndCashEquivalentsEndOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Imputed interest, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LossGainOnDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Loss (gain) on debt settlement, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LossGainOnDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Net loss, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NonCashTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NonCashTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PrincipalPayamentsOnDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Principal payaments on debt, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PrincipalPayamentsOnDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProceedFromSaleOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Proceed from sale of common stock, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ProceedFromSaleOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Transfer of advances from related party to unrelated party, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TransferOfAdvancesFromRelatedPartyToUnrelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Transfer of convertible note from related party to unrelated parties, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TransferOfConvertibleNoteFromRelatedPartyToUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344871743056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8. Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Note 8. Subsequent Events</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 8. Subsequent Events</b></p> <p>In July 2015, the Company filed a Form 8-K/12G with the SEC for the merger between the Company and Emerald Medical Applications Ltd. On August 5, 2015, the Company filed a registration statement on Form S-1 for selling security holders offering 19,361,758 shares of common stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624238896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7. Advances To Related Party<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtDescription', window );">Note 7. Advances To Related Party</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 7. Advances to Related Party</b></p> <p>On February 3, 2015, March 23, 2015, 4 May, 2015, June 6, 2015 and June 26, 2015, $90,000, $100,000, $100,000, $100,000, $100,000 respectively, were advanced to a company that Zaxis is in merger discussions with. These loans shall bear interest at the rate of one (1%) percent per annum (the &quot;Interest Rate&quot;) and shall be due and payable ninety (90) days from the date of the Loan (the &quot;Maturity Date&quot;). Since collectability is not reasonably assured this amount is being expensed in the statement of operations. </p> <p>The ability of the third party loanee Emerald Medical Applications Ltd to repay the loans as a standalone company is highly in doubt since it used the loan proceeds for ongoing business operations. If, for any reason, the merger with Zaxis, which is in advance stages of closing, does not close Emerald Medical Applications Ltd. will not have sufficient funds to repay the loan. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about borrowings which initially required repayment in less than twelve months (or normal operating cycle, if longer) after its issuance and that does not otherwise qualify as long-term debt. It typically is comprised of borrowings under letters of credit, lines of credit, commercial paper, and notes payable of short duration. Disclosures include amounts of borrowings under each arrangement, description of underlying arrangements, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements such as the effects of refinancings and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344624688672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Uncertain Tax Positions (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxUncertaintiesPolicy', window );">Uncertain Tax Positions:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Uncertain Tax Positions:</i>&nbsp;&nbsp; </p> <p>When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, <i>Accounting for Uncertain Income Tax Positions,</i> the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</p> <p>Our federal and state income tax returns are open for fiscal years ending on or after December 31, 2011. We are not under examination by any jurisdiction for any tax year. At March 31, 2015 we had no material unrecognized tax benefits and no adjustments to liabilities or operations were required under FIN&nbsp;48.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxUncertaintiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for tax positions taken in the Company's tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of contingencies related to income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420479&amp;loc=d3e26513-109311<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxUncertaintiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344866026336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Fair Value of Financial Instruments (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Fair Value of Financial Instruments:</i>&nbsp;&nbsp; </p> <p>FASB ASC 825, <i>Financial Instruments</i>, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2015 and 2014, the carrying value of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair value due to the short-term nature of the instruments or interest rates, which are comparable with current rates. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13279-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 60<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344870771600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Property and Equipment (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Property and Equipment:</i>&nbsp;&nbsp; </p> <p>New property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344630368272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Use of Estimates (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates:</a></td>
<td class="text"><!--egx--><p><i>Use of Estimates:</i>&nbsp;&nbsp; </p> <p>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-108592<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344872946304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Cash and Cash Equivalents (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Cash and Cash Equivalents:</i>&nbsp;&nbsp; </p> <p>For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents. There were no cash equivalents as of June 30, 2015 and December 31, 2014.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 305<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Financial Reporting Release (FRR)<br><br><br><br> -Number 203<br><br><br><br> -Paragraph 02-03<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344871743056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Valuation of Long-lived Assets (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentBasisOfValuation', window );">Valuation of Long-lived Assets:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Valuation of Long-Lived Assets:</i>&nbsp;&nbsp; </p> <p>We review the recoverability of our long-lived assets including equipment, goodwill and other intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference between estimated fair value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make estimates of these cash flows related to long-lived assets, as well as other fair value determinations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentBasisOfValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the basis at which an entity records its property, plant and equipment (for example at cost, fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentBasisOfValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344640622512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Earnings Per Common Share (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Common Share:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Earnings per Common Share:</i>&nbsp;&nbsp; </p> <p>We compute net income (loss) per share in accordance with ASC 260,&nbsp;<i>Earning per Share</i>. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. All per share disclosures retroactively reflect shares outstanding or issuable as though the reverse split had occurred January 1, 2012.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344820907168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4. Related Party Transactions Not Disclosed Elsewhere: Schedule of Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><!--egx--><p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp; </p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>June 30, 2015</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>December 31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Beginning balance</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>161,729</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Increase due to payments made on behalf of the company</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>21,625</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less March 24, 2014 conversion to convertible note</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(40,000)</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less December 15, 2014 conversion to promissory note</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(22,375)</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Obligation transferred to unrelated party</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(120,979)</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="15%" style='width:15.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less current portion</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="68%" style='width:68.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Due after one year</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="15%" style='width:15.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344640622848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Note 1. The Company</a></td>
<td class="text"><!--egx--><p><b>Note 1. The Company</b></p> <p><i>Organizational Background:</i>&nbsp;&nbsp; Emerald Medical Applications Corp. (&quot;the Company&quot;) (f/k/a Zaxis International Inc.) was incorporated in Ohio in 1989. On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company (&quot;InFerGene&quot;) and InFerGene changed its name to Zaxis International Inc. InFerGene was incorporated in California in 1984 and subsequently changed its domicile in connection with the merger into Zaxis to Delaware in 1985. Operations ceased operations in 2002. In November 2002, the Company and its subsidiaries filed a petition for bankruptcy in the U.S. Bankruptcy Court Northern District of Ohio. On October 13, 2004, the Company emerged from bankruptcy. At present, the Company has no business operations and is deemed to be a shell company.</p> <p><i>Basis of Presentation:</i>&nbsp;&nbsp; The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of June 30, 2015, the cash resources of the Company were insufficient to meet its current business plan, and the Company had negative working capital. These and other factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.</p> <p><i>Significant Accounting Policies</i></p> <p><i>Use of Estimates:</i>&nbsp;&nbsp; </p> <p>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Cash and Cash Equivalents:</i>&nbsp;&nbsp; </p> <p>For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents. There were no cash equivalents as of June 30, 2015 and December 31, 2014.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Property and Equipment:</i>&nbsp;&nbsp; </p> <p>New property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Valuation of Long-Lived Assets:</i>&nbsp;&nbsp; </p> <p>We review the recoverability of our long-lived assets including equipment, goodwill and other intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference between estimated fair value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make estimates of these cash flows related to long-lived assets, as well as other fair value determinations.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Stock Based Compensation:&nbsp;</i>&nbsp; </p> <p>Stock-based awards are accounted for using the fair value method in accordance with ASC 718,&nbsp;<i>Share-Based Payments</i>. Our primary type of share-based compensation consists of stock options. We use the Black-Scholes option pricing model in valuing options. The inputs for the valuation analysis of the options include the market value of the Company's common stock, the estimated volatility of the Company's common stock, the exercise price of the warrants and the risk free interest rate.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Accounting For Obligations And Instruments Potentially To Be Settled In The Company's Own Stock:</i>&nbsp;&nbsp; </p> <p>We account for obligations and instruments potentially to be settled in the Company's stock in accordance with FASB ASC 815,&nbsp;Accounting for Derivative Financial Instruments.&nbsp;This issue addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially settled in, the Company's own stock.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Fair Value of Financial Instruments:</i>&nbsp;&nbsp; </p> <p>FASB ASC 825, <i>Financial Instruments</i>, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2015 and 2014, the carrying value of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair value due to the short-term nature of the instruments or interest rates, which are comparable with current rates. </p> <p style='margin:0in;margin-bottom:.0001pt'><i>Fair Value Measurements:</i>&nbsp;&nbsp; </p> <p>The Company measures fair value under a framework that utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of inputs which prioritize the inputs used in measuring fair value are:</p> <p><i>Level 1:</i> Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access. <i>Level 2:</i> Inputs to the valuation methodology include: - Quoted prices for similar assets or liabilities in active markets; - Quoted prices for identical or similar assets or liabilities in inactive markets; - Inputs other than quoted prices that are observable for the asset or liability; - Inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability. <i>Level 3:</i> Inputs to the valuation methodology are unobservable and significant to the fair value measurement.</p> <p>The assets or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. The following table presents assets that were measured and recognize at fair value on March 31, 2015 and the year then ended on a recurring basis:</p> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="100%" colspan="9" valign="top" style='width:100.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Fair Value Measurements at June 30, 2015</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Quoted Prices in Active</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant Other</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Markets for Identical Assets</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Observable Inputs</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Unobservable Inputs</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>Total</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 1)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 2) </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 3) </p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>None</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total assets at fair value</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> </tr> <tr align="left"> <td colspan="9" valign="top" style='padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp; &nbsp;</p> </td> </tr> </table> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td colspan="9" style='padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Fair Value Measurements at December&nbsp;31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td style='padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Quoted Prices in Active</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant Other</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Markets for Identical Assets</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Observable Inputs</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Unobservable Inputs</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>Total</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 1)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 2) </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 3) </p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>None</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total assets at fair value</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> </tr> <tr align="left"> <td colspan="9" valign="top" style='padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it may need to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. For the fiscal periods ended Jun e30, 2015 and December 31, 2014, there were no significant transfers of financial assets or financial liabilities between the hierarchy levels.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Earnings per Common Share:</i>&nbsp;&nbsp; </p> <p>We compute net income (loss) per share in accordance with ASC 260,&nbsp;<i>Earning per Share</i>. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. All per share disclosures retroactively reflect shares outstanding or issuable as though the reverse split had occurred January 1, 2012.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Income Taxes:</i>&nbsp;&nbsp; </p> <p>We have adopted FASB ASC 740,&nbsp;<i>Accounting for Income Taxes</i>.&nbsp;Pursuant to ASC 740, we are required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.</p> <p>We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes.</p> <p>Deferred tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect when the differences are expected to reverse. ASC 740 provides for the recognition of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.</p> <p>In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be.</p> <p>ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current period and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Uncertain Tax Positions:</i>&nbsp;&nbsp; </p> <p>When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, <i>Accounting for Uncertain Income Tax Positions,</i> the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</p> <p>Our federal and state income tax returns are open for fiscal years ending on or after December 31, 2011. We are not under examination by any jurisdiction for any tax year. At March 31, 2015 we had no material unrecognized tax benefits and no adjustments to liabilities or operations were required under FIN&nbsp;48.</p> <p style='margin:0in;margin-bottom:.0001pt'><i>Recent Accounting Pronouncements</i></p> <p>On June 10, 2014, the FASB issued Accounting Standards Update (&quot;ASU&quot;) No. 2014-10 , which eliminates development stage reporting requirements under FASB ASC 915, as well as amends provisions of existing variable interest entity guidance under ASC 810. Additionally, the ASU indicates that the lack of commencement of principal operations represents a risk and uncertainty and, accordingly, is subject to the disclosure requirements of FASB ASC 275. As a result of the changes, existing development stage entity presentation and disclosure requirements are eliminated. The presentation and disclosure changes to FASB ASC 915 are effective for public entities for annual periods beginning after December 15, 2014, and the revisions to the consolidation standards are effective for annual periods beginning after December 15, 2015. The Company has adopted these provisions and enhanced disclosure of risks and uncertainties as required. </p> <p>In April 2014, the FASB issued ASU 2014-08,<i> Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity</i>. The amendments in this ASU change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization's operations and financial results and include disposals of a major geographic area, a major line of business, or a major equity method investment. The new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. Additionally, the new guidance requires disclosure of the pre-tax income attributable to a disposal of a significant part of an organization that does not qualify for discontinued operations reporting. The amendments in the ASU are effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2014. Early adoption is permitted. The Company is currently evaluating the impact of this pronouncement.</p> <p>In August 2014, the FASB issued ASU 2014-15, <i>Presentation of Financial Statements - Going Concern</i>. The new standard requires management of public and private companies to evaluate whether there is substantial doubt about the entity's ability to continue as a going concern and, if so, disclose that fact. Management will also be required to evaluate and disclose whether its plans alleviate that doubt. The standard requires management to evaluate, for each reporting period, whether there are conditions or events that raise substantial doubt about a company's ability to continue as a going concern within one year from the date the financial statements are issued. The new standard is effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. We do not expect the adoption of the ASU to have a significant impact on our consolidated financial statements.</p> <p>Management does not anticipate that the adoption of these standards will have a material impact on the financial statements.</p> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6003-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=SL51803626-108592<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344820849776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6. Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Note 6. Income Taxes</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><b>Note 6. Income Taxes</b></p> <p>We have adopted ASC 740 which provides for the recognition of a deferred tax asset based upon the value the loss carry-forwards will have to reduce future income taxes and management's estimate of the probability of the realization of these tax benefits. Our net operating loss carryovers incurred prior to 2014 considered available to reduce future income taxes were reduced or eliminated through our recent change of control (I.R.C. Section 382(a)) and the continuity of business limitation of I.R.C. Section 382(c). </p> <p>We have a current operating loss carry-forward of $784,725 resulting in deferred tax assets of $0. We have determined it more likely than not that these timing differences will not materialize and have provided a valuation allowance against substantially all our net deferred tax asset.</p> <p>Future utilization of currently generated federal and state NOL and tax credit carry forwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended and similar state provisions. The annual limitation may result in the expiration of NOL and tax credit carry forwards before full utilization.</p> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="70%" style='width:70.0%;padding:0;height:.75pt'></td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='text-align:right'>June 30, 2015</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='text-align:right'>December 31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Individual components giving rise to the deferred tax assets are as follows:</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Future tax benefit arising from net operating loss carryovers </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>784,725</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>157,172</p> </td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less valuation allowance</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(784,725)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(157,172)</p> </td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Net deferred asset</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt'> <p align="right" style='text-align:right'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt'> <p align="right" style='text-align:right'>-</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company is not under examination by any jurisdiction for any tax year. Our federal and state income tax returns are open for fiscal years ending on or after December 31, 2011.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344820316256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6. Income Taxes: Schedule of Deferred Tax Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><!--egx--><p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="70%" style='width:70.0%;padding:0;height:.75pt'></td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='text-align:right'>June 30, 2015</p> </td> <td width="2%" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="right" style='text-align:right'>December 31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Individual components giving rise to the deferred tax assets are as follows:</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Future tax benefit arising from net operating loss carryovers </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>784,725</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>157,172</p> </td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Less valuation allowance</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(784,725)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(157,172)</p> </td> </tr> <tr style='height:.75pt'> <td width="70%" valign="top" style='width:70.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Net deferred asset</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt'> <p align="right" style='text-align:right'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.5pt;border-right:none;padding:0;height:.75pt'> <p align="right" style='text-align:right'>-</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>41
<FILENAME>0001295345-15-000202-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001295345-15-000202-xbrl.zip
M4$L#!!0````(`+M>!T=Q;/XQU5```&]Z`@`1`!P`>GAS:2TR,#$U,#8S,"YX
M;6Q55`D``Y'4Q%61U,15=7@+``$$)0X```0Y`0``[#UK<]NVEI]W9_8_X,[L
MK9,92Q;U\B--[SAVTLEM$KMQVM[NSDX'(B$)-Q2I$J0=Y=?O.0<@"5(4]71B
M-^J'1B:!\\9Y$02__\>GB<]N1:1D&#P_<)JM`R8"-_1D,'I^(%78.#GIG3:<
M@W_\\%__^?W?&@UV'85>X@J/#6;LY>6/Y^]5(F/!5#B,[W@D#MFY=\L#''`1
M3J9)+"+V.@C"6QX#!G4(?[C-0[@WG45R-([9DXNGK-UJG33:+:?'_O?Z^E]O
M3WYR3G]R.IWNN]\OSM^_Z?U?D]W=W36%-^(186NZX80U&DC2IT'D,^`A4,\/
MQG$\/3LZPK%XN1E&HR,`W3F2@8J1I@,]\BQ1C1'GTVS&D*L!C38WCI"61LMI
M=)QT"@+T9#;#AM\_TC?3H9XHC5/";8["VR.X@9"[1<A#Z6?#/1%-.#`W!4DB
MDT1(J]]I963X,OA8X/2N0W0XIZ>G1W0W8S*.%HKD]`CNI@/G0!:%A[<'7&7"
M`Z/HMIWC.G'K$1G-2E91#$.=HW^]?7/CCL6$-\HZ0I!R%9V"%?S']TCDF2)(
M[\60D2#.XME4/#]0<C+U$2Q=&T=B^/S@,]#42&7;_*2\`W9$<$!%9Y>AFTQ$
M$'^`Z<P-@UA\BM_CK$L8[[2</XQ*?G!:C9^_/RI/F8-S+2(9>B\#[Y+']0"U
MV?4;G581;`%"!O\<;GEX^Y7/1[5PA]Q70H,L3,I`O0QB&<_>BY%4<<2#^!V?
MU%/Z/_R35+"687D'M+*Y3RM;(ZD"5\)U`21$W'\=>.+33V)6BZP%_QV?'O>Z
M;1M\"4(&_T/$T7O=S":#T*^%BU:@(1;F9)`NDBA"24GE<O]WP:-5=-AH.&U8
MW1KN(@AE882321C<Q*'[\68,2U]=)3%:-]+$/.'*"2CP^<'K=Z\."KA?.KV?
MVP<L":3^6T\^^*'?`V):16G5H"A1<YT,?.F^\D,>KX/\EYO+@Q^ZL#9;-EX+
M6`G-*^F+Z`*$,0JC>OW?``4PEKT7TS"*42886G@PLQ$5P)7EJ]60S;^)>9RH
M6IR_"U407R6$$II?0S\)8AYI6NKAOPMM\*69);B_"=__*0CO@AO!51@([[52
M"<AC=?@+(,RYJMQ07\&5>@[0617=5&GV`NC:F2V'_W.["KHUF^";B'UVP=7X
M//#PGY=_)O*6^S!%G<<7/(IFH+!?N9^(]<VY?]PY`7M>"\NNZ>J6J7)HC6U.
MT[E2(E;&I+>620':IGB6\+@,QXZ86!OR2F07H;IN"$M=7?,9'_@"%`=7HD1X
M;R0?2%_&4FRL&1OSZFCNA[PYR1SW6EO0!TGRF2DLTCF;B*<"S&;@YQ7?;IT>
MGR[!H%FDK$FH>%L^*J%MA6R.JTZOT^HM19<J=;<FO,12MS9(I]\Y/NFNC.]=
M&&]E>E5P-D0PQTJ[W3GNU:!`_7T(8^Z_"8/1!Z@Q+5XW-;]%\+9$N(BWI2@K
MU+@CZ]L,_+R]G?2=WNER#-=0H0JP/X^2=9T?2._Y@;G_1\7]/XB;/R24L5#2
MG`7848AAM2YGV92]V^'N+L=<ED8)KU6=S",MW[2X75?!4!A9B5,)[E84=9?3
M,V<1W:74H-73I4T=3^>D1QE)&=`&T.?(7P0VB_&>)W5KX)I+"!P7?"IA`:_-
M@],^Z72P]E\">'OD\_'OY*3;:ZV'^;V(N802ZR6/`DB_%03.9)+X4)EZEV(H
M7;E^5&Q`=N'TG>.<D.5(=DK3G&`:O>-NJ]_=F"`RFG'H>U#M8M42S[9.X>=!
M;H5QGF7GI%=PX$L06OX=TMM[8'@9@AU2LZ3.68N2]^)6!$E]^/Q]271.86P`
MN'L_@$O=BWO!T-48NIM@^%$$(N(^%EK>1`;4F(WEK7CY:2H"5>OZ*Y5Q<M(Y
MM7`N`;\[4BK4UR]4EE^(DGI].YUVI]W_"D35F8C3;?<V%-15/!:1F;"IQ72P
MC6_AKX"Y'<[ZE;UC=/7Z[Y[>*Z\KNX*E>*<"E1Z,S,WUG7*GY`CF(&Z#;^EB
MWR&V>H7VV\4%O5/$:RS:>KRO`S><B#>A4J^B<'(!2&20P&`S*PS6UV^CK.#E
M.'9*4H4)-(HV\$4)JK>21ME,OC!M=8;4*%G2VJ3IOM^FWK_A]$].;.P%<)NC
MJK*/3NMXYYB6*+[;/SV]!YRU"FWWCU>4Z*48Q&'T7H31B`?R,ZGW=2PFZD>H
MV=`$KH(;$<>^P.=L5T.*&A<^EQ/U3L3.^KKNM2W"MD/^A?A8HMY=,X1]DU<R
MX($K<0<#KL0-%M9U$@FT@[;3UZV8:I!;8>Q68:0%=B\(%^K!8.ZUV_>'>L%J
M2\5,RVT%U-=1>"MQ/]VK,-(C/O!/ZZ56&J5IL"V`MQV^*KW>'[XE:KU/Q+5*
M70%Q]E!%Q'G(W""-.FWU6U9F4`"W*:+*Y.C$CGX[0+,TY3GN]3H[QEB?R/1/
M;7>\&&':B[P6$>UY>L&5=*'>O91^$@MO+24J+X4"%+2:+8N`)6AV1U*WGJ36
M%R=IL6F4:',Z7X&V1494EINS&6V_"=R_++SS6TB81^)=,AF(Z&I(\ZS-=5L8
M7;J=K]L_:7?M5;T9ZGNGOEM)/2S7GF,710^2^H6F_+B4L-#J[T,;&#K!^VX<
M0$QBE480"]QZX.OS-A,NJJ#C'YBT7P68T^=)^Q;<]%)<BV!OB7R5=&8IZM?T
M8D:VEV<+=KN.8S17@KD9KE6XJT)D-34BP96X%/K?UT%IH]D6B<YQN>M4CVF7
M=*W8[=T!3:4M>%N(J],[Z726T%;"MF/RZJ1VZA1[)VL2!XX$]]M2W>`)[\7L
M%X46F75GS]U8WFXKP7Z_W^[V"HGNBDCOA=;:G/SXV.XM[I;2U\$MK/,=274Y
ME17H[H7*%1?UFE3:^T^QL?M>T!Z,:QYM++>"]UT,>VOTM<Y?&]B*%%Q',G#E
M%'?IS#A&/J5#X7:=IVP?XB+P6^)?K5.Q%'7H"N&A<&ZX+ZZ&UKZR+=AW'&LC
M61V.'1"R8L>FGH0ER\>T\';C4R`':O?;RSUU!=)[H;7.LZSDJ)<16OW*B7XU
MIQQ+MWB(WN^O\/)--=9[(G=%G[TVI6C2U9->B)$,L"=Q-=3S5]^H959NMFQ7
M1+!;@CJ+5O!NJ'D9>*O14=5?3S?4K01^5X34--Y7I^%#Q`,UQ#K](H1$`*(?
M9/>X[;\4%&<?PE^":.487"VF=,/_YCCOG^XJJ5H1:[>T+\A`RI-K]U2NEFVM
MC_/>R*V-RMU6A:C7(CF+2#P&B%=#:\M#W4NBW_GQL[\U&F+TJ='X;A0_P[^G
MZ8\!_D`M,Z?)/HQ%^MHPWCL:I*..:#PKS)3XX\IZOLM]]H*['T<1E-/>&4VC
M,=_QR?19,%!3ZQ=[.<']5AY[*SSIPLSSZ=2''YJ;BS":-MD3&OYG$L;/8HNP
M[.)3]F1X]/&(LT4OVC]E=UPQ2`8!7!BA+.$/=C66(?[KG)Z<-ME5P,Z34:)B
MUNX=PK53^+^&!P2.8,:=C,>,,Y4,E/0DCV8L')*@(`70^\92RFR"LYLVN3SP
MK%GNF`>(0,:*!7B60!PNY,2:5L72!??E,(P"R0UC7<*%-(L_$W"0_JR`S@LG
MTI6^P-%@.8%P$9=F%45-K$=P-R,)?ER".>+I)09%#V1GV1^&:8^%^148U6ZU
MVD@Z>Q?>"FR9TI5#9FF3Z$22,OFB&X,U`L`XFXJ87B5@P!P;\.!CE$QC=X:P
M$<8OS9LFF%QV^2),HAB01;B;(&"7N%U3NC$J#)5.RKYRXQ`I<3J'2$VW2(TP
M2A_"<K00-MEYS*:14"#*XH0Q:",(V2!1,A!*V0(@SM`E`U`/!3@0:$=CX>.)
M"S2]6;NVL)VLD/AKC9G@+EM7:)G<-?#Q&(!A^B">*8!`/4X%9-\*H$<$R!4>
MI.(94P!!3W"GN[9ZW1E#*%-=4_F@G)'>*@DF!??%U)@@Z0,<'OR%[_T+(OP<
MQ`F+^I#=C:4[UDYJ,O73XR%DD!!/.+1@$R`\-@H1+PQS09<%UV2$'C,H[OG`
MER!2,!:XKD#_KD!HD=[>C5)WP?8B,K$P;:W`-16K0](01]-SQX<$%'C$MQH1
MFC7:Q^8ZZ-=%TT>.@>0F>Y60F1TB!,#XSP369J>%1N7TM(VXD*,`)9HJ56;R
M3M!24LD0W_S`GC80.Q$B)EI=\[IF9E@@M4!37#0_CP5B1'N2V5T8?23N]`LW
M)#-(UG%.B*2R(0?CCQ2+N(3KN.)B#EK`-W["!"IO/@B3F!5\[314ST`;U.";
M:7&2WL1")2TW/B\D[8$L_<03I#GN_1M<L+X-2"(Q],$G$2E`@<),A`T3C'I,
M#(=P"\2I;2X2I."40F36]3E,&9IH@G+G^C5U<"(XA4^HW[M@K&^U3N,QC]F$
MSU"+B1]KMU`@"O@SF$OJ72*JVH5_(T<!T00&<)ZOP>O01TM1E@>H@P)E*A+U
M4L60L,""7.8YJH"A0K6'R.13J=(*YU'A)JK]200A2H*`0=`!'^G'.[@4^$>!
M*UP3;]:J2B93[5U)-9QL`2#@B2.(P&@V5SE.LS6*?WM2N;"FT9A@H-;2"+$N
MFJ,-T4.W9;1<(81L;591$Z7OKN`@D6UX3B*413Z))$-5#$0<-TX`OK8\3/`2
M'TD'CJ/<#C/YS!D4$#;SQ7.]@B<\@I+QK"4#\[,Q".,XG)PU(25UIK$>5;`>
M++"(6OIAE5J;F-$K6'E5(IM:@8U-$TAI0"S%``OJ@;P`3XJ)QR%ZK3'(J0'Y
MT01<MAR-P;Y\"=1A$,)NK[9'LL`PDL`J()Q@OJQU2?J+!*0XH/8QN00?W:L.
MS^2QX1+]*W*>R;.!N9#/AG!?OE\5`TAXE\+5B4_'H:O=G>OI.L)`93P?JFF*
M$MA$2>_$'2C$@B92:`RS/G2TD8=F'5/\;`)SH#_0*&E/*DIJZ-D[QBQMUOB^
M##XZ;_@0Q2"Z@0XA&&%`MJT79XAAXH,F;_-`J5?CH>5(>FPF>`3:H-V$GL1X
MH"@WA%@I[J`J([H'(D;[T(J)1!H/Y6?A54R=R"#$_$!,`!>Z.AEI,!,.^:]`
MHQ4:S)A3;@BF8F=Y>=;09/A`F4P*,X9D"F)18"","(S!Q^E'USHO"0<J!--S
M!>45*HUY>3:5)R"I#S`WM(?0$KPE;PFNDC($5^S<OO`]Z\SWX[D"C3>@)(_I
M8ULVL;/?T)9N)5A;1?P&))`N@0`!D4^(C%/6V0)*(S-+,(TP].XDY--YC@,Z
M@SJ'8G-J0'=CR'-)4K3>=2&D8Y:,W&2BS\B#>R[H40<6&6!5"OZ>_M+)G#XI
MB-W2F^ZVC5*&@!G-P&+'%R8=@A%*D>)A3IXW3-#0Z#+H?J"+IX!XMY(M`VTI
M`7D\`.LF&S+)$BS01LP_:8<U],,[Q9Y`<0X!$$,3);JZPL7$3Z;;#[2EJZ<I
M$M.(L,P>JCJZI80-&E>)]J8@X@5$8[*MJ<9LUI8#+1I:"&X(^<]GY,)D;#KL
MT4J!Q7V'=4ON.X8`P,"GC*Z`$FH^$"ED&Q.LW"=0I9JP;\VR%6"))F=,:]),
M3E5I4;Y:!A-62"R5+(R>,WFJ+.ZP6L3H8A+XC&A/H(^3@=''KI>]?@3U@L2"
MH1@2%E-^YLN\8NE7+GB"U=`BQ@Z"IRW%9(-&S7G,L)@T`0-6*@Z.//+%%-O/
M;R[8L7-R6"1'DXZ[LAJ:]&L^HSB0TUHT"#S]DJR2YF@278M=G7XHG<0IDDDX
M-2L`_!B$+2+Y!;C>CXT;=XP>W8Q`'/AX"#(-3_C(`_*$%S((:%4R@)BI,DN_
MS=PMF)(_,PT`'0[2OHHNFZA/PZ./L/P+'J%4NKGTS$_3?EB*NK<A6%]5]5(S
M^9.(7*P>D;L,)R@5C[!4>0XLU4?P2D+D3@6;53LW4ZLZPASS:N#+D0G,Y]1L
M@P0DT9G`=0C!'(M=2"0^A.R%8'K3%XXJ-#X-[U=W`2/+W3#&&?,FS8867=06
MLNB:6G3I+%09NDRX+]&EK;!B2;PZOWE!Z^+$Z5GKPA(1DG()R<.M[A=DKVC8
M<FKF,S^,)3IDA8[5\T")BDIBU*FDKL&`^X1>C;%M42JE*84JNDPLM2*.Q;NN
MWJ@!XH%)H0/4S0U;&KD<#JL$$=X9R]RY5;U"#_1KNJ@JQ;11%90I"%O-.;8J
M^#GXPSR\H&1T7R),BUA1=IF%"MVRLT,&;(\7E;A6S,5;F,Q8ETRKI:#N0[(F
MW=>3E,1,4;6@?4QO@,#4S5C$-9DM`@AA0^QME:CGE?1C#,Q[-UB#:-3:'+-1
MNDH>H)_*^MU@BED[#4_:55QWN]-,`A-(*KSULRSJ]<Y7<EB\'2[(:5PHF3#S
MKQ0\>^*FI72Y;#Q,G00(SVQQI#:'WE>7]0F:3QF?0F7VR202=A:@:PDJM;+"
MF`7T?"AUSC8M851TR"IMS5*!0V=J$QGD4%*AT<#FG$GO<)6]S?W$QFVJM&%@
M?$Y!3)#R0O8$EA7QB<`VJ79`"0:_S]B5L0>/)62YD3N>Z4$0Z$)L'GS.G!\%
M;)!Z'JMCX8X#^2<V>!*ET[DTU;2M'\G,H8^HV(WIVFB,&C&H*`XD@>Z)`C1\
M>@3_4,15VO.3_];17^<.TD/G@`_2\EZGO<"?^%``^<RQ7;)ZFL5K2$;G"8`*
M542W7+<YB6D#I5.$HAG3;14:0#F+F:+-*Q>B+4.2%?"CH5&$LG+Y2)S5]C??
M:(XL>P$'FNJFF$OI/#+TP]&,+'VA<%<1Y;P"LB+1?D!!WBHOY;`)JLPJLLAO
MKTN^2?_.6(/]/$>ZDA/I\VA5PI]5`LGY7P4BN+PYF(8/7;-0+5B4<A;]+0M+
M$V!=T%IX9A;$;**'68P&J+?Z0;I`13#6]V$4A0/S<'0PLY&8?-GC,<<[.!(+
M,.IN1(9>,,:\OJT@AY3+F8)"&Y(=0/$D36L2[C]ENC-):THK6!L[F^`CYL$<
MR]9#&,S_,)8G4/&1&P\7D3!G19W-%H%%"STNMAX[F-F%6BQ;\I5/+])F1]%*
MLFRM&I(1$H8;D^U6.F*[0K?<E9Z,.4,P,V+6W1NU!B_LUX5N/!#&EW,(O:GO
M2O1CE7GG2`DOI,;ED16.5'O,8>@#(U3VTCW3#5>I&(D7:CD;>G5REB5FF`79
MN5/`WJ*XTEYS+_/NV#7%'P%DD)Z6(D<P$-\1^P"?,U?[VF*QG]_5!`^P(1P]
M_XZV-[3T/Y`,^;Z:<BQ]*^Y,H9*8OW,GO7ALKCFMUM_-93O!H"%G<+,)M[-D
M0A,3%4:.Z66ML^9QSTX[]$AO$2HW1*(#<^/47`7!@AV9BW$X74+7,\/=6:N.
MB"FSH;H"\[$*P,LRJF>XWZ=!H,X,D`S/@M0*#::0V9:T>A1[UN]H>P%W^HM5
MV>FO(K$R624$[;^OJZGV#K`ZG;71.IW'R^UQ)5IMC8L9/GY("\)D.==9"DV;
MMD6-_3\,T5>C72;ZE5!_*=';FQGHF)<'+_3JU;U,Z"LM\*\@]+V/W_OX;\+'
MO[7:(:^S&E8_IW[P/N<OX.BO\BI'EZ`/7NA_`4?_BUU<+A7[WN'?@\/75?!9
M$`;"_$[UIT)?>FR`#X>9TVR!)G=I-C5601\!>?#+;XN8\P!E_L3THY\^>+EO
M$6L>KMS;3\M/AAZ>X+>(-P]7\)U:P>\XXJRLK]4"T58/,M^!+KZZR57HDCX9
MO66:H6%D6/Y[=3[OK6[Z4AE58Z_3%2-UK4X?5&GXJ'2Z&Y6MS\?#JB:_097=
ML^?<+,K5Z>$O'-RI@LIVR]G/61^373[PD&\261A8D<6:F[X8QE5I+[ZQBH^@
MYV<0(WK*%\J$'Y6O>N`IPZ.RB7V`^R(YR:.RB;W*]Z%AH_3)1H6LZ5^V9#?>
MI)0QNZ/LR-Z.O6B+V").CVCO6$Y"$5X)R./=9U:MJTJE/-S-8NGKZ[E^TO?8
M[Z,J6$<XCZG!N]\S\&`;0S\G^WUA7W^+TGY?V'Y?V*/Q>GL?_\A\_'Y?V'Y?
MV#?GZ/?[PKZZPW^`6S;V^\+V^\+V^\(>G.#W^\+^2H^.]_O"]OO"OA&=[O>%
M/;H'<OM]88].9?M]80\GN._WA7T!P_T6'OY_JS:QWQ>V#W#[?6'?O,KWH6'E
M].E1[@M;D;WR9K`-\?Z&9YL5OAJ2GO$/65I^`IYUUK9UY&1V:.OBS[_D6=XA
M$Y*."30GK]H?$S#'I9I#!MT0/S-!1SYG9PN:#S`=XHFY]-$`<\!<;+X':+YQ
M4GW8(AXB&6@X^N`[<V)>?DQ>X8R\0-S9YVP6OZ"5G2&GS)GT*079UVX$?E$A
M/?Z_^&V:_+S+?!9].Z%)AW#K[^,H?,BJQRMS[-P_DX")^L^CT,F)UH=6"L?X
MY<B&\UHK?&'&%EMZS&]15/J<TIV?'/V21_AA5H6<,_VY94;GT6]XB+CYI`HH
MD[Z7%4X$>X+?27A*".C4^D6GX[?[K:K3\?^_O6_];1O)\OT\"]S_@8M-(PY`
M.Y)L^=&3:2"=I.=F-IUDXF06>[\,*+$DLYLB/23EQ_SU][RJZI"B9-EMQ[)-
M8&<[MDE6U:GSKE/G)S.D]VEF?F([]CW?<;H&T`-DIQ[2V"]P+$A**0&^&+UL
MGM76N\_'+RPO`M^K=L2T#`<"A`A^^#UXO@8B,[J$SY\E!/FQN/SH+$I2VVK:
MMJG'@4_RE-""MK(Y(DR"N+W`3U&7>E+HV$41$3JF0-4Y,9_M_P],!-)2P<)P
MS*W89#D!+.`G%%23!6AZ*XO'B7,O7X8F(T%-4R8.=D9U/<UK$ZV/MO!]!8A0
M%:2L+@-N_2Z@"-10V@.UXE:!<&"32'[,OY],MN5!$\O;A,K(I,:GU%*X=ZFE
M$'^*>_W;#JTRO\3W[[58%';`!;H2<)<#03R=@PB2JE*X)0(KT(190+FVZ`)U
MDIL+:H1;+J.U#)T0UX'ZELU)4,%7R;9]`Y@^317?>G`P[(I>%3FWMTTO'2A=
MR^YAUUQ8(G=2):2J^?1$="=0$F&K3D$=$5P?:4K<IK]%V1PQ*%CU#6Y=%[UG
M@?D:7=P,^PW4#\%$1G%.Z&VN=_O!7JMF:0`-Z.&5CO$O?IX70#+NSVH_"S(J
M8%.D@&*1;M*!B&/#O7!')C.31"PYZH8Z5B-L#O9H3QA9!`%'V/AYWG`?`'9K
M?9\6SI`^8#I4*WRVN64K`AS:FG%D,4&<*Q)E@@V$4D!(F\2%LQS1<I+?#?7]
MC3+&1*RH';WM3"Z&_.H%XKP$\H<ALI9L*'4A)EP:V[.^CK#WVSR>.D0_+=:B
M?7$/I"T]$;\5U$UPW"S^Y+(1&&XIL4!!Z7B>.CMC9^?V?,$M\XWK46V0(O$H
M00XJ"T8F^9S8/;0#6(!0A<?'"@X'A-^M7%@;<=]:[;M\RM*YFHF*%DZ[:WKR
MUF7QD_`NF.WIB\.,+$#LDO&4"8&G"[<':71.%!*5>&Z]9ST'G*M#DR(H*E)D
M.U94$2H.K+/QT#4-"L<M!$F0\!"6_-MMM(>#*I<*!8*EL7OYI?XRHF6A=+0.
MA<B["/6&.T=0;/@T8\D1(37P:G0AS9F)R1NR1`X6XB^`&8Q$#_T&YKJ,D[%@
M4>:R+&,UB[=L3+>(VE0C^&U>H,ZO43H30[@HZ"%:EH^?/H0,.B'"SMA#I*(4
M-V%(T4H]<=9+)PUZ<-(V^!A***R/%H$SHL_+'B,4LP(FPJ[5C(HWC1!<HM'$
M'.WQRLW9"7[U.%DT`8>4BK@A/)(1ZM&&UR%6%[_H4*0MGE;+;*FE.^&KU1#9
MVC_HL&*I17QYFK.=;R,"A2HN$B0+=DXH)`R86`-0\S"W^(:PVZ+K!PS'RNW<
ML++F22K`+T:QLE)-L624E@A)45S6T>0L=J#5&[/D@M$9:&R+58C:'GX&3<V.
M/7`:.,M9"Z_KN3&S+J(ZL?>!H$&D#<(V#9_+_.MP`F=YBHYTC-L.-*%@9IZ)
M-;"0`^2@>KAX1A::G:;F@BEBIC(."XKOEZ['0JV%+(OH`97=^GE,MKF<^X$(
M8]S#"RX2I$9M!WH#<P*U6C%`=!;;'O3FHI+-)R*&CD:@("KTE%@>1H3L0AP+
M9(;]HX^";#EY%VP2AC?ST'(6<A:=<X1U!T8'CF"FQ`];=Y2:Z"<:-%EUE6?;
M(HIL-7<VYE/_;$+0Z(AK9U`5R&1H3V0R)"!1IJG`V(,X2$XX;:"`2HL`SQ2J
MHV!>,1N'6JIYC:;F@0K/K:7CKOU";:TG*&YI97-K#7D.+FYNV$(/N>;]*.-!
M?P@?=#+/8OXIT]X6Q"#S(O-6UF:99/DBK`U@-S%?Y*VQC8^JJDA&\\J&S,M-
M$5F:;6]J?JUC>#E=J>:HX1D,XH%8>K.?88$[G1,2LF!7BZ"*;5\7A3PR"4&A
MQO,Q9P=4"L#SJP##*\=E9*V(B6\]Q/IF51.&.<'GO.2$WXVB+7+"U(:C`S9)
M4A.'$C`(VK%SC9'%2R32J1V7@&`S,3\()`?&)B+G@!P@<Q%9^V%3(C`@.95S
M"%D+[U<C%Z+NXEF`>?]-\AI>%U\JM/@9\&+E@`KM=&0V-=#UQ6<(X\).6&DZ
M-W=*53037/B-Z3SAWR!&FXI-M_L]A:[6B$K]COGXU&]<Z#>.$<]$"1(L&6Z.
MFW<=I]1BERR!1E?J2M2I:'\G->@S>7XVZ'3!1$,-*#HR:6+.**>]W%.V:L_-
MTYJ3Y:P0:@DEC5GFF!IAS05VUB"N,N6B*P$Q1+4\)CC`$%UZB')WB(Y-1HP*
M#J+SR40@;*+I%,PSZ2B&Z":CZMY;^`RN9X;@@L1FL.1M7O(V+GE;P=0),\'D
M,0%((WO0%`9C2@G4MM*<J.R<!8XANA)!ASW<M#&AU#"=,0$J6H@5BF`\$TZA
M>+/"G.*?B';2,G9IDQ&%I;'B-$J5Y8BI;2E4M="5YFHNQL;$-50\O6*(S,:@
M\?&'47Y&\'`B9!YHFH",O%$D&-9,L75-KUK':SSFQ`:N"=%1\12.H98T/""F
MY7+KP6$:1*W+(=`1X",8C)3/-VJJP-I&<9P6%=4"([?:9W23)R9&`''&.$+!
M;+.O!$=U:C)):]#Q!8=_1G)\I,JB"<Q]X=RB3TZ-97=&FVMH6Z2!=AS%`;VD
M2>!`A#O8`/`Y-Y0RS'(7GJW8(`9N5#$&!:;:Y\5S*(]<3H&+2[3QI']Y_]';
MJ;W#6S>87PS)DU+*GXL\R]&L-&`O6S<S8_B:?D^=%K'N)Z<]UA\^QN0L@0U_
M.T4&#;9H970(^OKXF__A1?`QWZ'O@>4(;%X)M"UM'T4C9R;-"7(<^6>J3\2$
M?DQNH:&U14?]80W#.8*GXM+[M&0QS4525AQ;POYR%D+$@^`^+[V=X\\SPFL/
MV,4YS>DE4P*6Y9#+%2H=G7=SD#0S0FD"([?@:9HK8&D.AHIA?)&O:G8_BT,Q
MR#!O'!OQMKR/P)DDFT6O4TB;ZL'!$!9!PU",:E6A'*F&GC2+&R"DJ1U/\8%4
M^[B4S;([:M/!*UZVQ[JP'+V=_!WRJ/&P`47X=#X"1>^A65FLL[DZ_1P9D`W*
MHC:T!_('\['#33:6-8207L,F!,1L>7IQ(M<<=%@_$"90.TGT<RBIV)22I-D)
M,F&-2IA'!0XI&RQ"J<[2J99%Y%#)#[P&!DR7"3*P,HED[S!TV@.41?TXTD/G
M'GN':^MK?@H[,N@-&=\2-`P0I0(^_0P&JF)BOX.Y,4/)X[O[O1<_!E^<8+]%
M('C.2L7!)R\?=&RMSHA@%O`C*+J(82^1H'EFF1W<B'?$JOJ4E9#R4!<H!Q%$
M")?,?,<[#V8.53YMKE<XL9Z7UN;DM?,NV>?L'.T(P#31#KC`L2E<B8#5+B$8
M.$PPN+4X14`\!*R'H=L4*%6>)).*`G0_NO<NY"5Q0MHGBR3`.H?&-]UG^-@)
M;-YON3NWDS1Y7DRC3%+`;%]*/8]ZZE[GOBQL>JPWRXXQ-?FTB$Y/,/L%-`K=
M'U),)J#;AZET(PE9-S/@H>K2@]2#<U[QB?;7!G$5A/,%B%M<$Z-2(JEE.\M^
M$?KQDHYM/9R8EQBND;M%+FR2`=_,1+FY2(UCZ;!^D,+>4*C/0H@Z2W=OT?*T
M+[:N*BK6N=N4,6`'K)F5B-SV\.[H\@^$9Q:1TDS`Y(ESPY'_OT`')A/V99<1
MU`E3NRBR'5VJZ2TKK%+YH;`<"O#,J62'<DDU/HT7KC02.\&[J,#T>LQ'XP2Y
MC>FNJFI6]V`9!:>)X'G)I[MB`'AD++:60+N5^[4LD?MZ/L5SPRLT=5^#FJ^E
MJ;>#O^8XKS<YVHZLJ2.1J:S%\TRE0F+T87A3*)(@8'N!L<ZD8LJ=)D@V5NJ+
MV&.QAQ8!5@962DS8O;#Z1:'XNH,*"IVFN01!.'OVBR`<+O-0H[-3^=BXY="#
M$O:C^EFWFZ[R1_S<T<L_!1M&-0_@*?`I";$_S)^)MI)@:@3&;S<192WK]5UA
M@UB,#:ZKV?#PU`*4%A$>P"ZC9B3;<5UBBJR`)67T4G>>%MNCH=9D"]5#$5^V
ML%!2KG:9)-!KE[_]E3)]3>=K_PIAAF`RSE4FDW6W?59T*0H>4%&,I5:55L8Y
MAUX+TMNHUBKVBEN=<O7G)3ZX:,RJ-,I))39WQEP"6#^Y9;NHY_/JY;S<GD;1
MZ8\?"=3^T\3[8C_]G__XTRO[YV//@&^1_UXC^Y%Z$>WRU5Q4/Z=86H1\!S]\
M,9._/'_;'_;ZO?X_X3_[N[WG/^'0_[F];:87V]LV#/TC4>\(__$Q!XH-=EJT
MW6A9J/NUF6II97>B+96H@&$%`TE>5SF?665O#4+]D'51W!9C`3#07*7$]28A
M_3+#U!T*CS.F>&`3E2?!),W/2SDWIE,?J:^P2,=\'B&,J\Q4XXA>,5TY)\!T
M@ABO2'!!1]D2!Y`3$U.F<EZ,6=&?8C61U'/(D8<WU4#'T:HL$1>J*!VW6JFI
M15Q/K=F2F-;-%(FWCBHES70NAW*A6,&H:U[(B*OH7"W/B\[ZLE$7*2S$DWK*
M=^3K(B/[X.>^)6IW)]!3Y,<"GNEJZ<)$DE3?'4JJ#?>T5D!*)1]G5/N@4N)\
M;(\%F6R%)"&)R;AZ<2?M3K_7"WO\/WQS[\C_R(]Q]:%DP6MY(0[^]1<+,\-S
M"]AL"A)C?!<\".<"DU'7\A6;<<HZH5&&*+D@2BC@]MFS4N>M]7_<L]X$_IW?
M.H^T_6S2#^VI)9V46Q44`]):9'Y@]B[&YK2BW^.BSY&1,^S!&-(9""TUE.)/
M$F8I_I2:4JWR,$<6R2$?UM_J<DU5BDL20BNXOU)/Q-V^HMJS+4WZ'@>B@UE.
M+%`U.>[(ZC3IVX4C>ZZ_7ZBVQ_RR>/%[87\P5(QI2S1J?+(%7M!0^!<C.;=B
MSR4OJ*[L0O(8R!2V1AEF],R.0<G'?`9CYT`2W/^R/4OTLU3".>H-U>T!3I:[
M7VG6+^D0"+:_XE!R$/:&`QIZGMG"43)<Z!PEL?&L_^S@D!<8H07ARF?\=6]G
MKQ=LX1@^<_P-OZ42R2'[TS@$N;VHIND6!;JQS',+HH>5)?#7-RD8[N"U8W<I
MB&8VJW#XPYYB73Y6";#<(1CL0<2?52<LL51J1`ZNN[-BU0F/2*\B'\3($[:V
MFJ3[V>ZP'^[UCWRQ07.JS_8&A^'PL.^?J,];[+W_*L8/-`E=T/XS9J2WC\>@
M+S`^R6.3\K0&_?T?@K,<5^`*4RB*Q],MKE^$[T[Q.[9&$O9E[P>4\][.P0\\
M>LO&TG&M/?9*[(KL&5-46JZWQZ4B%>R]6S:?F0(K6>220FJJ9;E-R[6<X.PK
MEJ7CB\'1&AS;#T%+H+1=S;%[O>&3Y=C^\!`TU^X*CAWL[8>'!P=WQ+&*61N<
MV=_?_2'8#OH'!S^LQ\=#Q\?]^V5DY3BNZP'6_,8O7.WX.2JJRZ]X:2OB4KG-
M\1SWL)282S)IEH&>9@"/V!0_WC5)2W..>9`K74JV1P-WJ(/V$_-@"04XDJ*2
M$S?E:F+(!L$[[A+X"[.Y+14]BUQ-%ORAF&/.FM2#F-*]<(":A*X%@@1'DPGP
M(3M$)PGX7I@PE6(#]S$J[J*+=:=FC.D"$DCQV*2:<">`M;2<43T;#,+=@Z&5
MS0H+EK1G9,__42[]?2/*ZC:,/3AB$%O-9FC1\6N:^`F='4URK*^50JJFE_3X
MP`+T4/N'RT?:/[SS!B?+R]36N95^UPWR[JD-WAWTS"!/P%Z&W1Q*#U=0>O@P
M*;T0]JQ_]?Y!2O#/+ODL&OG[<=?FM9NY4G-LQI)NT@'DT>S1E3IG,Y;4W^^'
M!X.C1ZX]WMOLIC2X$*<0CQ%CNILP,B=1.E$I2DJ#/V'V[53,YN_1`U$Q@WZX
M/UCE#3X&#?,!3^0D5MZ31#3'BZ6<L.BV%A@O/F7.[;3+YN_1`]$N6WMTLK$*
MB.#1Z)>%_%5#Q30R4D^9>SL-L_E[]%`T#*>('[N&^31*[4U(VY1.ZC?Q=A;G
M[RG[_I19]A'F;#L5]+@RPUO]02\\.CAZ[/KJIK!?]W6:LQG<\1VE_9&8_SO'
MA-B$R,(U8.$+_)O#))W![0Y&.W'5![]8@T^%3_8:T5/VWSKU\+CV\PDKI%M"
M#5A:2+8Q'_S*S?#Y2I6][8`5M-3!T7;1:78,P@L/N4M1[%!3%->K0QW:XE6\
M>;TA3T7=^%2S4VHOZ1O+P0.'/V"!'E[SE_Y"C:XGA[M#CP/@[Q]03X6%"PC2
M<&J>XO4DV_L/BY?[_7#0[_%U&]L.1=KT2GTA%<72Y1:L(:5KY+899'2:0,#3
M7M)ZC>+46E'KASR;?@72OS6CZK[+5X'`^-\R^,QUO[3.I96I^`^Z*_)&':LM
MOK^JZT[]M"Y4]T:B1@_Z6E;=]8QR';>>[;G+4,VB54J8$8Y&K>"9;MY'V&36
M%&?)V)2^*:VT2)$*>JYT)?J,I&VOYVJYWD2\U?^!RM+QRNZ,>M?$<F_0M6-L
M+)A+]Y.RMM2%8OM>;^C+W:F&MDDUG(24_$KU!,D`35GG$:GBU]8$-Q[+@PF6
MRB]0CI$N(G?QIXQFJI-08:^4JT,0FKO@`&"K4&D7)_W+'"*)GXSNF.MF5+]Q
M%DT+032A1J?2<18O[F*!/%W=IGMQ#?+"\W^;I_9NU'[[I8I:4;)K`$771EF+
M_&N.2\4.$6D*5`+'SV3,AE+!SE?,5O"K;W)FV]2IBFW%Q/8:$]T5\*7.0.Y\
M\2+56I>FB.?+JM9";O$^H%R4LJ7K5!6NU3?.;7<8#HZ&8C/<;5+7HE`Q`'=]
MQ3N%>(/T-$KXGIJN2UW:V=>W8Y3F_?]UB`=MC6:+;PVU9$"&?9^553&72_HP
M\/\U,5U_>(U7[FSC2>.Z$\1*6%@+XG*R[=A4$5@)W#NU$G(C5*]8OB3\K[G<
M>8^C683-G,8I-N</26ES+T3;)9YJX*<Y?,]A6%AQ\SUE55.$8&+H-GKI^HW@
M7=_,7U*)_<H3O7+N+LSMJ(^Q]?DM+2J(DYCVVR(*C?CZ^)PZ\5"O@U)/RE]`
M5M-K-G8I$]K@.M<XE4>$.\]%<%RW(-DZNLLC2$BU*SV->]-M]U#!V:#'+:E"
M]'ZXS=V8453<;&0?N%48MWN6/IF^0T%C1'^_L39V8J^OV^NE,`1VUDRP*Q)H
M0]I5?[$R19.T*QT"N7N7#+?L%A,3[ISVP2`8BK2VQYU2+]7ZA,1FS)8./]X"
M+F'7M&Y3#;K8'Y"BM"S%?2^KQKW]P-VLM\M:8(%S&F!D*@RPI?,D(3,U=YX`
M?BS00<2+*JGQZ)7;>AXUKCNMTS)BT?$A619?)]BF^SW*%[K2^VFY"Z,=H*N=
M'KDX<UVG9V7AI36Y^*BX1LL\H^8E0+<>9\75C4!VHQ8?N06GJG&)=]^Z52@(
MVBHK1">4G*7N@/O>'GT)6[2@T=*[@PIJJ9%7!ITM-MV%1-K!6[8M=K7VAM%M
MO<9Y\(I=L+,G#XC<\85=6'SD6KM`=]Q7;$.-;+P;MH7I#;;#U+P4$5WR*@A/
M`T&:O/J<)$5)S;H*U![D\K@UX93/H^1,+(ETJHXA[LH+WRFQ--BN@R5.C:7&
MD">N/T@[OLO2#XNOMIX.:)M%DU#M%%X^`0S9T?'FUE+T.6!DGP[04<<S.?*T
M5P(=8V3B[W`S8]XDW#19`LX4F?S9KMR.S^+:,J1=1*,3<L3@(LX#EUB?=?FS
MX>"0T2?RC"BO7]=M4W5>X(AGOU;\WT9%PM2S/K&"1F&FM;V4.--BI<JMT_:(
M]KK!P[PL>U8G4_@*,ORRNCPUW.Y^Y&0XEB^XZ(L3$_>2OOFZ+"VS'PX.>TTD
MN*79'>X8$/;[NTM>J04;?RS9T[;9]2Q4V3YJ*PYE37&?1+5F[["B_:,C7MQN
M.!@.D52GQO8.83C&>F!F5V.+@\0R")_5PW0+WYE;M*;%X9&@-'S_(-P[ZE&/
MI"8OR)#M2;#69%8MW<7=\;]&%YMS:7M_9Q%3;FG2JPE>5\?IN`J[*FK#&.)F
M_2[AP"X^Q0*HP^JP&:KU&8%#(6B%[8)5@P#!;?0-^JP_KV%DQ+R,&B!(#1PM
MUF*Z'SA#!"UB2O%,,=957;Y`72`E<E<JZP1.XVRN6(<T$V=P#NP0Z)HMP]0*
MZI'#:$34V$;:PU`,!N*<I\'6^YTO.V\@*)9$U.[A8"MZ\<*9>PEKA`"NL1>U
M`G-$:/G&^$6[-77\X<[SVZAD]U,:P^R%!X.A*$8&Q6N'CJ)\X.9C="T'Z&I5
MIKSKC$SH@9=<GU&!5L-TPT*__8^?/O!.P@AC&`J[C5`G`B<OB&`UJD&-1+7V
M:])@4>VWW$]#YLC/8>CR)#FUC.4?4^EB\?'>HX;$QG5?)-1]D\?L/!\=[H>N
M3[OD84OX4AH5L@Z?DI.^"@NSPG5(.W/Q`4$1)[Y9R]64&!D$WV+G2Q&[/<)]
MW*T0#E:,=-"[A:J.IUJ2\^#:$CP\0G[WK@->6,[TS*O\]`_*T!\ZP7Z?$8CW
MG,&O;6?\*?P.P3.P^Y]%C&C#3RW,BF8PZ[#CVJ1XH$4@N]=>Z'H5MAU]OR]]
M'[$&^,5C$5JL+>Q?2V>$[:BW.D*Y=YF_+P[Y/K(@,4U'Y;OM'#(\"/L'@Z?I
M`5#1?$MDVO'<W=YM$M%>=;>IH_-MW"%CX;[S.V2;*=T?=0*)W/9[Y[?'XT5*
M(`L/MD2Q\L?43*JVL!?Q"C`%)&\,_1NT$'[ENT3"-ZG2[SCBJ7+$0ZCSUV`I
M4K]R4\S7[X5/VW8*N.J,KPX$<I(7E3TO?$LGQPS0<#\'@0=8J"@-C:N\WLEY
M]:G@IRSXQ8P**G_9M=5"4HSL?MZ#WUS:'R@?NK_0P=V5&CT32(_@F<7Z6/FO
MVE%QR*=F4HDAK9+MX3X="?V_Z"*AELA)9IMV8QOQ><EEP5AC82%ETCPB',:(
M^GY'Q=(:(;P+M]7_X84#MW850\T*I??V"U^B6HD8,ZJ,M%!AE"40T5\&6T>]
M%T$<798-Z"XYOOP`TVV.]ZLM%'\;-4K2CJD2=9RG6`EH#T)%\K!;89[!T(0Q
M3?#7#';)A2M)*9C=<B#NR@@]="(21:$;MC$.'?;4#V!5DVTBOC'!NQG*<1S\
M:A"#-PU>,P@XGT-]J&(^0P5"R;$Q(;F57'"2Q0B8K8H[RN`$M"87%##X$-?C
M)H3U&+M/,!@[(H&C9L@S+OET)Z1Z9>\GH5-!3#8N*!'6HI(=8CD+@LR<9TN%
M"'J7*V=!6\`HH8<&8Z"ZJPBPX\\RZ>RRG$^P^),J:>:(C;Q`H"5]Z9<HI`5$
M,+P4D%7O"*[NONL7#K'DVTXIX#FM5E?O,[X7P:JF5O69I'3B^TM>S(+#[?]^
MV1_\U9=[';][XRH;9&\MS$#MM@;BX%ZY8Y\<_N,P7#&3PDP3PG,5G&(K6QG/
M\7B[+Z6J*?6O+\V89=UC!D$0@7_I'X6[V&EU>+BD5'LIQ%7K9M=8XEMI/DW>
M27%%>7T^L/^@:F'X&$[-?8[/)Y*&Q[&TG;K3*PS=YDZ(6['!N.`4$5V19K31
M?-Y.A_ECQ%3B"R'V^H7<6TF-PV%N`D'.HM]]:5AI[_G,9Z<*=39B%"4&B,0!
M2*<R=*X<T="M!`\QW\#1E@H/F!$7];6_LU@`UX9PZS&R%V=CX>;J&+:J&+2)
M<8EE==5<802/"7F8RRZ\R7+T:66Z.CO5..U-5)Z\SF+\#P)G@)N/^_@9?/;Q
MY?TH(KX"B#7*2"/ZAYK939CW%_)$%S>J!JQ^.B]@%GB]1VL-6V%$`%IX&0H5
M^C;6R836[/%=%P6K+.C&.003"=9OR+VRQ,C]J`(L,,'*$$1IBL:/KU=08;8M
MT#9^S>0ZX2T#0U7/"W\7]+(UR@5;N6,M%J@QC44J)YQR>-6!E-\[W]B9U;'3
M;\(T'\TY>BS^:\8AL4>%$=PX+E4=YV6U`\0&?L+[S0)_@PX2E3IZ=!ZT.QAA
M;A-<M^!QX_E138;Q#3.98[G.F7%WZBPBME>G0XZK$*L.P2D3ONC%*.R9.4<8
M%IPWWWSQL+-2B(HUFBVO0EB(R'$@(3`6E7L7MO@/'?6,:[7P,U1L2ZZBQC7W
MM7H[P5\1!A!9',_*J!ZQC+"T'R=8@:;GJT-<'I6/2H0L&AMR'5MNT_BC-ZL)
MY0]2J4L4/".;`0:#\(?'II7?U^7>]5C^YZA,RD^3?[B#@^_.\WYH8!6LF-W^
M0/<%7A/'W(3W_X=``A.0`%MS"CRJP@JLR$MQH)0&$G/)5S@IA+'$`7;-\YA1
MI!&.B^XE`A\AIA3C0#%3GR-&CX`UHP*DZCCV)I)B/)]AW$'P@@A4*"7K&3J"
M&N&73F-Q^-JE-JZ)Q7(W].9':CFI7`;`)\K2`74#L]+<$/\W(;FAV,Q>#<.U
MJVML\K4K)^`M-0$E8_4AGS=;I'D%3[L%(8:`<$EU'QH4!'1UL3)+7_G"5]ER
M;J$>14FIID:^Q:).LCA8TMD^Z1+O>]*L\1:+I@,)<E*K\K;NNZ\#=2Z\UV?J
MJB%=[JX-R;DE\`-GF.UH7M#CM_0&*-+XA?%.RLMV*]7,U_,M\Q:*J5+X!98/
M]?4/9FXU:5M/*_MQ+574U"J--!=L(]U51#<%7$AZY!,YQ/"1]QFF2V":^%6Q
MX]]?*Q$DF]RHU-/\L9'E;&BF5GU$W]IF#HBX^I1*KFH7A[V957L@-C:I704G
M]XP*[?N'87TZ/'6D[S9/_;/<;O1SK?.KO2%#(:!,<:R6:V_,$W/Q!5L&C>5+
MP/:>;!VW3V!E\?XJKHEA_&`-N"9*H=HO(-,G&;@9_H:`.L$&Y_.R3)P'(6\Y
MX&;N>7"MF\]APU%1J()KO\SPBZ9^0=O!&KK@*2E_!Z5I&LTAVF/JZ\M#/092
M;TF2]@VX=/<?!:DV!1C#^':^90#KJO4J^)QC4P8NFO^:!S^;X)@NJ>%3&C3=
M;LRG<X'HO:%_(++'N3PU+[YOY^=UJN;%44XI\TJR-H:12^Z+\NHO?O6'2FB7
M=W+XQ45\BDX[_LVO)Y2R)C#V.`8.*^D:.3)<0J7\%B>P/#&F8CA.1"*TPA4W
MS0U=$8G&%@(]HJLG,?`[&@^^$*JIX>D0MA$B/U^51EJ396ML_@NH130HYM/$
MT4:1YKX,!4XK^(=50*V[=J.@W_$+`EWZT=J^[S\?>D\!-XJ"=FRN(2B;+8T3
M6CM4A`$L^V19'DFY3Q%?#=:_DFM;->[C=+CDNLD?/45.`V:4&T_N(I9NT*!)
M@,4/F&AOS#YJG3\#AKMKP<#,/#1+AWN*4U$CXW"TV="ZFTKJ=JAS"C$6H.P6
M]P+:"5Y7+8D+WX=HT3T=@\.$@64KX8.ML<T<-;,DH=59I8>AS7QS&IN,VWG!
M%U,OQ"?4#IV_R>/S0$'&+2#$D.FYY$7=>+GC"HJ?4=PI"F']9HE&#[:?)JPE
MP.TB_ZM75?S8O=LV)?9J<C=.3MN$G>CDVK[QF3>P>A'-S'E>_,X*FB\M82Y6
M/WR20`15C$_D9),N'(+8_ML9!_*V@`V\HU69\4F68+<2.?'*71BCQ1&GZ;\^
MI>0.77I/IB?((C+4)??GC^+?YB7Z6'BVR#<?QQP21W0L*ZX;.WZ$W$OG(O9J
M7U'3.%LI!-=IT-<FJ_27%B'069Q`/L)V'<2@LFCYRF[]*[PP3FO2`R7?+Z=7
M[#562T1-P[D<<O+7R(*K.+$P[:"ZEG\^\(H4OX!&MWM3=X0Y",C3?'I)HK>4
MN.N0<G$#F@U\Z")TI0YB\;Q\#-\7L5;3'UQW^N*[_QAL!W]?F+J]`[CFQ/_<
M^A&__G6^"&IHX9NR#HZ'*<]0I[+SCA2'V>B%DR5JG$OU1?<B-8@R"J8:W"E*
ML&#N*"^*?)3S#<_1I1Y$@ITXJB+\"SY)D.Y<D<+S!6;TN9.6Z=#F1A:6&H;8
MLF[?/$I?!'PR0#+%&\S,'LSP7'*TL.3Z95?7R\*VSFR?P@(7[=Y,"-1<^`8I
M."#HWW)J9"&0=B+?>L/3)M+J7.*\V?8O"9'0_MF>26V*6&=_E+KBE]&)P3($
M(K-M9K'^6H)_+%7CMD79+`)?P.JN.1^F+BI'"@@@=&@^V:)(66/R;3'*643<
MXX].HTI+1EH+'?G(?&/IA">>(KIEVIFS?1SEK&?HM#N>$N`_LH"O"V/T@I\!
MAX/!=\OD20*8JZ'&.4[:%@H>7;OFL7>=`F;]5<Q,F.(/UG?*1_Q-IG;7:J%K
MXEU7@N_N+]_*W?W-O=YW5T6Q#W.U!ZW#,C<N7_#!)@F$>#F?G0M-W3PW_V9/
M^[!7D?ZFI>9W0OIC98D_H8>U\41OE^ZKB'[3FSYW3?1.QW<Z_DGH^%]5.N2]
MBV&Y!F+C=<XC4/2??)3#(>C&$_T1*/IO.KB\DNR=PK^SFVYWUM!G*=NLX(J;
MPB@^&)NS@33?DGSTYE]C_P.V9G/I/GCQ4#NPK&5O-I?PNRL)?\L69^W]6L\0
M_;&&`K`7]\YRC^?"^*9X5%T3@'4M]<H]W:C0\$'MZ>ULV?77L5G1Y!/<LCO6
MG#>S<G<.O;N9QITB*%>^I\]9'Q)?;KC)O\4>,;W;ZA%S$T_X0>FJ#7<9'A1/
M=`;NN_@D#XHGNBWO3,.-W"<]%"Z-_Z4I>^,B);?86_*.=#GVLA*Q=5NEU;_7
M^,C#K3-KWZO63=G<8C';/L+OSUUB!%R'.`\IP=O5#&QL8NCO\ZXN[/Y+E+JZ
ML*XN[,%HO4['/S`=W]6%=75A3T[1=W5A]Z[P-[!DHZL+Z^K"NKJPC2-\5Q?V
MF(Z.N[JPKB[LB>QI5Q?VX`[DNKJP![=E75W8YACWKB[L.S#N4SC\?ZH\T=6%
M=0:NJPM[\EO>F8:UW:<'61>VYO)N"3?S?TX:@&$./Z+2B-ZJ4;IJ.>FZR"X'
M??)>7AB8A-H$2BM8#50A_5NER>`X1U@5:HGM>@M.HG&5%V6(+7P)D$(:S%&?
MW`DU2\0>P^W-%K&)9,;?X<9WTC'/M\FK]<C+S+GNL[FC>X#['G*EX!W8&3B,
M*X-H'19:HHY(Y?M=^K<(EV.'FI0S*A;!?O+SI;2=^]L\"\QJ>"+JG*B`CFIM
M_/Q@D\5=JR$\:;)I/#E/*NY3VMI9>^V6N;5&N^^B(@,2E9]-0=WH[[V]KIT0
MH6:^X2[\-+,;]GL7-"/@J\JBOFXA'`C!<S+ZP3*4A<%^KPUE069([]/,_,1V
M['N^&W<-JPLX@/IK8^O"L4"YI82U9/2R>59;[SX?O[!B`2*H6C73,AP>V`ZB
M5<#WX/D:?M/H$CY_EA"RS>+RH[,H26T;;@MW@`-;P,"M;([8A2#Y+_!3A'9`
MM@4;.B(0S12H.B<YL#@2P,\@N(BUB6-NQ2;+"4<$/Z&PXBQ"W%M9/$Z<VPH;
MQL-#G9&F3!QLTNK:S]<F6A]MX?L*6*,J2"8N`^[2+^`:U&P[SV`I52*-+`5G
MG1_S[R>3;7G0Q/+V#N(3,*GQ*;44;J-J*<2?8LP(VRQ6YI?X5L(6<L4.N$!7
M0@YDK3LRB/D&&AS?5?`\`D_1A.M`%6-1*NHD-Q?4D[=<1FL9.B&N`TLBFX/0
MK_#`MGT#F#Y-%=]Z=$+L&%\5>21PO!8;JVWWL($O+)&;NA)HW7QZ(FH<*(D(
M=J>@&8.3*&:EC=OTMR@CI&'6PH-6M7B%@JLI0X?7?.]:D&<2P%1N!GL)BH_P
M7Z,X)^!*UU'_8*]5IS70*/3P2KOY%S_/"]@L;E)K/PO:01#F2/7%HE=(^R)0
M%#<$'IG,3!)Q9U`K>7PTU$L(&@K,FC`V#D+FL`?@N=)]`!B]]7U:.&-F@?U4
M``7L>)2MX)=H<,>11;5Q_EB4"?B613YF$(-9CG!4R>^&FA]'&0T'?R+`,&G/
M+M[,U0O$>0FF%N/B+=E0:L5,P$\62:`.+OK;/)XZ,%.M4!38N8`%",9Y"[*D
M@$E:T.ME(S">66*1N-+Q/'46SL[.[?F";^KA!%!AD0KS,%P.'P]&)LTPL7MH
M!Q`L4@U%RJH5!X3?K5Q8&W'?6KV_?,K2OIN)BK95^ZQZ\M9O\Y/P?JAM;(S#
M4/?B%3BORG@A2+W;@S0Z)PJ),CZW(82>`\[5P;41UANIT!TKJH@/"7Z!\>!+
M#0K'+01)D/`0F_W;;;3'6RN7"@4B)+*/_:7^,L+1H72T#E7"KQ'?$7>.\!?Q
M:0:0)$(J6&MX33I4$Y,W9(E<.T3%``,<B1[Z#1R%,D[&`L.;R[*,U2S>IC+=
M(NK5#7P$VXC6ID;I3$SPHJ"':-,^?OH0,A2("#NC9Y&*4MR$<54K]21B*9TT
MZ,$=U#=***R/%H$SHL_+'B-TM(+6PM;=#(4YC1#RH]')'3V!E9NS$_SJ@>AH
M`@P_S&&EX9&,4(\VO`[JOOA%1EZJ/&!=RVRIKST!&-8@#]L_2!X/Z27LDU^>
MYNQAM!&!XC47#I,%.R=L&$9)K2$4,O2"!>`3=EMT.H'A6+F=&U;6/$F%J,<X
M;%:J*:".TA)Q.8K+.ERC!0RU>F.67#!$!8UM`4H)OGZ&FII#"N`T<-.S%E[7
M<V-F-:WZ\#U"TG,6(&S3\+G,OXZI<):GZ,+'N.U`$PJCYIE8`XN[0*ZQAT`7
MZ/'3U%PP1<Q4QF%!\4WC]5BHM9!E$4*ALEL_C\DVEW,_T+>=XQV%W[E(D!JU
M'101S`G4*K["X%?2B!\<0-E\(F+H:`0*HD)/B>5A1'@[Q+%`9M@_^BC(EI-W
M`6AA@#Z/W6C1MC$LR#*#N!O`$<R4^&'K"!.2@(-U:+369]LBBFPU=S;F4_\L
M3")CX$B#JD`F0WLBDR$!B3)-!0;WQ$%R0AH$!53B)HMQ-DWHVRMFXZ"*-:_1
MU#P2Z+FU=`Q=(-36>H(BIE8VM]:0Y^`B]H8M]*"!WH\R'HJ)0($G\RSFGS+M
M;4'T,R\R;V5MJDV6+\+:@"84\T7>&MOXJ*J*9#2O;+"^W!21I=GVIN;7.M";
MTY5JCAJCPB`HBJ4W^QD6&=<Y(2$+=K6(6MKV=5'((Y,0_G$\'W->0B4?/+^6
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M#KK5MFZ>UHHM9X50*P92U&6.N2!6F&#>#6*XTSE`)0";:`W&!%498B0!P?4.
MT;')B%'!L7L^F0A\4#2=@E=`JI'VD6VY>V_A,[B>&0)?$IO!DK=YR=NXY&V%
M62C,!)/'C">-[`%K&`@K);#J2G.B,J\6M(?H2@0=]G#3QH00Q'3&C*\H/]9C
M@B=/&)KB1`MSBELD2E'+V*7-@126QHK3*#>8CQ-/H:J%KC17<S$V)JY!).H5
M0T`X!D.#/XSR,\(*%"'SH/8$(N5M,>$79XJM:^K<^GOC,>=3<$T(*XPGH`QS
MI;$B,0^96\<1LR]J70Z.D,!(P4ZE?+944P76)(N_MJBH%ABYU2U`[WQB8G"/
M&?R=!+/-K!,4V*G)))M"1T<<=1I):I(JBR8P]X4SHS[Y4I;=&>FOH6V1!MI?
M%;_WDB:!`Q$(90,\Z=Q0CC3+752X8H,8Q5.%-A0/:U<;SP`=-#O'2RZ_QY/^
MY?U';Z?V#E?;Z1837+/5'\VYU[Z?BSS+T7PHE,A[S\Q^,23>RD;4IZGL>!MO
M98QDU.^I@T,V112ZQ/K#QY@<)]#P;Z<H+\$6$9K.PU\??_,_O`@^YCOT/3!D
M@<VN@?(G;J*8[,RD.0&T(SM/]>&H;"?OOFRI-8U'_6$-*CZ"I^+2>_9DP,U%
M4E8<80.[<2Y&I!53MJ`EG-GESS,8<@^XUX4.Z253`I:%V,,8'1H%4$BE#QPJ
MSHQ0&G]V.'J:26%I#I&,X;B1S6MN2!:'XA_`O'%LA%[S+@OGT^PI1IU"VG,8
M'`QA$30,1>I6,\OI>NA)L[@!0IK:\2`?"+:/2SD]NZ,V*;[B97O"#\O1V\G?
MH;@"#WM0HYS.1R!3'C:8M4PV5P?A(P.R0;GDAC)#_F`^=OCGQK*&$-(K_(0`
MU2U/+T[DFH,.Z[4!A&\HQQT<4"LVI51Q=H),6*,29I.!0\H&BU#"MW2:;J?5
M_08?\S4P8+I,D(&5221[AZ'3'J`LZL?!'M;YV/M_6U_S4]B106_(4*>@88`H
M%?`I(L%73.QW,#=F*'E\=[_WXL?@BQ/LM[!,R<W%P2<O'U3!H,[H8!;P(RBZ
MB!%0D:!Y9ID=O)IWQ*KZE)M`$U$7*'\51`B7S'S'.P]6%RT0;:Y7.+&>ES8N
M%$3P+MGG[!SM",`TT0YXY+$I7+6(U2XAV%M,L[BU.$5`/`2LAP'L%"A5GB23
MBM(4?G3O[,A+XA.U3Q9)@"4OC6^ZS_#A&YC@WW)W;BJ'!7DQC3))A+-]*?4\
MZ@<8.@,H$*IJ@11C\!A3DT^+Z/0$<X!`H]#](<64"GJA>*!@)"WM9@8\5%W:
M\_`D@UBAXHJ"KPWB*GCQ"Q"WN"9&I01VRW:6W30,*R0IW7I$,R\Q>B3OCSSJ
M)`.^F8ER<X$C9Q3"^G$2.V>A/A$BZBS=O47+T[[8NJJH6.=N4]Z$_<%F;B9R
MV\.[HRN!$#I<1$HS`9,GS@WG/_X%.C"9L&N]C*!.F-I%D>WH4DUO66&5R@^%
MY5"`9TXE.\!3*O=JO'"ED=@)WD4%'C+$7)I`</"8]*NJ9J$7EK%PL@R>EU,%
M5XP!CXS%UA*@O'*_EJ6S7\^G>'IZA:;&B3I5O9:FW@[^FN.\WN1H.[*FCD2F
MLA;/,Y6*T-&'X4VAP*9(SM#/XW!)BN?<F8KDI*74C#T6>W038)%HI<2$W0NK
M7Q2@LSNNH4ANFDM,AK-GOPBB\S(/+>=+.A8K`!>/?NC88E0_\7?35?Z(GSL&
M':=@PZCF!#P%/BLB]H?Y,]%6$DR-$!+;FHARM_52O[!!+,:MUX6->(1LL6J+
M"(^AEU$SDNVX+C%%5L"2,I"M.U6,[0%9:^Z'ZM&(+UM8*"E7NTP2=[;+W_Y*
MF;ZF\[5_A3!#;!OG*I_+NML^*[H4!0^H*,92JTHKXWR24,L9M%&M5>P5MSKE
MZD^-?'#1F%5IE)-*;.Z,N<33?G++=K$U"+YN;%L+C%UU)S<`DL1^_"G[8O&0
ML0:P_`.!\<I"Z(?;T'+)4!UP\MU>?NQZZ3S<U3Z"YFE_GW<-,N^_5V/7(/,>
MB-[I^$['/PD=WS7([!ID/CE%WS7(O'>%OX&]Z[H&F5V#S*Y!YL81OFN0^9AZ
M:'4-,N^CS5O7N.@!=;OJ]O0&>]HUR'RB6]8UR-P<X]XUR/P.C/L4NJ`]59[H
M&F1V!JYKD/GDM[PS#6N[3P^R068'G-P!)]]65'`=XCRD!&]7,["QB:&_S[NZ
ML/LO4>KJPKJZL`>C]3H=_\!T?%<7UM6%/3E%W]6%W;O"W\"2C:XNK*L+Z^K"
M-H[P75W88SHZ[NK"NKJP)[*G75W8@SN0Z^K"'MR6=75AFV/<N[JP[\"X3^'P
M_ZGR1%<7UAFXKB[LR6]Y9QK6=I\>9%W8FLOSQ6`MP+5KMC:K]44['I^8>)Z:
M3Y,OC-/T.2JJRZ^(N1LQR,]7'+'KB[;*]=X_7#[2_N&=^]C+84[648QWG:.]
MITSL';AMZ[:"^\Z4'JZ@]/!A4GH!(/RN@^=[EN"?7;=00?3X?MRU>1'/E9IC
M,Y9T$R?TT>S1E3IG,Y;4W^^'!X.C1ZX]WF=CQ&<GW$3L!RS(B-CW.29(O9$Y
MB=*)0]>0=LQ/F'T[%;/Y>_1`5,R@'^X/[KPQ\#UKF`^(=L!`68,]]L@P$$0\
M50)@R.6G*L%P+LNKSH'IM,M&[]$#T2Y;>[T0'EI5"_=H],L"WDE#Q9P6^2PI
MR[RX[#1,IV$V?H\>BH89#,+=@^%CUS"?1JE%TJTPN2U0VX2O7'#FF_"ENK#H
M<>5L.Q7TN#+#6_U!+SPZ.'KL^NJF-T_NZS1G,[CC.TK[(S'_=UZ6N`F1A4`A
M6@#XS6&2SN!V!Z.=N.J#7\2"),!$B_OXE/VW3CT\KOU\P@JIK7#MNK5G2PK7
MWAH.YK]&%UP!]SJ+/WATZZY^[4JE?[!BI(.U@#H[/^J:M;\;6DOV\`CYW4O%
MO+"L78J]G@S]P1J0.#E+8H2@QOH.V!XL`)G"[[)I4"`^=Y4S>K:QJ<_HPMW+
M*@B!>Y*G:7Y>_G@#=GSLMW`>5Q.KITO?1ZP!?IE7<Y!C%.N1R<PDJ4"NDQ+E
M?U+DLR`S59"?FB)"^/0@S3$O$A7%98Y'K,&]R_Q]<<CWD86#P[WP8&694$?E
M6RCW'!Z$_8/!T_0`*-.)-ZOYE#-"6W[#4O*.YZYQ("6BO?GMJAXXG46X[_S@
M;S.E^R-8;^>ZD]M^[_SV>+S(6[PD.[RM2[+7CX0?U*WHCB/NF2/63\Y>*[]*
M.5K)L09)_)?G[_K#OP^>XZ__]`I["5>7].\_O4JHM?`D,:"H8:R9^<OSDZHZ
M_?'ER_/S\YW2C'>F^=G+-^__^_E/P!*]@Z.#X=[@U4O_&G_SI?KH*PAODCRV
M`V1E%6753YAAV^[M;^_VX&WY';_J'W_U4N:\,/]FCO@>%@)3+JJW465D*7WX
MOU<O_6_Y*9/%ZAE>KOW=^LM]U]^[[\W:V^X/MG?[-]FL_[TW9FONT=X=[M'_
M]O<V895[:ZQR[^:K?-O?8\';VPS!VUM#\/[`<M_U=^];\'9O+GCO[HTE:XKC
M6EI^GB4\^6_';V7J,^Z=\5-2YGN#_L&/\)=7+^TOZ0/X4OWMXY.H,&7C`R7]
M\LIW/\/?&F^>PO^[\KUO9?S9%#2RO$[9?\N1^-S'^0QS?3D3<(VU_4E&:KQ(
M'WMKLGR69&V?:UFI_5+SK5<O_2S5JM(D^_W'29Y7>*OC`_P07-"OJLM3X!;8
M+1`F$S^7WQ9Y6N>ABU&1[N3%].6@U]M]B7]^B0\*7>@=<$QJWX2?<5+VDVDT
M,NE?GHOG\\_/A3@\QQ4X--19Y9_DQ?P3'K3OG!1X@/Q?5[^3P,Q?JKG8A=8F
M!!3,Y\78-&9DG_WG</AF[\WNNS>]ZU#!O@WOS%+X9#8%:F;;WXZ?__2L1VXV
M5KQS,[X_!WVZ:(3_"WA+@VA>G>1%\F\3_SE`GS5(RG)NXIU7+VL+:5G;ZZ).
M[Z@8/P_XC/PYN-!V$9B6OB;9JWP556"<*P@C3[R<1.-JVQ/HY2TSR]ZU665O
M*:/<(C'W-IJ4;_+9+,^N(71+7KA5B>O?I<2M%+G]<#CLA?N]01!E<;#G?F(I
MI%_F\PH-'0:2V%NS5E-`#RP<CH<!#'-J"+0KO;PK4;YZ)UN9K[]9S+=*B%L?
MOU4)OFI"=TG!!EN@389?OWJ)7X!__']02P,$%`````@`NUX'1Z&1`8M4`P``
M]Q,``!4`'`!Z>'-I+3(P,34P-C,P7V-A;"YX;6Q55`D``Y'4Q%61U,15=7@+
M``$$)0X```0Y`0``U5AA;]HP$/W<2OT/'OV036H(@3(55%8Q6DU5Z82H-G6;
MILK$!UAU[,QV"NS7SPZD"R5IJ;0.^@6(\WSW[KW3.>3X9!HR=`=24<%;CE^N
M.`AX(`CEHY9#E7"/CNH-UW=./NSM'K]Q7=23@L0!$#28H;/33^V^BJD&I,10
M3["$`]0F=YA;0$>$4:Q!HG/.Q1W6)H,Z,!=!^<#<BV:2CL8:O>V\0]5*Y<BM
M5OPZ^M'K75\>7?B-"[]6._S\K=/N=^L_RV@RF92!C+!,LI4#$2+7M908Y;=-
M^S'`"I`IAJM6::QUU/0\NVDZD*PLY,@S.6I>"BSM[>[L).#F5-&E#9-:"O>]
MZ\ON53"&$+N4*VVKFF]4M*F2]:X(DKK62(D*$?;*36&N77+]JEOSRU-%,D2'
ME-VG(2!#;$2(C.)6#,^*5WE?JV3P-N(SI5C9LA##;S0:7G(WBS;AB+Z'9Z/7
MO?G-!VCZ")U[@8VI.W-7I6#0AR&RWU_ZYT\7[UFD1XF\^8ZG5)USTWP\\0<S
MTW8?,;,9KL8`6I504D]3SR)HE10-(P;IVEC"L%7Z;6QVT]#6B_TU(WM_2P@P
M"V*6`+OF>BDG3#5P`B3-:LG_XQHMD043)H)L=H?9SA72R9;L9*T<8C5([(F5
M.\(X2AAXP+1*5Q)QW(J_:-7]Q?)-6RF3O!-+"5RG"1@>`&LY^1AODT0?9;A$
M+>-F6RZSQ#)(XYB?B95.8:\O$)Z*PS")YIJ9%J;[AU*$*S329*)(0A0KDU)$
M\TYPD)"FA18#?0)VTLXO-B1UE^(!9513>*(Q<H";ZHX@$#'7JH=G>,"@S8E9
MD3&0M6MY3H1-]UEQ44L]]QQ-7JHC5P>S.1IO%H\=*;4'EN0AMEORW)KR):V^
ME*1S;Y,S!I1^1-E\X"L0N*#"?)UK6S),K[0(;L>"&5+J[)=Y()X5#*`<X(8H
M]TPL,!:0A-)7S.*'??08<M.-5"QX=CCFUKC=Q[+YBQ8*_J0G*[#78<AJ=?]W
M?B:9BZ?FTNWM5G2UFNV>D&U"Z)Q:#U,SWCLXHMKRS'].*T!OMR=/UIIOT>&6
M6-0'C2D'<H8EIWRDS%$<AU9A(*<PI`$M>JI>8^/K,&X=!?(]K.=Z>.SEO7.P
M+\F\I;=D9N4/4$L#!!0````(`+M>!T>Y<$,L_@0``*(N```5`!P`>GAS:2TR
M,#$U,#8S,%]D968N>&UL550)``.1U,15D=3$575X"P`!!"4.```$.0$``,U:
M;7,:-Q#^[,SD/US=#VYG?!P8D]H>NQEBXXP3'!@@G;2=3D?<+:")D(BDXZ6_
MOJOC)3@V<&")\Q=>=*O=9Y]')ZUT=_EVW&?>$*2B@E\=%7+Y(P]X*"+*NU='
M5`G_[*QT[A>.WO[^^M7E3[[OU:6(XA`BKSWQ*C?ORPT54PV>$AT](A*.O7(T
M)-P87(O^(-8@O3O.Q9!HC*".\4^8.\9K@XFDW9[V?KG^U3O)Y\_\DWRAY/U=
MKW^Y/_M8./]8*!9//_UY76Y42__DO-%HE(.H2V02+1>*ON?[!A*C_.N%^6@3
M!1XFP]7584_KP440F$[CMF0Y(;L!QB@&<\/#UZ\.#A+CB[&B#SJ,BG/S0O#E
MOMH,>]`G/N5*FZRF'16]4$E[581)7BE">BLMS#]_;N:;)K]PXA<+N;&*EH!V
M*%N$B4#V"9(P0,8-&8$A+_^FF%^R-QZWI.)1EQD9A?/S\R"YNFR-[B*],%_V
M7@JF%W^PIFO@+`A&40^FJA(92L&@`1UO]O-SX^YQ/,IU$-%^,+,)"&.'7@+V
M0D\&<'6H:'_`8-[6D]!9B6,.W*A0,OS_;+P%S\;40R`RC-O@8RMP<[-9Q/B4
M]^=C7OCR(^B0F&F+B!_[MHI7]`FU2?`CUQ;0)H[\/O3;(&U"?>!W"><<Y(\(
M5TXE08*31O+?&Q'&2(">?Y=Y5.&:ZLD=[PCLK5,-Y_]PVO3GSA.LJ7TOI8'C
MA7)J6JOX]T%0&&O@$43SL`:_]33M,/H7&5-UQW%QY(E;PG!9?$>8F0&;/0"M
M=N4SA>?]L+D=$-M<-C718$14M4X-9\=I]6&5U!4A,F1W,R*7-%\3U;ME8N2.
MY>\17@C)3P)ZSD1+5<B$BB5\$AH*K1Z8&IKPR<ZSZTJ'>YI2T\2W1MC)>X';
MEFN!,XS<?4%:XS(+TE8BL$9;L:E%^+4G&/94E6^XP;(TWIYRG`6%&W!8(_*T
M`0PGAZA.I)ZT).&*A,D4C!=GEA!5F()1#R38X7C+F%G0OSM$:\J4S(>JDPEI
M,TO$/W29!:\K$5BC[0VN=Z(/+3*&G5?U-1ZS(&T5`&N<_38[_U(ML3SN[="W
MRGD63*;`8HW4LV;<5O`MQK*K,C2UEQTZ'[O-@LBU*%Q4DY\5U#H5I2GN:7$"
M$8R&U-8-OCE,QI7G9E0N*#<[A3*/S)<I0(:$&:&=4;\A7,82I$?G0HJZ%+@W
MUA-SO(/1!V8OYTR(M<$REB$M-A<B_$%8G.RI:YVJX-TJ'4)45@H<WA,I0F8L
MR'8(7<B2;)3>$:S'30-@I6[@.)-D0[B,Y4B/SH44Y3`4,=>X][\5LM9FM#L]
MSL.[]8XK+9,C:AP8F+RFA+%)2[R#)FC-``V6LJB->)*),Q7=(<UX`.PE,1=C
MYY90:283K'1N*<<BG9JCRR7$CD9"VK@9Z[H#3*<JW0,QE_>DS9/17HHBF\"Y
MT*%"),=[7-5!8DM?\&8/O3@38D.XC)5(C\Z%%$N',\[X?RI&QJ1O@.3D#,`\
M3]"$<HQ:%RI)V.%1P-IH69\(I`7G0H<&A.95@T6E@9LRCC]#QZM!RK`9*[,]
MRKVMTXO&Z09M=BFJ\0\QAV+>N,<R\083,"_B%`O8<-HR!_5[6MF?@>\EU@)V
MTLGH29]YAS2*&9:;J[K9'!F.L+W\)X>[I.+D4=EW(#?0`8GC%)NG`]>FT-N%
MS/IA6SJ$E\E[R8L7NK'E?U!+`P04````"`"[7@='IM6,;SL6``"`$`$`%0`<
M`'IX<VDM,C`Q-3`V,S!?;&%B+GAM;%54"0`#D=3$59'4Q%5U>`L``00E#@``
M!#D!``#=7?]OVSBR_WD/N/^!KP=<6J!.FDV[K^UM[^#F2\^OV3I(TML['!X6
MBD0[NI4EKR0GS3V\__UQ*,F6)9*B-)1,/Z!(4IN:&0X_(H?#X<R/?_FV",@#
MC1,_"C\<'!^^.B`T="//#^<?#OPD&KU]^^;=Z/C@+W_^_>]^_(_1B%S%D;=R
MJ4?NGLCYV:?Q=;+R4TJ2:)8^.C%]2<;>@Q-"@]-HL5RE-":3,(P>G)1Q2%ZR
M_[B'+]EWRZ?8G]^GY/GI"_+]JU=O1]^_.GY#_GEU]?>?WGX^?O?Y^.3D]9=_
MG(ZO+]_\]R%Y?'P\I-[<B3FW0S=:D-$(1`K\\-?W\./.22AAG0F3#\_NTW3Y
M_N@('OIV%P>'43P_8CQ.CHJ&SW[_N^^^XXW??TO\K0<>3XKFQT=__^GRQKVG
M"V?DATD*O<H>3/SW"?_\,G)YOS18$FD+^-^H:#:"CT;'WX].C@^_)5Y)T)D?
MK-EX-%XX3`E+IG%0QA$H[]4/)Z]*[8%B2U74'LF5<?SNW;LC_FVY-2/GI>OF
M9>IOCK(O*ZU]A3AK!;-!_>['.`KH-9T1SO-]^K2D'YXE_F(9T&?Y9_<QG8G)
M!7%\!,\?A73NI-0#C;X#C1[_`!K]0_[QI7-'@V<$6GZ]GD@E>[=%*WOH:"@9
MKVCL1]YYV$W8RM,#2WV3.G&*D+OT_&"2W[)YD':2N?3D<-)&J1-TDW;S9"9M
M-HO"!Y?LKRVAZ;>4AA[U"K&!CN(]YFSX3`&$"\J16Z9Y$,"T&<4'94T<E.>1
MF9/<<9JK9#1WG"6?WXYHD";%)WRY&+TZSN?)/^0?_W+A^/'?G&!%?Z).LHKI
M@H;I513X[E/V\Y;UYR/C_VO!G/?ZPT'[YX_*'00B6UV,:1*M8I=6V+!?OW06
ME:O^H$'UP.<`%D+&$M9P&HZ^WAS\&9@1SHV4V"7O?SS:B%?MT#AV212SM28W
M#,K]<V*W^(#]V2!9WN+(C=@,OTQ'A9#\\5D<+;KHOQ`GZJK5H]T@%"P*;Q70
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M?@N)]PRF%<64$2G$Q)!&!5,<#`![%9SD_B*('I/Q79+&S/21VA&*1PR8#LT"
MH6S=@GX"4Q^P()R'+7!IHX>Z7:`[,L,!;!*FE`U[>OYM2<.D.O*R5F@82=AB
MD%.0)#2C:1MB)%VN@D2IZN%P,673-)OTPWDN1W6]E+=#8T/*&H,.[NTC44&Z
M`(EU\XJT\U6<-"B^NWV4'UTE5\X3[*L%=E*U!<I>DK##C'5!DBPSFJ;L)X2H
M+>TH9O/2U(F?B+.(5F$*2V&U4R^)PY?(;0O+8S^M,JTD.BN;6$HX#6AJW4=Q
M>DOCQ1F]2\]HXL;^,A\MH9DE:XXWL1H$03MC_O-P@Z;;:-NE:`MV=)51L[&T
MA@6Q>XQ"L-U*[D>).=[0&+?';!0"AY%PY(+AG6[H6W-$HM?]K1V<YB`,:7.[
M,742>D:SWY-P[+HPSTO67/WG#-CEFJ)A`/:\H/Z"K5S97^P/XN2<=);MW1CP
MFKJIF_2MQFU`(Y\9#_$G&C)+,E!O`$4M\8:^G#T&7ISLVL`G(^(4BUT:D3A?
M[)9LL?,M-/_E*JEM`)J&I/LBQ_VM<OM_ZVO40B9BA/,>,7JFS?ZN0N)M_JWN
M[(G!+])6>3F6@Z?MO)=0]W`>/1QYU(<I[S7\`5A^79KIV$>_G.7C<.$GKA/\
M@SKQ!?NDZM!0M>R,<0WV&+@7I$E&FP!QPJG;@@@-!13@T!Z`OG!R'J9^^O2W
M*&!O'WL/+_R`QB*4B-NA,*)DC4%(1IBL*9.,M$WP4/:]#`X-O?<+C:O57>"[
M%T'D5#=[XC8&("%@:0`.&57"R=H'!4&?ZS"0ZGD7,6QG=$;CF'JWSK=QDM`T
M&8?>I>_<^8$/1F;+4+9VU`Q&M'7JAJG`MH(Y8=Q)QMX6:!K2E#RP#3'BP\']
M:\(D/4]2?\%,3MEQ4*41&IQBIAC,,8H`MS5-:SQ;ZBY7P:-2]'"8$,2T-40G
MJ)Y`HT5#'*SSW+I)2://5>QHCT%W#\*$WWKSBL-L@1.AV@+E1Y"P0X439"39
M5CNC:<J;@!"UI4.AVH,]"\J2**KL2U!B:+A9\-R)0Z;7Y(K&-_=.3#\ZB>^R
M)?S,#T"\AAE1]VGT[-A23,S+PTD3)_2(EQ$'@)$$N.;N+?O6W9;JJ4ZJG89Q
M.(R6`FGYQ2`)&&O-T*B3,<;`ZU0SXGL7,)+UMXH7M:;[=63\3(/@<Q@]AC?4
M2:*0S:!)LJ)Q912;VQMP<#2(8L#9`1Q&OP(+4O`@&1-;H*.MC;H;1&MDAIME
MOM`4SMJOXNC!]ZCW\8EM4]CR/`D?V/+,9L>QF_H/?$\KF7]:$$#/3.V%1<U9
M$%&Q2K@]QO[E/(BS9F(+&KNKISK%=1U,:RRW;A9;[Y9:/Q9:J'';Q$*[K*,]
M9O#JW8,/>6,NHG@2NM&"WCK?:M.;JB7VPIV*/?*N74::S*(8`G48<9("=8.7
M[+#"M[]?)^G3GFV.&U17N5/7C+OAIMQ*Z!-[(]DG\8J6'=ZGJSAF8R:9?MM0
M0$_%'<1%A:Y78N#X#.UD'$FP86D+%A%JJD[8G8>UW[U2:9_&UY%DNDHA2Q,D
M!Y-NF)0/&=@UZ0AE8.N4[[-OLIO'&2=28F4+"MLIIKZ+TA^N`1TVS')F[P#\
M@AP"#TX`JUB6%JH:4"ISYK0A@7?T=!`8>SMZ'3[\W"N%%!.(7K<%FQCUU'Q&
MG0?41A=`@U^\`Z$!70(FO>7<-3"#V\!9X@>1=\`Z=WEW575W$^S:B0YWBJ+X
MFK*'G=#_-]]T3%*Z2#XY?@AI`J;A#4W3(+_DS2.T3P/'7R2LC\>R$W$<4?RA
MN9%.H>Z#`*<7A%D:'I.%)&MNMF'>C*IJQ_$&`3#<NU"RRB7`+K=`HU3`#G\=
MW.(-E:"_5=Q(]3O@9IY'J\GVZ=F7^"WX%A/\J#<'%_8O8;I./HH0<R<;_:VN
MUO;P@B$?#HT_4TBF3;WQ`XV=.?VR6MS1>#KC6[K2CD[/R=^1&!KMN$X8/1*P
M#7LXU52Q:F*`NY\;9-F'HW`.=]7E:ZFR*>KDH$D``ZLK(SY*&77==79H\?$7
M]!0=W9/K>DUZ+)\DZ`$1D7DF\_<6X7R*!#3BAK@\-$KF2)\^=]\7<9C&T]*@
M)3>0G4;2QSUY"]0JW$I6HP&]03-)9.=Y^FF&E8^8R!_1*!`Z?\T/AR3C0VZ;
MCJ-WE">B40>"%!&:HX(P.2`#R@QLG-,H9$9/ZC/D@D(AW>I6;NWH:QAO_B^Q
M2A#4<(8+OALHVR9GGV7F70M`0D`F=]^64TP\0<Z)5=@BZX2%JFBY/)C0T)ZL
M&P8&8,O`,O5.X;/_53B*YP!%8R,Y`>5"H.RQ(AU,#8L&7TTS76CYYBE[MF<1
M3LT*%.40;$+BSL]!UVD[L>>@*D)]G8-J"&_R''23K77_SD$U5*5Y#JH]T#LY
M^QF'7KW<10.BM1\W>6JD)2@&O9>3\<?)Y>1V<GY#QE_.R,WM]/3S7Z>79^?7
M-WF]D[/SB\GIY-8V"+?5DN(@JL5X]ARVET4*L@4RBN'E@=SKPIQ/RN8F0O64
M@I@(TLL8D#4'DK&P!66ZJA"$Y6D,2E\H&C.SR^.IJ`)'%.>Y_3T*)T)6*`.W
M($B`HDTX$':U//`*M?8UTCG*-BG'SD/OC!F0@D&7-D6-?Y,`*),JGQS*">(8
M>0+T;0)&DP[*&-$;A9Z7%R9`[`23T*/?/M,G^;I2:6=B01&S-K&29)0))TT8
M;9L0HNR\8.U0*;Z[>Z1(4,CLG(S/))Q%\<)I2`2N]1C*9=)&,`Q4UBDG(4X@
MQTV)E37;L[8Z*3L3VH_6#DK[9J$V>7U7;QI>4Y?-BWG`0J)=X5>7C+E"ORT%
MQX!U4^_W91Y.5=3]]2#:]+]6(24GKUX2T#4']!EU*82!D)-C_NEK6^",U:*T
M0'"G\1\T;0EDMN:O7N[7.XV2--&K8ZW[M(DD)VW$-'!#$/9Y%U%,IG>!/^=\
M$X[@2<CFIU560.TJ2MEOWPF")ZCS\9&2+(Z8IR"XO:=POVOIA$^9=R(AT\?\
MKI<ULWA'_0IRK;3'07<C`6*V(79[&D)H]R9V6V`82)NBC($F`5!N+D:;/)]W
MB-@?N@<M#T_4'=NSTY,F_97-'3T,8EZ'6L38L<)65C9'OA;-@N!>#4$<H#5S
MJ:X&MJ&A.Q9])^_/+CG*73/B=D82]PM9&]E#992M=,@H.R]*V:]0_'#FXG:F
MY)O5<IE-90T'4HV/H0U$7<%0D4G`(SDJTDI;<P#05@=5ZZW=Z`R8_WUU!Y<$
MP,`^BU9W3)YHE7Z*F)%P"LJ(P\:4[_H$\%G>6PN+#M/\_I!P!B3G8!L>VZND
MEL&]XP#NY*1>G52GC]PY_:3(R>Y<N/G!AN&K)69$U[C=UU+^'8<%-*3N,9VA
MQT!`_%=X_U*VJP&ALGV^!/G*1\P%Q"L$PKP-:[*\;L95E/C<%V3-KJ.-'J1!
M\8TC,^RB3W];,8B?/X#K0&>-%[<WLJ0K14&OX&\/R88)R;C8!JQ&+8@6;8T1
M&3!2U$E7,9W.\D`_]O9*L"1HB(_TE#)'H^?XL.QDM@TW\H[7XC(;U-[=,W;A
MAT[H^G!,#3.=N`2KHB'*&Z9FCCIV*R@7&3:?Y\587YAR#^-E;^D<EG=ISQS#
M:LV5?7\ZF!LZTTB#'Z?2R%#F$9,^FO'-S?GMC2V`4/=3G-S#=*6@CTX`-S=N
M[BDCKCH7D#1$S8%JYKAD&IPRR4C;,N#-?2[/`#H:[]OO?\O(*MS]_&LC7OXR
M(R/.?2!HR[C+.BIRY-=5NH/MNUY\A[2YN6U[#Q$<Y;OK]N[3-4,K](:@^_(@
M3GEZ'GK367;B)%@IFI]!+1K:(J'OPD%`#^2R)73#AXP(91]'L]RZ-&52&^W5
MLC@,E#E!][M[+3</VIW=DUOOVKHL&Q,M7\I!UYRMQ,F3L)YW7K[^-#]J8BW2
M%A`SY3P_*^70SO-J^^&Z^D"^X;7&ENVB'L'JU7(`APQ]37@AZ'SCW;3WE38W
M$-RJ%@2US`%M/C<6\++.(FKJ?CW85&<@AL/1-7V@X4HZAZV_1N.DR@B#BYR6
M;5BH=K$Z]F)E#G@ZU?8J?I^7[_N];E^FGE^O]^C,=_W4NAFD_8WZON[0FZN4
MI[=!;WK*>*6\'K;K!0N(UEQ7Q`%>UN%,4QE-E?+0.WDSB*N(T3"1R5JC$=8@
M!@99G+2%@3\-7:[B1TOUF`J+;#?B+YT`<FWRBTW9106!XT?:%%EC42T`"@(%
M;9XP-;NVE5\^,5=E$2]^ZS*+TE[MV7%ID_*V"RWJH&_G&<CR<UU\!C(5H;XR
MD&D(C_:ZEC*0S0IV>YB!3$-5FAG(M`=ZP'``[U^K).4OV6UT34%+?D"9_-EY
M!%QINXW,Y-_KA14^-*%'!:`"'#9R06+7N)!L75X:/G7+M=#W(LM?G^JNQ5GT
M#K@AG4\0MDN]8H\Q=IDAL>(WL,^RW;K4+=7XH`&'E:YPR`O[!=7"0V$;NO45
M47=XM1NF?K,R7=.Y#W@/TR_,`!.$C0B;&<C))&9L("73AC`!RK8`IZGG]7Q,
M*IT/:1(_;O)GL.DS9'^Z_#)A?JU`SZW5FHP!<[B;X#@?O`MQ3*6$(]N,;0$C
M5D=U*Q@SN@,ZR&(PG=*G*S9J/%?5;RM_"6+RU#W3&>3W*3;L0I>9]O-X)UI;
M43&X71.#4`J>DR'P']CBF\6O6F=:MM9-S?_6;1PM`*K>;*O]>'\P[6%V+7AE
MB?0*1ON#3LW)M-O@#;E!*575@/(;L`F-PD2_H%(;"@:V+*W%1=_C>GU(<K:$
M\R5EQH0U(3EWUN`\2.CC/8VML501BJOO=3H.]*`NWXV30.[-+;4QX:BMLT1A
MCJ;D.7B*E+?%=N1HK7=5X$.5J7?H.'J0``JBG$9@RJZ8-=MXQ53C04.Q]3K"
MH:(9@<&+K4(BC+)MD-+7A3CP7G^D[*D.(H%>XV.]5P,Q`;LLNT>)$[?O!,%*
M&4O;\*BKHK8E0'9W3N3QA!AP*.M[D_#46?IL@*1'/>+6!DYKE&+@#EP*TF3)
M:,.)BIM1MPU;#4JH'X-H#,:0FU@ZHW%,,W#SW,G2_6J]I8&MJ90];A>:DR4)
MT+4-,HI>US>:#5KO]^CAP@]H?,KV!_,HEI>#V&YEX.!!R-;`N0.G2PK"ML"B
MH=_U4P>%O@>TA_(DJA`+U.1,$+?%6SXJ$=`.@C>'X`5@ILY5<V'SG1@UJM[7
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MFC@+$2OG"55DLVMX`&7CZ0F#NWQ=<("U?&K=\9J^%LHK=YLQ&7#!!M=*[EF1
M+<GE)OA%5\`0ZR-*^$U`"WU#HL[6ED>I>G=9R*%AJ5,\T$-A!Z.7\/+2")<6
M%M'2UT!SC81=3RSBC<J8F8)Q_,362-49E]ZS^-1#;41$F_[_<_R_)FN(&!<^
MI7%"50X(V]Z25AJHY5%J#[&^D]%F)>>S_?L%^ZRZ15:W-9*F5BH"!OWKG+49
M]:(N':=O"Z:TE"#*9]LP$'UAYC9V8*-Q\[2XBZKQ)O7O4=@0LD*>O0!!DE&T
M"0'"KI9'7:'6'11IG\Y*6?37A9F5Y8CTGC57CEU'1`R6-C788:NXJ:-08F:=
M===*.=+2ZOH#.&"".'"$?'02*("]J8D]7<)/MMA.0KCRYS]0N*ZAQFD72OB4
M<MW%Q[D[(O=7POF2,F/K@(O03RT%'79\=[V1T;M<IO=L3QN9'JZ5K8_C^!\E
M7M9AM95*]#8'EMPITT^CT^Z(341@P$1+QN"YS'G!`9LHPY)M2&VOHNZ)E7:%
MV4\TI+$3L'=J["W\D.=J@.E=7)-,]RDT.C7%PD`R9\$G36>+B6TXU%1&%7RM
M!FF7N8IEEF8/5X'ZO/PCN.Q#.0OR/,__8Z0.GIFN:)0J1O9G)W:P]L4EBZXJ
M\?04ZBK=VVT,U;?KK3:WP\G;A@UAI\6U[G9<S'I+"*W2A\9/^I0BF#CD<^Q,
MRJ+LMQ(LV[HO]^N2_<4^*SYB/^[8]II]\G]02P,$%`````@`NUX'1Q>\83*Q
M#@``9^(``!4`'`!Z>'-I+3(P,34P-C,P7W!R92YX;6Q55`D``Y'4Q%61U,15
M=7@+``$$)0X```0Y`0``[5UM;]LX$O[<!?8_^+H?<@?4<9RTW;9H;^$Z29%K
M&AN)NR]W.!2T1-N\RJ27I)QX?_V1DNU(,BE1MF2)@;_T11Z2,\^C&9&<$?7^
MEX>IUYA#RA#!'X[:QR='#8@=XB(\_G"$&&F^>?/J;;-]],L_?_SA_=^:S4:?
M$M=WH-L8+AH7YY\ZM\Q''#88&?%[0.&+1L>=`RP%NF0Z\SFDC2N,R1QP,0)[
M(?[C'+\0O\T6%(TGO/'W[C\:IR<G;YJG)^U7C?_T^[]_>?.Y_?9S^^SLY<T?
MW<[M]:O_'C?N[^^/H3L&-!CMV"'31K,I5?(0_OY._C$$##:$,9A]>#[A?/:N
MU9*-'H;4.R9TW!)CG+56@L]__.'9LT#XW0-#L0;W9ROQ=NOW+]=WS@1.01-A
MQJ5584.&WK'@^C5Q`KL,AFQH)>3_FBNQIKS4;)\VS]K'#\R-*#I"WGH8%](I
M$"#,!.(2C)8$[^3UV4E$7O:8$XJ-)DLPVF_?OFT%OT:E17<N7XM'>W_5"G],
M2*,4==8`"U*?A:Q2XL%;.&K(O[_>7F4;WY*2+>32;^?$\:<0\]7?'>Q>8([X
MX@J/B&@M.7O>""QZQQ<S^.$Y0].9!U?7)A2./CS_2Q#=7'4NV?C)N._6HQDS
M"ID0"ZY?BPNQ8>$#A]B%[FI@:4'AADI=ELIXQ(F.?^3)&YC0HZC=1YMVBWOO
M6]H0G2'C%#A\U8\'AM#[<&3<K)57Q>A-QZ!S/"9S`1>2"+V4_Y#JOVR>M)=N
M]).X]"T<_A:.D1P5\QLPA0F%M6)1!:.$=FA<64"=59?BGP&;1]I[?BG1DOQB
MWG0FR'-7K4>43',`N%*"I-C0\)G0ALQD0^`=-0@5-U@8\_>"_\J0@>A6@7OL
M9\OPCINFQOETWSCW(45$V.">`YX&>%S.4N03QJHI.-L7!0,*Y`SJ;C$=$D\!
M??QWRR!/&*>&^N6^H.X(]5UIPJ4'Q@JHX[];!G7".#74K_8%=:AV5ZA#@7<E
MIBT/G^%"^P1-RED&O<98-06O]T5!UZ?2T$O$'.#]`0'5AW>MJ&5$Z$U6<_'S
MGMV!3*<$WW'B?+^;".-9S^=R*2-#I-XWTAI9QH\)#&JFWNR7J;X_])!SZ1&0
M7*>H9:SD(6:D&O:W^X7]$GF0=H7#C@G5/RWB4E9"GS!4L]HZV7-X"J/G+9P1
MRN6L30#I,WU@4HM;R8?.=`TQ>UL'A]K]2CQ?H$C#VT;/2%+.2BHVC-5PL+<U
M<JC6;]#S/F-RC^\@8`1#]XHQ'U(M%SIY*SG1&J_A9F^+YY5)CS.^2W%%Y2$Z
M2<OXT!JL86)O:^NX8N$6BQD745FKV8@9K>%CO0!_W]HP\EI<*"2E\6_P@-@5
MYI!B$"IPA9V/P)-)D[L)A)QMF]`PZ'E?Z0P#58I)9L3Z;*>D+S2".[G?"+!A
M<"?[K#D&8!8`T8(>9ZLK@<(19UQ>_M9A3*BA45<C5*'[I:,L'4YG6$FIBEV1
M7TXIC0A(REK$PX:9)64TMJ>C"]A$!'7YU\6?/IH#3^C+.KP+*%V(N?ZOP/.3
MFV+YVEI!ER$,^FQ(0Y@V@H)M]SH$2:MZH+<(S`P&DK7P0Q/_LX/(A%DEY51V
MA3T5;YN`3DNEY'4)PH%7J4M<(S!$'N((,A$+@BW8"?&$/4S&!+[(>%H9-[>"
M7W,P2LKD%,*CV3PCI8%M7!G..';.[>P0`1V'^.+AV@<+,/2@N+G$%>J+*+%A
MA2Y,YNC!"OYR05)@"DB]I%O6G:ZT4:SEDA*U!EEI4H$)'0V((8'!$APRGH*E
M6K#^D&H,+"M;4^3CP/@Q4&\:T@Q,R<WL<5ZF]HUK@L<#2*<1O=-VCE+%:TU0
MMK%EI6^V]Y8;PG6A7RE2:P+41A69EU'?X8/`9S:95]S=6M%:`YMN9%GIED*>
M`=G!O][0*TW*2JCL'_'<RV?;%\SYE\CM"M?(_=4<(%`[;9=7)6D%(4H3-4Q4
MN!Z.%/RE;K8GQ:S@8-,X#0$%KE^#T?0+KMC/M09QTQ@->#L7(NZPF^.Z*%2G
M#Y!8#7;!#'&0?%4C2[K6-&2:JDGJ5;CDO84<(`S="T`QPF,F%NO^U/<`A^XY
M'"$'Z1["!@VMX,H$``UM%>;&-Z<0QG,E.VA1&:BAX?0I9I"VS!S906ZV\1JJ
MSRHK^Y*5S%#6J+'>J#>#-#Q;H=#Z+\T0E1:":70J:OJEZCQE?R^C066/T#G$
MOG:[8/USA:YIAG3\L;@RJG9U85W"N(P;%P\SB!G,JLW3BEO%A][HVA6*?8)8
M6.3)W*0[13@X#X&C.5RJKJ$IJY55;&5"4-++\MN3UN,32)=JIQ.EDK2*'*6I
MM2O_6MJ"QRN/U]&Q(6<7&9MFEO3*_?94B'D0F<)KPMBEL+1+L-#7%RH_6JCA
MQJ"A5629`%&[&J]5W4%Z5$M*6<9+PL3:E7*=PZ'H^1:*Q@"COP*3KH25[!-`
M6-Y0/7P'.?<"NX79,D1W/8"F[`;RMH:S'3NUBN)=`2R]%NP28;'Z1\&J400)
MM;>E"%K!1IJAI1>*]2F9(WEHY"6AX=@#\*"L%-!)6H.QUM3ZU8P)]WI\+.K*
M8&(R5K"@,:^L%_FWQW^U;]^'-#@%Y2-@R!$+KW/D^1RZ&9L#IJVMXLP8DOK5
ME&6HOAV+3XJ]\@X+V)ZUWZ`\5UC<67-AX!C>^-,AI+W1QJE$&<Z8NQNK>,T/
M4OV*X])LB)A@YK5;=O9D2$\#K';''D1-E^^^7GKDOKSTU^,(M<E^/:I45<9_
MJ4M$E<PZR90FU4V7I2[!!%_0]7'QE<E70];;@!V'HWF8&4XW;HN.*HH<>1A,
M3+US0U5@LDZ]"!5**18ZT5\L03EF3($Y--V++"S8J>EAN9'SN%.CP%$K:A&P
M>G-KE_CJN/_S&0^"_(#<0H=@!WDPMNP=D&)"5BE#67)7E`MW@=D[M?]>!=]5
M6;_#J'#;I(0EO"B-JV,&CD+`X#D,_[["B1>A]0FXC':6T)0#B!HFX!0Z)]Y9
MS\-?LNE3H'`#CMIE\,QGHSM/V&UC-`\T)1W+73BO5W@N'@4%+,C2.GH:/*="
M5=)YX/O@>V>>GRZ_-4U$JK1?IJMW=^2TCIX&T:E0%9GY3#]-1]96W<+@#:0^
MH)K#`%*$+2$CR^0BDY.Z@@HDZ)[)M_06(-SF#?8KE!45&E&+P-:;6_XQ%\+5
M'`A=R?,=\*#0]O%U7W4!BU[<*LC3S*Y??L\\,.[\[+"%QFV@J=\9&^I3:\.3
MUI,+4@VUN;JPC-Q\\!1Y1H<Z7*KU^0C'",O:D-XH5$T1.4U;6D)0+C!23NS(
M^7[P+.A1*$EYH>>9J4VYP&YN1J-MK.<R!D#*L1];L2@Z+Y3#&X*E^@,*,!,6
MHM1/,:<(6\1:FLE%'C2B.2)-#CN293-=(I;B8GDP]*`\IRVQ:E@,R%=,LQ9.
MN_1F$64[@5;D,259G&J6@$F]D@<B;-F)E0R:0Y1U4$F996/GB#D>83X-;K/V
M8`*[4AXOMJT2TW>XKZ(PO085O46UUF<@3/LH1OJ>L9>7UJ*J-2;@0IUH`:5N
M+;DI6+'[&N`?6S(J+,THT-J?@YY^(F+R+!X.#J2X&!>-=UF-D\9U.+CI]O6F
M_E!6)W,$O'/B#WEG2'P>!7>MJ:[ZU+P#N]PZ#S*U<?>SS5.6BG%Z5<?5N+Y*
MDT,`*/"(.0FR0E%M];EI>\O<WQR7VGC_R]BRX7$9S\2/2TGH7G@,WD\@A<4$
MAIQC5A,S<BIY""<[G)*F!MH\H.3IP:Z0D@N;V@255]%O)103,^)=5A,2XCH<
M/'[[(TZ7'WR0-099OJV6M<N+-?;6QE]?1T[2*,9=8SU6XZTQ%0[.NN,99P)&
M\^=Q:A.[7#?=^MIX\,^K3(!\=>IQRE",,^LZK\:O==H<7'S[!?V$4+YZ0)U#
MYE`4W-.Z];M.W"[7UEM=&[=^(W<4X9^^&.9B+NLABG'HS6ZK<>5-/0Y.O-.V
M?!1+DUUXM;QE;JRWNS9^'$D0?V6P-[I@'$V!7$P2#SFHJ%EW]C"5Y\<U>E7C
M,L'P"U.?UTE7Y.]Q)#4Z)X0J]NP,O*->G;2NCJZLJ0TNRZ4SAJO<M3/T.[AX
M4;7Y<27S%>4GVMH3$`RQJ&.<Z%,R@V*)*C_2(52?R3*_TJ)$ZF"5QXA4[0X1
M(K_R2SS['L!\`]3,(&'<W)XX88Y('4.%_,!I,%1O)),&UV@.W0YCL,1IA<&0
ME8<-`QT/P:.XX"$/'66]T1KUO-%CH_T3"!^;F-0Q?@0E2$)5Z,H+$+-@W-)B
M1\9PE<>-#/T.,6.+5$%X\'@<T5[@!<)=KK`C6!;A6?K/<G:NS2+D[\F>.+(5
M3G6,*,M3Y!`>7Q+:&WIHO#S;6AHA[/>GX3J,PZ#NV5L,R$<8GNLI!"*NV+L/
M3S<H+1B5IVGE<:P\TPXA,/^N3,2AEQGHX!N<AOLRAJWM"77&>-0QO%T"1.6<
M#O9&D<\W15RJI&!E.F[EH<=4T4,@R:V\";2ZV9-96WN"B"$6M0XA7R"0/^\I
M<"A'JT^X4*IW"!+;!XD(H*&*9O,-\_86!HML3.H8,"+?\5J>^B87BZ5%C(SA
M*@\9&?H=8D9NY9,?BC.+%%FM[(D/F?;7,2I$7E<H+12HQJC<_U5*'9Q^^_<T
MS+Q=*VZ/F^LMKJ-_?Y4G0'"`<*`P0\$&7GGUGZFC5>[SZ>H=O'][[U\C*P]L
M2]U"2&UB81106E['2'`+9?+G<4^_3PD6_W1*WCDP'+;RV&"HYR%(Y%;^!MZG
MPFJXI9"[&WN"27Z$ZAA@E)MPZXMAX=3R)[>'_^5C>'8BNY??&1;.)[]$?-86
M%UX.Y$D'>]K#W$&_RD-6T095$QZ"P=>W]IT_FX7?YLP(<IG-JMXY3>(O'C`^
MI<N/:V>^)Y>[FXJCG2F+R@U58ZAJ$_;RG=-TYTR@Z\OO;>B:%1GR2M+-A@.Q
MC(TYA+HBJO+,T,Y\)3AO-Q:&NOQ0U2;414^T>33C?/GA`W$YC-Y%1K!\0U9_
MT$^VCH=X4VB\V8!93&DCGZO-&7;R]69U],D)W-9!:/F+_&,(&!17_@]02P,$
M%`````@`NUX'1PHEY??M"```6$L``!$`'`!Z>'-I+3(P,34P-C,P+GAS9%54
M"0`#D=3$59'4Q%5U>`L``00E#@``!#D!``#M7%MOX[H1?CX%^A_8/-1[@/@6
M)]DD3?8@UT7.R<9&XBU.6Q0+6J)LXLBDEZ22N+^^,]3%LF,QTFZV,0KMPT82
MAS/?Z.,,;Z*/?WF:AN2!*<VE.&ET6YT&8<*3/A?CDP;7LGEPL'?8[#9^^?#G
M/QW_I=DD`R7]R&,^&<W)Y<7'TSL=<<.(EH%YI(IMDU/_@0H4.)?36628(M="
MR`=JP(+>AANOM0UEL[GBXXDA[\Y_)CN=SD%SI]/=(_\:#'[_=/!;]_"W;J^W
M>_N/\].[F[U_M\CCXV.+^6.JK+66)Z>DV41(VINP*27@A=`GC8DQLZ-V&Z4?
M>RVIQFU0W6W__NGFWLHU8L&C2#?'E,ZR"@'5(RN>%+013+/3;?:Z:96`AYFX
MS]24`H89.(Q8K'AGO]=)A7W&,^&GD0I;FGFML7R`FAR%=Y=U/X5<_+$.???P
M\+!M2S-1T.:;9>6)GWOMN+!!#%5C9F[IE.D9]5AYW,]PY/7WVE@\HIKEP7"'
M/!?:8%N`-A6R*1/F2JKI!0MH%((+7R,:\H`SOT&H,8J/H+$L"41B(0)<_W1,
MH2$9VY#P%NYG,RX":6]^.D9T1RG$.Q80^^*.S'S&3K8TG\Y"MI4\FR@6G&S]
MYTGS9OH*OLS@G8!;J8B2(50K=`V+VU!%@U<6T<W"<*J"*N^9EF?$@A(Y8\IP
MIK/WN]5^'9=\%E1U":IPP3?5H9".JCH$55BXB;YX-*SJ"U3QHO`'-S?4,00?
M"%Y\OKO.]!5FCQ@<]]67"ZZ]4.I(L5MI6._>2.^/B0RAIK[\"IE[OD6X?[)5
M3C0&E:!:M,L/'?CWOD.:9*$";E`+Z;5(7M%?Z4SJOY%8WW%[55%>?Z29WQ<?
M[/5J6"<U$Y&B6LN14Z[."J%K*B6/4E)>BZA_TB>NKP7TSL):IR'TR_?@LDW3
MNA_TH9'$7?:"LBJ57.3UD+RL'EQ;Q61)LQTGY,4TD0%9&*C9+`R[G8\21F_G
M$CI>)8H";EG(Q=;^^E#;:1&K@B0Z:D(*"7F?#(GU4-XQ@,/\`57%N;!(W$%2
MM[N>I/>M=#BNR5"21!VQ^FK"7LJ'9S3$5W<_8<R\E`:795WQM%,B^VVGZ2]1
M2V*]-66%,=8=3AA..*F8#^(1SOQ4^-CSS_`U#V3(/1CS%,5<V>JN&-Q;'X/=
M%@'E)-%^1%+]A`J?9!;(N]3&SS7+95C^K%D_N-2&3R&2=`5^"RJZF.V58Q8T
MXR`ETUUS6H;3W7PG-U14:.K9(1X4)I+,OPPU>YPPQ7`=QX]"H+"HVI".PN*&
M\(.L.5K/3L$`:K>UW!^3O%H4(1D>D@$Z(BDD;&F.^N]B8'7#*Y5,[*3Q#*;"
M/CY@\!H17(6D\H("5W(IF,JN)A=K@5@3)&^C3C)EN-Z'\92<LB%]8GH1U!<L
M8$HQ'QZ?:@T#+'?NJ*;$E1(*.-]OD=@$L3:6@SVU@V4DME1'>:4H+Q''SI%[
MJ0%>3449*JXH5W^G8<0^,8K%=H4G>QBW[J0(,/X:"=;KH'H8E%\PCTU'3/6Z
MN)'BCM@?:-$5WB5G`FB=6/,D#RI?L)U&>@J-0,9'<*37V29VRPRG$2E"TNO:
MI[MU9JC4''.)O4*GOZZ6JUGLE&L6^2Z@[MU??PKQ.E,#9T]Q\(I#_IKW,A%\
MZGDR$H:+\954_5'(Q_$^`:3O:Z&-BFQJ'4`E$*)A.!_*,W;/C`D9".0&\OU'
M88?:%?+`C[/MFC<4M+'5;+(`1P`=R<&S/4<.(,DAQ-7B,T82D(2+O-)X6TT3
M@)M,2^HL]6V[;.=43ZY"^5AEDVU1QY6!=K]YCPWU$VN@YK+4?++,=-$9R9U2
ML\&:C5++PK@9:2@7\,X&4EM_*JT..^N[1G=E%XE3`W8>GYFH4V@!T=*SO5/Z
M%W=EH(\R,/@.)-1&1#E:RTB[TF:\CYK4SE_:S1JKBN1TU525B4GL48`)_(/[
M70\TC,=#I8/R!06NW+I;+BIMIX<<VXN<D3HNRY!]<!^--/L:@=.7#_C:BDA]
M+N@BKV#"?-`B"S4DUE.34TC.'OZG!W2.*T)%Q"P+N5+DX7I2]EKV+\PB8ATU
M(652XQWSL)O*YF@#)05<>FQ:,4665.0:P)1,E;&E_+QRV5:=,2NV@4NJ!+Q&
M/6`*GDREN)^`E@K<OZ#`Q7G!=V.KG*<6")@@L0UBC=1DO\;&1P6NW?5=5!?,
M,DMN2M1$?RO1_>"*"RH\CBLYN=7`ZI2_H,DUDBKHM!WDRX!DUI96">N&4*TA
MX.NT>/K!C13C&_[`_'A3KT(;**'$17_!)TBK]&=6D'VTTPS14/:UP?\A\\?M
MW"$RN%DZ87;,IS.I#(D/&=Y(SY8X#KSA73,]]=;$1\WN3K/7;3UIOT'$LP-Y
MCB-S[:H`?*/:>/:H+2!0%??0_"&:[^Z7,K]:_WL02''[O2"D:'XSD-QA2`2P
M5V1Z[>G)V%IR8)$('H8XG3EI0`)D#6)/=S7LP<<C&`4Q0]7\VK`I-J@&T3`M
M-=Q$".VCDM$L%>4@TB#Q]0R<DO[0*HKI-FG1*/[<^Z3A*>9S>`R)H1'P\$OZ
M%7\RN8J=.6D\>[R9X#T/S/MV[X%IL^I#0>E&NC*$[!!B9AQ"CW##Z8B'',_2
MI<X4EV^D._%NXS(?R\^685/`H:AG4M@N-T`2I@S?X80?Q6>]%G!=R[JG";34
MC7*R&^7>TAF2[JI#1:4;Y<*:IO_,$;?,1KFS_G#CJD,O294/?9]Y?`JC^]?T
M(3=GP,W$RR?\=#B+]J+2M\4\4/*!XT]27$F5VT5-01<6ORWJ6V9NI,Y09K=O
MBPHQ?*1<],4%&YGXBPX$L@C'HO*WQ7UM?STD&Q>D<)\]?EN4Z0CL2LEI[ONQ
MW)#`)?'64<8A]&<TQ-X^SE^V#2S"K*C\K7%+CS$?7^@]Q4_PDU5/'+CD4H1#
MYG^)/QN+I?#7[V:>L3$7N,C:#P:V=NI):?$-=.I2^.7<61+<J"'`K12(-?>E
MYFKW[Y)X4TXLHH`I;/SB`7_T`VSCPL]**IH/Y6>AUB:O[U+QMEEB`;T@`Z]B
MGC]WNGQ-]/6X'2].P.5_`5!+`0(>`Q0````(`+M>!T=Q;/XQU5```&]Z`@`1
M`!@```````$```"D@0````!Z>'-I+3(P,34P-C,P+GAM;%54!0`#D=3$575X
M"P`!!"4.```$.0$``%!+`0(>`Q0````(`+M>!T>AD0&+5`,``/<3```5`!@`
M``````$```"D@2!1``!Z>'-I+3(P,34P-C,P7V-A;"YX;6Q55`4``Y'4Q%5U
M>`L``00E#@``!#D!``!02P$"'@,4````"`"[7@='N7!#+/X$``"B+@``%0`8
M```````!````I('#5```>GAS:2TR,#$U,#8S,%]D968N>&UL550%``.1U,15
M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`NUX'1Z;5C&\[%@``@!`!`!4`
M&````````0```*2!$%H``'IX<VDM,C`Q-3`V,S!?;&%B+GAM;%54!0`#D=3$
M575X"P`!!"4.```$.0$``%!+`0(>`Q0````(`+M>!T<7O&$RL0X``&?B```5
M`!@```````$```"D@9IP``!Z>'-I+3(P,34P-C,P7W!R92YX;6Q55`4``Y'4
MQ%5U>`L``00E#@``!#D!``!02P$"'@,4````"`"[7@='"B7E]^T(``!82P``
M$0`8```````!````I(&:?P``>GAS:2TR,#$U,#8S,"YX<V155`4``Y'4Q%5U
D>`L``00E#@``!#D!``!02P4&``````8`!@`:`@``TH@`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.2.0.727</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>83</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - Zaxis International, Inc. - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncBalanceSheets</Role>
      <ShortName>Zaxis International, Inc. - Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - Zaxis International Inc. - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfOperations</Role>
      <ShortName>Zaxis International Inc. - Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - Zaxis International Inc. - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_ZaxisInternationalIncStatementsOfCashFlows</Role>
      <ShortName>Zaxis International Inc. - Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000050 - Disclosure - Note 1. The Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompany</Role>
      <ShortName>Note 1. The Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000060 - Disclosure - Note 2. Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote2GoingConcern</Role>
      <ShortName>Note 2. Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000070 - Disclosure - Note 3. Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote3StockholdersEquity</Role>
      <ShortName>Note 3. Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000080 - Disclosure - Note 4. Related Party Transactions Not Disclosed Elsewhere</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhere</Role>
      <ShortName>Note 4. Related Party Transactions Not Disclosed Elsewhere</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000090 - Disclosure - Note 5. Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote5NotesPayable</Role>
      <ShortName>Note 5. Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000100 - Disclosure - Note 6. Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxes</Role>
      <ShortName>Note 6. Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000110 - Disclosure - Note 7. Advances To Related Party</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote7AdvancesToRelatedParty</Role>
      <ShortName>Note 7. Advances To Related Party</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000120 - Disclosure - Note 8. Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote8SubsequentEvents</Role>
      <ShortName>Note 8. Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000130 - Disclosure - Note 1. The Company: Use of Estimates (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUseOfEstimatesPolicies</Role>
      <ShortName>Note 1. The Company: Use of Estimates (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000140 - Disclosure - Note 1. The Company: Cash and Cash Equivalents (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyCashAndCashEquivalentsPolicies</Role>
      <ShortName>Note 1. The Company: Cash and Cash Equivalents (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000150 - Disclosure - Note 1. The Company: Property and Equipment (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyPropertyAndEquipmentPolicies</Role>
      <ShortName>Note 1. The Company: Property and Equipment (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000160 - Disclosure - Note 1. The Company: Valuation of Long-lived Assets (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyValuationOfLongLivedAssetsPolicies</Role>
      <ShortName>Note 1. The Company: Valuation of Long-lived Assets (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000170 - Disclosure - Note 1. The Company: Stock Based Compensation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyStockBasedCompensationPolicies</Role>
      <ShortName>Note 1. The Company: Stock Based Compensation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000180 - Disclosure - Note 1. The Company: Accounting For Obligations and Instruments Potentially To Be Settled in The Company's Own Stock (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyAccountingForObligationsAndInstrumentsPotentiallyToBeSettledInTheCompanySOwnStockPolicies</Role>
      <ShortName>Note 1. The Company: Accounting For Obligations and Instruments Potentially To Be Settled in The Company's Own Stock (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000190 - Disclosure - Note 1. The Company: Fair Value of Financial Instruments (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueOfFinancialInstrumentsPolicies</Role>
      <ShortName>Note 1. The Company: Fair Value of Financial Instruments (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000200 - Disclosure - Note 1. The Company: Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsPolicies</Role>
      <ShortName>Note 1. The Company: Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000210 - Disclosure - Note 1. The Company: Earnings Per Common Share (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyEarningsPerCommonSharePolicies</Role>
      <ShortName>Note 1. The Company: Earnings Per Common Share (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000220 - Disclosure - Note 1. The Company: Income Taxes (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyIncomeTaxesPolicies</Role>
      <ShortName>Note 1. The Company: Income Taxes (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000230 - Disclosure - Note 1. The Company: Uncertain Tax Positions (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyUncertainTaxPositionsPolicies</Role>
      <ShortName>Note 1. The Company: Uncertain Tax Positions (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000240 - Disclosure - Note 1. The Company: Recent Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyRecentAccountingPronouncementsPolicies</Role>
      <ShortName>Note 1. The Company: Recent Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000250 - Disclosure - Note 1. The Company: Fair Value Measurements: Fair Value, Assets Measured on June 30, 2015 and December 31, 2014 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote1TheCompanyFairValueMeasurementsFairValueAssetsMeasuredOnJune302015AndDecember312014Tables</Role>
      <ShortName>Note 1. The Company: Fair Value Measurements: Fair Value, Assets Measured on June 30, 2015 and December 31, 2014 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000260 - Disclosure - Note 4. Related Party Transactions Not Disclosed Elsewhere: Schedule of Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote4RelatedPartyTransactionsNotDisclosedElsewhereScheduleOfRelatedPartyTransactionsTables</Role>
      <ShortName>Note 4. Related Party Transactions Not Disclosed Elsewhere: Schedule of Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000270 - Disclosure - Note 6. Income Taxes: Schedule of Deferred Tax Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/20150630/role/idr_DisclosureNote6IncomeTaxesScheduleOfDeferredTaxAssetsTables</Role>
      <ShortName>Note 6. Income Taxes: Schedule of Deferred Tax Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>zxsi-20150630.xml</File>
    <File>zxsi-20150630_cal.xml</File>
    <File>zxsi-20150630_def.xml</File>
    <File>zxsi-20150630_lab.xml</File>
    <File>zxsi-20150630_pre.xml</File>
    <File>zxsi-20150630.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.2.0.727</span><table class="report" border="0" cellspacing="2" id="idm140344820316256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1. The Company: Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements:</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><i>Fair Value Measurements:</i>&nbsp;&nbsp; </p> <p>The Company measures fair value under a framework that utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of inputs which prioritize the inputs used in measuring fair value are:</p> <p><i>Level 1:</i> Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access. <i>Level 2:</i> Inputs to the valuation methodology include: - Quoted prices for similar assets or liabilities in active markets; - Quoted prices for identical or similar assets or liabilities in inactive markets; - Inputs other than quoted prices that are observable for the asset or liability; - Inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability. <i>Level 3:</i> Inputs to the valuation methodology are unobservable and significant to the fair value measurement.</p> <p>The assets or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. The following table presents assets that were measured and recognize at fair value on March 31, 2015 and the year then ended on a recurring basis:</p> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td width="100%" colspan="9" valign="top" style='width:100.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Fair Value Measurements at June 30, 2015</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Quoted Prices in Active</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant Other</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Markets for Identical Assets</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Observable Inputs</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Unobservable Inputs</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>Total</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 1)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 2) </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 3) </p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>None</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total assets at fair value</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> </tr> <tr align="left"> <td colspan="9" valign="top" style='padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp; &nbsp;</p> </td> </tr> </table> <p>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%'> <tr style='height:.75pt'> <td colspan="9" style='padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Fair Value Measurements at December&nbsp;31, 2014</p> </td> </tr> <tr style='height:.75pt'> <td style='padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Quoted Prices in Active</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant Other</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Significant</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Markets for Identical Assets</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Observable Inputs</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Unobservable Inputs</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" style='width:36.0%;padding:0;height:.75pt'></td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="top" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>Total</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="17%" valign="bottom" style='width:17.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 1)</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="12%" valign="bottom" style='width:12.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 2) </p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'></td> <td width="13%" valign="bottom" style='width:13.0%;border:none;border-bottom:solid black 1.0pt;padding:0;height:.75pt'> <p align="center" style='text-align:center'>(Level 3) </p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>None</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>-</p> </td> </tr> <tr style='height:.75pt'> <td width="36%" valign="top" style='width:36.0%;padding:0;height:.75pt'> <p style='margin:0in;margin-bottom:.0001pt'>Total assets at fair value</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="17%" valign="top" style='width:17.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="12%" valign="top" style='width:12.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> <td width="2%" valign="top" style='width:2.0%;padding:0;height:.75pt'> <p align="right" style='text-align:right'>$</p> </td> <td width="13%" valign="top" style='width:13.0%;border-top:solid black 1.0pt;border-left:none;border-bottom:double black 1.0pt;border-right:none;padding:0;height:.75pt'> <p align="center" style='text-align:center'>-</p> </td> </tr> <tr align="left"> <td colspan="9" valign="top" style='padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>When the Company changes its valuation inputs for measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it may need to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these transfers at the end of the reporting period that the transfers occur. For the fiscal periods ended Jun e30, 2015 and December 31, 2014, there were no significant transfers of financial assets or financial liabilities between the hierarchy levels.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
